This paper is in the following e-collection/theme issue:

Research Instruments, Questionnaires, and Tools (651)

Published on in Vol 23, No 7 (2021): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27633, first published .
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Authors of this article:

András Lánczky1, 2 Author Orcid Image ;   Balázs Győrffy1, 2 Author Orcid Image
Article Authors Cited by (979) Tweetations (7) Metrics

Journals

  1. Soares-Lima S, Gonzaga I, Camuzi D, Nicolau-Neto P, Vieira da Silva R, Guaraldi S, Ferreira M, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto L. IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 2021;11 View
  2. Mikaeili Namini A, Jahangir M, Mohseni M, Kolahi A, Hassanian-Moghaddam H, Mazloumi Z, Motallebi M, Sheikhpour M, Movafagh A. An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC). Scientific Reports 2022;12(1) View
  3. Nelczyk A, Ma L, Gupta A, Gamage H, McHenry M, Henn M, Kadiri M, Wang Y, Krawczynska N, Bendre S, He S, Shahoei S, Madak-Erdogan Z, Hsiao S, Saleh T, Carpenter V, Gewirtz D, Spinella M, Nelson E. The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868(11):166515 View
  4. Iqbal M, Ahmad N, Mirza Z, Karim S. Gene expression and survival analysis study of KIAA0101 gene revealed its prognostic and diagnostic importance in breast cancer. Vegetos 2023;36(1):249 View
  5. Nishimura T, Takadate T, Maeda S, Suzuki T, Minowa T, Fukuda T, Bando Y, Unno M. Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma. Scientific Reports 2022;12(1) View
  6. Wei M, Mo Y, Liu J, Zhai J, Li H, Xu Y, Peng Y, Tang Z, Wei T, Yang X, Huang L, Shao X, Li J, Zhou L, Zhong H, Wei C, Xie Q, Min M, Wu F. Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation. Frontiers in Oncology 2022;12 View
  7. Ucche S, Yokoyama S, Mojic M, Oki K, Ohshima C, Tsuihiji H, Takasaki I, Tahara H, Hayakawa Y. GSTA4 Governs Melanoma Immune Resistance and Metastasis. Molecular Cancer Research 2023;21(1):76 View
  8. Yang Y, Chen C, Zuo Q, Lu H, Salman S, Lyu Y, Huang T, Wicks E, Jackson W, Datan E, Wang R, Wang Y, Le N, Zhu Y, Qin W, Semenza G. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science Advances 2022;8(49) View
  9. Ma J, Song P, Liu X, Ma C, Zheng M, Ren X, Wang R, Liu W, Lu Z, Li J. Insights into the roles and driving forces of CCT3 in human tumors. Frontiers in Pharmacology 2022;13 View
  10. Zhang P, Zhao J, Chen L, Bian Z, Ju L, Wang H, Cai W. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. BMC Gastroenterology 2023;23(1) View
  11. Chen X, Han M, Li Y, Li X, Zhang J, Zhu Y. Identification of functional gene modules by integrating multi-omics data and known molecular interactions. Frontiers in Genetics 2023;14 View
  12. Ge Y, Zhang Y, Yang S, Liu T, Zhang T, Feng Y, Wang C, Liang G, Li Y. The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer. Journal of Oncology 2023;2023:1 View
  13. Purazo M, Ice R, Shimpi R, Hoenerhoff M, Pugacheva E. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers 2023;15(4):1119 View
  14. Song X, Li J, Pietras R. Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  15. Chen W, Wang H, Mi S, Shao L, Xu Z, Xue M. ALKBH1‐mediated m1A demethylation of METTL3mRNA promotes the metastasis of colorectal cancer by downregulating SMAD7 expression. Molecular Oncology 2023;17(2):344 View
  16. Shen C, Chang W, Chen Y, Weng C, Regmi P, Kier M, Su K, Chang G, Chen J, Chen Y, Yu S. Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma. Journal of Proteome Research 2023;22(4):1056 View
  17. Petkevicius V, Thon C, Steponaitiene R, Skieceviciene J, Janciauskas D, Jechorek D, Malfertheiner P, Kupcinskas J, Link A. Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer. Clinical and Translational Gastroenterology 2022;13(5):e00483 View
  18. Prieto‐Garcia C, Hartmann O, Reissland M, Braun F, Bozkurt S, Pahor N, Fuss C, Schirbel A, Schülein‐Völk C, Buchberger A, Calzado Canale M, Rosenfeldt M, Dikic I, Münch C, Diefenbacher M. USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. Molecular Oncology 2022;16(17):3082 View
  19. Zhao Y, Zuo J, Shen Y, Yan D, Chen J, Qi X. Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis. Symmetry 2022;14(7):1403 View
  20. Zhang J, Li Y, Zou J, Lai C, Zeng T, Peng J, Zou W, Cao B, Liu D, Zhu L, Li H, Li Y. Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance. Frontiers in Oncology 2022;12 View
  21. Qi Y, Zhang C, Wu D, Zhang Y, Zhao Y, Li W. Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells. Pharmaceuticals 2022;15(10):1257 View
  22. Beltrán-Navarro Y, Reyes-Cruz G, Vázquez-Prado J. P-Rex1 Signaling Hub in Lower Grade Glioma Patients, Found by In Silico Data Mining, Correlates With Reduced Survival and Augmented Immune Tumor Microenvironment. Frontiers in Oncology 2022;12 View
  23. Gao S, Zhang H, Lai L, Zhang J, Li Y, Miao Z, Rahman S, Zhang H, Qian A, Zhang W. S100A10 might be a novel prognostic biomarker for head and neck squamous cell carcinoma based on bioinformatics analysis. Computers in Biology and Medicine 2022;149:106000 View
  24. Han M, Li Y, Guo Y, Zhu W, Jiang J. Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors. International Journal of Molecular Sciences 2022;23(22):13998 View
  25. Wang M, Qiu Z, Wang Y, Lian B, Bai J, Zhou Y, Ji H. Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma. BMC Cancer 2023;23(1) View
  26. Criscuolo D, Avolio R, Parri M, Romano S, Chiarugi P, Matassa D, Esposito F. Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer. Antioxidants 2022;11(8):1544 View
  27. Zhang Z, Wang Z, Liu Y, Zhao L, Fu W. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Journal of Environmental Pathology, Toxicology and Oncology 2023;42(2):11 View
  28. Wang L, Zhao J, Zhu C, Yang K, Zhu L, Liu Y. Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma. Genes 2022;13(5):785 View
  29. Raivola J, Dini A, Karvonen H, Piki E, Salokas K, Niininen W, Kaleva L, Zhang K, Arjama M, Gudoityte G, Seashore-Ludlow B, Varjosalo M, Kallioniemi O, Hautaniemi S, Murumägi A, Ungureanu D. Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention. Cell Death & Disease 2022;13(8) View
  30. Liu K, Cui L, Li C, Tang C, Niu Y, Hao J, Bu Y, Chen B. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker. Frontiers in Genetics 2022;13 View
  31. Hu Y, Xie Q, Wu X, Liu W, Li D, Li C, Zhao W, Chen L, Zheng Z, Li G, Guo J. Tension of plus-end tracking protein Clip170 confers directionality and aggressiveness during breast cancer migration. Cell Death & Disease 2022;13(10) View
  32. Stafford M, McKenna D. MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. International Journal of Molecular Sciences 2023;24(3):1824 View
  33. Liu Y, Fang Y, Bao L, Wu F, Wang S, Hao S. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. Biomolecules 2022;12(10):1478 View
  34. Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M, Dutt A. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. Breast Cancer Research 2022;24(1) View
  35. Xu Y, Zhang M, Shi Q, Cheng X, Du R, Li C, Zhang Y. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis. European Journal of Medical Research 2023;28(1) View
  36. Matassa D, Criscuolo D, Avolio R, Agliarulo I, Sarnataro D, Pacelli C, Scrima R, Colamatteo A, Matarese G, Capitanio N, Landriscina M, Esposito F. Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells. Cancer Cell International 2022;22(1) View
  37. Zhang X, Zhang Q, Liu G. Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance. Frontiers in Genetics 2022;13 View
  38. Sudha B, Swathi K, Suganya K, Poornima A, Senthil Kumar N, Sumathi S. Identification of Key Candidate Genes in the Progression of Cervical Cancer: An in Silico Analysis. Indian Journal of Gynecologic Oncology 2022;20(4) View
  39. Eid R, Soltan M, Eldeen M, Shati A, Dawood S, Eissa M, Zaki M, Algahtani M, Theyab A, Abdel-Daim M, Kim B. Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. International Journal of Molecular Sciences 2022;23(22):14102 View
  40. Ji K, Dou W, Zhang N, Wen B, Zhong M, Zhang Q, Xu S, Zhou J, Liu J. Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells. Cell Biology International 2023;47(1):144 View
  41. Madgwick S, Luli S, Sellier H, Butterworth J, Leslie J, Moore A, Corbin E, Yemm A, Chiremba R, Tiniakos D, Oakley F, Perkins N, Hunter J. Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential. Biochemical Journal 2022;479(19):2115 View
  42. Benwell C, Johnson R, Taylor J, Price C, Robinson S. Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis. Cancer Research Communications 2022;2(12):1626 View
  43. Huang P, Xia L, Guo Q, Huang C, Wang Z, Huang Y, Qin S, Leng W, Li D. Genome-wide association studies identify miRNA-194 as a prognostic biomarker for gastrointestinal cancer by targeting ATP6V1F, PPP1R14B, BTF3L4 and SLC7A5. Frontiers in Oncology 2022;12 View
  44. Yang Y, Qiu R, Zhao S, Shen L, Tang B, Weng Q, Xu Z, Zheng L, Chen W, Shu G, Wang Y, Zhao Z, Chen M, Ji J. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells. BMC Biology 2022;20(1) View
  45. Le Noci V, Bernardo G, Manenti G, Infante G, Khaleghi Hashemian D, Minoli L, Canesi S, Bianchi F, Triulzi T, Arioli S, De Cecco L, Guglielmetti S, Ambrogi F, Recordati C, Gagliano N, Tagliabue E, Sommariva M, Sfondrini L. Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model. International Journal of Molecular Sciences 2022;23(21):12748 View
  46. Liu Q, Xie R, Li Y. Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival. International Journal of Molecular Sciences 2022;23(17):9611 View
  47. Ye S, Li S, Qin L, Zheng W, Liu B, Li X, Ren Z, Zhao H, Hu X, Ye N, Li G. GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling. Oncology Reports 2023;49(3) View
  48. Shi S, Chen H, Wang H, Wan J, Shi Y, Li J, Wang S, Shi J, Lv J, Wu T, Wang L, Sun F. Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis. Journal of Cancer Research and Clinical Oncology 2023;149(7):3349 View
  49. Wang S, Fu Y, Kuerban K, Liu J, Huang X, Pan D, Chen H, Zhu Y, Ye L. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. Frontiers in Immunology 2022;13 View
  50. Liu X, Chipurupalli S, Jiang P, Tavasoli M, Yoo B, McPhee M, Mazinani S, Francia G, Kerbel R, Rosen K. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth. Cell Death & Disease 2022;13(8) View
  51. Magallanes-Garza G, Santuario-Facio S, Lira-Albarrán S, Varela-Varela A, Cardona-Huerta S, Ruiz-Flores P, Haro-Santa-Cruz J, Perez-Paramo Y, Gomez-Macias G, Davila-Gonzalez D, Valero-Gomez J, Borrego-Soto G, Rojas-Martinez A, Ortiz-Lopez R, Li T. NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer. Journal of Oncology 2022;2022:1 View
  52. Wang R, Bhatt A, Minden-Birkenmaier B, Travis O, Tiwari S, Jia H, Rosikiewicz W, Martinot O, Childs E, Loesch R, Tossou G, Jamieson S, Finkelstein D, Xu B, Labelle M. ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis. Science Advances 2023;9(1) View
  53. Dwivedi K, Rajpal A, Rajpal S, Agarwal M, Kumar V, Kumar N. An explainable AI-driven biomarker discovery framework for Non-Small Cell Lung Cancer classification. Computers in Biology and Medicine 2023;153:106544 View
  54. Ko C, Chu T, Hsu C, Chen H, Huang S, Chang C, Tzou S, Chen T, Lin C, Shih P, Lin C, Chang C, Lee Y. Bioinformatics Analyses Identify the Therapeutic Potential of ST8SIA6 for Colon Cancer. Journal of Personalized Medicine 2022;12(3):401 View
  55. Chang Z, Duan Q, Yu C, Li D, Jiang H, Ge F, Xu G. Proteomics and Biochemical Analyses of Secreted Proteins Revealed a Novel Mechanism by Which ADAM12S Regulates the Migration of Gastric Cancer Cells. Journal of Proteome Research 2022;21(9):2160 View
  56. Bacon S, Seeneevassen L, Fratacci A, Rose F, Tiffon C, Sifré E, Haykal M, Moubarak M, Ducournau A, Bruhl L, Claverol S, Tokarski C, Gouloumi A, Pateras I, Daubon T, Lehours P, Varon C, Martin O. Nrf2 Downregulation Contributes to Epithelial-to-Mesenchymal Transition in Helicobacter pylori-Infected Cells. Cancers 2022;14(17):4316 View
  57. Cai Y, He Q, Liu W, Liang Q, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Peng J, Xu Z, Bai N. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Frontiers in Oncology 2022;12 View
  58. Zhang X, O’Brien D, Zhang X, Hussain T. Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  59. Ramos E, Tsai C, Jia Y, Cao Y, Manu M, Taftaf R, Hoffmann A, El-Shennawy L, Gritsenko M, Adorno-Cruz V, Schuster E, Scholten D, Patel D, Liu X, Patel P, Wray B, Zhang Y, Zhang S, Moore R, Mathews J, Schipma M, Liu T, Tokars V, Cristofanilli M, Shi T, Shen Y, Dashzeveg N, Liu H. Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. eLife 2022;11 View
  60. Schossig P, Coskun E, Arsenic R, Horst D, Sehouli J, Bergmann E, Andresen N, Sigler C, Busse A, Keller U, Ochsenreither S. Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences 2023;24(3):2292 View
  61. Boyero L, Noguera-Uclés J, Castillo-Peña A, Salinas A, Sánchez-Gastaldo A, Alonso M, Benedetti J, Bernabé-Caro R, Paz-Ares L, Molina-Pinelo S. Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers 2023;15(5):1466 View
  62. Kamran M, Bhattacharya U, Omar M, Marchionni L, Ince T. ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin. npj Breast Cancer 2022;8(1) View
  63. O’Connor G, Bakker E. Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma. BioMedInformatics 2022;2(4):580 View
  64. Karim S, Iqbal M, Ahmad N, Ansari M, Mirza Z, Merdad A, Jastaniah S, Kumar S. Gene expression study of breast cancer using Welch Satterthwaite t-test, Kaplan-Meier estimator plot and Huber loss robust regression model. Journal of King Saud University - Science 2023;35(1):102447 View
  65. Gao L, Ren R, Shen J, Hou J, Ning J, Feng Y, Wang M, Wu L, Sun Y, Wang H, Wang D, Cao J. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer 2022;22(1) View
  66. Sibilano M, Tullio V, Adorno G, Savini I, Gasperi V, Catani M. Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay. International Journal of Molecular Sciences 2022;23(10):5484 View
  67. Song J, Lin Z, Liu Q, Huang S, Han L, Fang Y, Zhong P, Dou R, Xiang Z, Zheng J, Zhang X, Wang S, Xiong B. MiR‐192‐5p/RB1/NF‐κBp65 signaling axis promotes IL‐10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment. Clinical and Translational Medicine 2022;12(8) View
  68. Mu L, Hu S, Li G, Wu P, Ren C, Lin T, Zhang S, Liang S. Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  69. Rasha F, Boligala G, Yang M, Martinez-Marin D, Castro-Piedras I, Furr K, Snitman A, Khan S, Brandi L, Castro M, Khan H, Jahan N, Almodovar S, Melkus M, Pruitt K, Layeequr Rahman R. Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer. BMC Cancer 2023;23(1) View
  70. Carmona-Rodríguez L, Martínez-Rey D, Martín-González P, Franch M, Sorokin L, Mira E, Mañes S. Superoxide Dismutase-3 Downregulates Laminin α5 Expression in Tumor Endothelial Cells via the Inhibition of Nuclear Factor Kappa B Signaling. Cancers 2022;14(5):1226 View
  71. Wong K, Bateman N, Ng C, Tsang Y, Sun C, Celestino J, Nguyen T, Malpica A, Hillman R, Zhang J, Futreal P, Rojas C, Conrads K, Hood B, Dalgard C, Wilkerson M, Phippen N, Conrads T, Maxwell G, Sood A, Gershenson D. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. Journal of Translational Medicine 2022;20(1) View
  72. Shen X, Mo X, Tan W, Mo X, Li L, Yu F, He J, Deng Z, Xing S, Chen Z, Yang J. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Pathology and Oncology Research 2022;28 View
  73. Luo M, Zhou Y, Gu W, Wang C, Shen N, Dong J, Lei H, Tang Y, Liang Q, Zou J, Xu L, Ma P, Zhuang G, Bi L, Xu L, Zhu L, Chen H, Shen Y. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer Research 2022;82(19):3516 View
  74. Zhang R, Zhao J, Zhao L. TRKB acts as a prognostic predictive marker in Her-2 positive breast cancer. Annals of Diagnostic Pathology 2022;60:152017 View
  75. Allameh A, Hüttmann N, Charlebois E, Katsarou A, Gu W, Gkouvatsos K, Pasini E, Bhat M, Minic Z, Berezovski M, Guido M, Fillebeen C, Pantopoulos K. Hemojuvelin deficiency promotes liver mitochondrial dysfunction and predisposes mice to hepatocellular carcinoma. Communications Biology 2022;5(1) View
  76. Roblek M, Bicher J, van Gogh M, György A, Seeböck R, Szulc B, Damme M, Olczak M, Borsig L, Siekhaus D. The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis. Frontiers in Oncology 2022;12 View
  77. Luo Q, Li J, Su X, Tan Q, Zhou F, Xie S. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer. Frontiers in Genetics 2022;13 View
  78. dos Santos E, Petrone I, Binato R, Abdelhay E. Iroquois Family Genes in Gastric Carcinogenesis: A Comprehensive Review. Genes 2023;14(3):621 View
  79. Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, Zi Y, Gao J, Mu Y, Guan Y, Cao Z, Wang X, Pei Q, Zeng Y, Fan Q, Zeng Z, Ou D, He J, Nie Y, Tan R, Weng L, Li Y, Xiang R, Deng Y, Sun L. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling. Oncogene 2022;41(16):2390 View
  80. Meng L, Zhang L, Xu W. Paxillin is a potential prognostic biomarker associated with immune cell infiltration in ovarian cancer. Heliyon 2023;9(3):e14095 View
  81. Fang X, Zhang T, Chen Z. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma. International Journal of General Medicine 2023;Volume 16:481 View
  82. Dai Y, Kawaguchi T, Nishio M, Otani J, Tashiro H, Terai Y, Sasaki R, Maehama T, Suzuki A. The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor. Genes to Cells 2022;27(11):633 View
  83. Duan Y, Du Y, Gu Z, Zheng X, Wang C. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2022;23(18):10316 View
  84. Luo D, Zeng X, Zhang S, Li D, Cheng Z, Wang Y, Long J, Hu Z, Long S, Zhou J, Zhang S, Zeng Z. Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF‐β/SMAD pathway. Journal of Cellular and Molecular Medicine 2023;27(3):456 View
  85. Yang J, Wang Y, Ge R, Jia X, Ge C, Cen Y, Pan D. Overexpression of Copines‐1 is associated with clinicopathological parameters and poor outcome in gastric cancer. Journal of Clinical Laboratory Analysis 2022;36(11) View
  86. Weber F, Schueler-Toprak S, Buechler C, Ortmann O, Treeck O. Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling. Diagnostics 2023;13(5):944 View
  87. Ding J, Yu X, He J, Chen D, Guo F. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity. Frontiers in Genetics 2022;13 View
  88. Skov N, Alves C, Ehmsen S, Ditzel H. Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 2022;23(17):10053 View
  89. Alessandro L, Low K, Abushelaibi A, Lim S, Cheng W, Chang S, Lai K, Sum Y, Maran S. Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer—An Integrated in Silico Approach. International Journal of Molecular Sciences 2022;23(22):14285 View
  90. Bae E, Byun W, Ock C, Kim W, Park H, Lee S. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Biomedicine & Pharmacotherapy 2023;157:114039 View
  91. Tan X, Liu Z, Wang Y, Wu Z, Zou Y, Luo S, Tang Y, Chen D, Yuan G, Yao K. miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death & Disease 2022;13(9) View
  92. Bhattacharyya N, Khan M, Bagabir S, Almalki A, Shahwan M, Haque S, Verma A, Mangangcha I. Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer. Biotechnology and Genetic Engineering Reviews 2023;39(2):1273 View
  93. Yang Z, Wang H, Zhao Z, Jin Y, Zhang Z, Tan J, Hu F. Gene–microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer. Genes 2022;13(8):1480 View
  94. Ota K, Sakai S, Ohhata T, Suzuki T, Uchida C, Niida H, Kitagawa M. APOBEC3B expression is promoted by lincNMR collaborating with TGF-β–Smad pathway. Carcinogenesis 2023;44(1):1 View
  95. Zhang X, Xu H, Zhang Y, Sun C, Li Z, Hu C, Zhao D, Guo C. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer. Frontiers in Oncology 2022;12 View
  96. Duan H, Chen B, Wang W, Luo H. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. Aging 2023 View
  97. Hua T, Zhao B, Fan S, Zhao C, Kong Y, Tian R, Zhang B. Prognostic implications of PPL expression in ovarian cancer. Discover Oncology 2022;13(1) View
  98. Müller F, Lim J, Bebber C, Seidel E, Tishina S, Dahlhaus A, Stroh J, Beck J, Yapici F, Nakayama K, Torres Fernández L, Brägelmann J, Leprivier G, von Karstedt S. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death & Differentiation 2023;30(2):442 View
  99. Yue H, Tian Y, Wu X, Yang X, Xu P, Zhu H, Sang N. Exploration of the damage and mechanisms of BPS exposure on the uterus and ovary of adult female mice. Science of The Total Environment 2023;868:161660 View
  100. Ren Y, Chen B, Zhang M, Imran A. Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan‐Cancer Analysis. BioMed Research International 2023;2023(1) View
  101. Hao H, Guo Z, Li Z, Li J, Jiang S, Fu J, Jiao Y, Deng X, Han S, Li P. Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4. Phytomedicine 2022;106:154409 View
  102. Pescatori S, Leone S, Cipolletti M, Bartoloni S, di Masi A, Acconcia F. Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. Journal of Experimental & Clinical Cancer Research 2022;41(1) View
  103. Xiao Z, Feng X, Zhou Y, Li P, Luo J, Zhang W, Zhou J, Zhao J, Wang D, Wang Y, Tian Z, Zhao X. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma. International Journal of Nanomedicine 2023;Volume 18:95 View
  104. Acconcia F. Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers. International Journal of Molecular Sciences 2022;23(19):11102 View
  105. Harrod A, Lai C, Goldsbrough I, Simmons G, Oppermans N, Santos D, Győrffy B, Allsopp R, Toghill B, Balachandran K, Lawson M, Morrow C, Surakala M, Carnevalli L, Zhang P, Guttery D, Shaw J, Coombes R, Buluwela L, Ali S. Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene 2022;41(44):4905 View
  106. Wang Y, Chen S, Gu D, Yeh Y, Tsai J, Yang K, Jou Y, Chou T, Tang T. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis. Journal of Biomedical Science 2022;29(1) View
  107. Rabelo-Fernández R, Noriega Rivera R, Rivera Y, Tous-Beveraggi J, Valiyeva F, Vivas-Mejia P. Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells. International Journal of Molecular Sciences 2022;23(23):14742 View
  108. Song Y, Wang Z, He L, Sun F, Zhang B, Wang F, Pan J. Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC. Journal of Oncology 2022;2022:1 View
  109. Yang H. Comprehensive Analysis of the Expression and Clinical Significance of a Ferroptosis-Related Genome in Ovarian Serous Cystadenocarcinoma: A Study Based on TCGA Data. Oncologie 2022;24(4):835 View
  110. Grajek J, Kather J, Poleszczuk J. An in silico model to study the impact of carbonic anhydrase IX expression on tumour growth and anti-PD-1 therapy. Journal of The Royal Society Interface 2023;20(198) View
  111. Amjad E, Sokouti B, Asnaashari S. An investigation of 6-Shogaol effects on MCF7 cell lines through a systems biology approach. Egyptian Journal of Medical Human Genetics 2022;23(1) View
  112. Han S, Jin X, Hu T, Chi F. LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway. Oncology Reports 2023;49(3) View
  113. Joshi V, Lakhani S, McCart Reed A. NDRG1 in Cancer: A Suppressor, Promoter, or Both?. Cancers 2022;14(23):5739 View
  114. Geoffroy K, Araripe Saraiva B, Viens M, Béland D, Bourgeois-Daigneault M. Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers. Scientific Reports 2023;13(1) View
  115. Xie D, Chen Y, Wan X, Li J, Pei Q, Luo Y, Liu J, Ye T. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer. Frontiers in Endocrinology 2022;13 View
  116. Wang H, Yuan H, Guo Q, Zeng X, Liu M, Ji R, Chen Z, Guan Q, Zheng Y, Wang Y, Zhou Y. A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression. Cancer Cell International 2023;23(1) View
  117. Zhao X, He Y, Wu Y, Liu T, Wang G. IOFS-SA: An interactive online feature selection tool for survival analysis. Computers in Biology and Medicine 2022;150:106121 View
  118. Yao Y, Ma W, Guo Y, Liu Y, Xia P, Wu X, Chen Y, Wang K, Mei C, Wang G, Li X, Zhang Z, Chen X, Yuan Y. USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. Oncogenesis 2022;11(1) View
  119. Özenver N, Efferth T. Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining. Pharmaceutics 2023;15(2):427 View
  120. Wang C, Jiang X, Qi J, Xu J, Yang G, Mi C. PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration. Frontiers in Genetics 2022;13 View
  121. Yang C, Song D, Zhao F, Wu J, Zhang B, Ren H, Sun Q, Qin S. Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer. Frontiers in Oncology 2022;12 View
  122. Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, Wei B, Eckel-Mahan K, Lorenzi P, Lehner R, Sun K. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight 2023;8(2) View
  123. Talebi A, Rokni P, Kerachian M. Transcriptome analysis of colorectal cancer liver metastasis: The importance of long non-coding RNAs and fusion transcripts in the disease pathogenesis. Molecular and Cellular Probes 2022;63:101816 View
  124. Lodi M, Voilquin L, Alpy F, Molière S, Reix N, Mathelin C, Chenard M, Tomasetto C. STARD3: A New Biomarker in HER2-Positive Breast Cancer. Cancers 2023;15(2):362 View
  125. Shi Y, Zhang W, Dai P, Deng J, Tan L. Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma. Scientific Reports 2022;12(1) View
  126. Cai Y, Zeng R, Peng J, Liu W, He Q, Xu Z, Bai N. The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer. Aging 2022;14(17):7038 View
  127. Xiong F, Guo T, Wang X, Wu G, Liu W, Wang Q, Wang B, Chen Y, Muhammad N. Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma. Disease Markers 2022;2022:1 View
  128. Desai S, Dharavath B, Manavalan S, Rane A, Redhu A, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam M, Banerjee A, Prabhash K, Nair S, Dutt A. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 2022;4(1) View
  129. Cruz-De la Rosa M, Jiménez-Wences H, Alarcón-Millán J, Romero-López M, Castañón-Sánchez C, Salmerón-Bárcenas E, Fernández-Tilapa G. miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer. International Journal of Molecular Sciences 2022;23(13):6993 View
  130. Habiburrahman M, Sutopo S, Wardoyo M. Role of DEK in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review. Critical Reviews in Oncology/Hematology 2023;181:103897 View
  131. Reich L, Leal A, Ellsworth E, Liby K. The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice. International Journal of Molecular Sciences 2023;24(5):4298 View
  132. Baldavira C, Prieto T, Machado-Rugolo J, de Miranda J, da Silveira L, Velosa A, Teodoro W, Ab’Saber A, Takagaki T, Capelozzi V. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in Oncology 2022;12 View
  133. Qiu P, Jie Y, Ma C, Chen H, Qin Y, Tu K, Wang L, Zhang Z. Paired box 8 facilitates the c-MYC related cell cycle progress in TP53-mutation uterine corpus endometrial carcinoma through interaction with DDX5. Cell Death Discovery 2022;8(1) View
  134. Li H, Cheng F, Su X, Mao S. miR‐2392 serves as an immunological and prognostic biomarker in hepatocellular carcinoma. Liver International 2022;42(12):2923 View
  135. Yu Y, Yao W, Wang T, Xue W, Meng Y, Cai L, Jian W, Yu Y, Zhang C. FBXL6 depletion restrains clear cell renal cell carcinoma progression. Translational Oncology 2022;26:101550 View
  136. Xu Z, Peng B, Kang F, Zhang W, Xiao M, Li J, Hong Q, Cai Y, Liu W, Yan Y, Peng J. The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer. Frontiers in Cell and Developmental Biology 2022;10 View
  137. Regev O, Kizner M, Roncato F, Dadiani M, Saini M, Castro-Giner F, Yajuk O, Kozlovski S, Levi N, Addadi Y, Golani O, Ben-Dor S, Granot Z, Aceto N, Alon R. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells. Frontiers in Immunology 2022;13 View
  138. Gao E, Wang X, Wang F, Deng S, Xia W, Wang R, Wang X, Zhao X, Qian H, Sheikh N. Systematic Characterization of Expression Patterns and Immunocorrelations of Formin‐Like Genes in Breast Cancer. BioMed Research International 2022;2022(1) View
  139. Zhang W, Peng W, Li Y, Pan T, Feng F, Xu J, Zhou X, Kuo C. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  140. Bell H, Huber A, Singhal R, Korimerla N, Rebernick R, Kumar R, El-derany M, Sajjakulnukit P, Das N, Kerk S, Solanki S, James J, Kim D, Zhang L, Chen B, Mehra R, Frankel T, Győrffy B, Fearon E, Pasca di Magliano M, Gonzalez F, Banerjee R, Wahl D, Lyssiotis C, Green M, Shah Y. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metabolism 2023;35(1):134 View
  141. Tkacz M, Tarnowski M, Poniewierska-Baran A, Serwin K, Madej-Michniewicz A, Deskur A, Czerny B, Starzyńska T. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022;12(3):700 View
  142. Lee T, Lee K. ECM1 is associated with endocrine resistance in ER+ breast cancers. Animal Cells and Systems 2022;26(3):99 View
  143. James N, Woodman M, De La Cruz P, Eurich K, Ozsoy M, Schorl C, Hanley L, Ribeiro J. Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways. Frontiers in Immunology 2022;13 View
  144. Hao X, Zhang M, Gu M, Wang Z, Zhou S, Li W, Xu S. Long non-coding RNA BZRAP1-AS1 functions in malignancy and prognosis for non-small-cell lung cancer. PeerJ 2022;10:e13871 View
  145. Wang J, Xia W, Huang Y, Li H, Tang Y, Li Y, Yi B, Zhang Z, Yang J, Cao Z, Zhou J. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. Frontiers in Immunology 2022;13 View
  146. Xing J, Chen W, Chen K, Zhu S, Lin F, Qi Y, Zhang Y, Han S, Rao T, Ruan Y, Zhao S, Yu W, Cheng F. TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers 2022;14(19):4809 View
  147. Ren A, Li Q, Guo Y, Cui X, Wang L, Huo Y, Chen H, Liu H, Huang H. Low expression of lncRNA APTR promotes gastric cancer progression. Translational Oncology 2022;25:101506 View
  148. Chai C, Maran S, Thew H, Tan Y, Rahman N, Cheng W, Lai K, Loh J, Yap W. Predicting Deleterious Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) of HRAS Gene and In Silico Evaluation of Their Structural and Functional Consequences towards Diagnosis and Prognosis of Cancer. Biology 2022;11(11):1604 View
  149. Liu Y, Luo G, Yan Y, Peng J. A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values. Frontiers in Genetics 2022;13 View
  150. King L, Flaus A, Coughlan S, Holian E, Golden A. GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal. HRB Open Research 2022;5:8 View
  151. Liu J, Pan C, Lu R, Zhang S. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells. Bioengineered 2022;13(3):7868 View
  152. Li C, Wang J, Wang W, Xu D, Zhou Y, Sun F, Li Y, Guo F, Ma J, Zhang X, Chang M, Xu B, Ma F, Qian H. Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity. Military Medical Research 2022;9(1) View
  153. Noei-Khesht Masjedi M, Asgari Y, Sadroddiny E. Differential expression analysis in epithelial ovarian cancer using functional genomics and integrated bioinformatics approaches. Informatics in Medicine Unlocked 2023;37:101172 View
  154. Ren Z, Zhao Y, Wang G, Miao L, Zhang Z, Ma L, Teng M, Li Y. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis. Clinica Chimica Acta 2022;531:25 View
  155. Lee H, Chang C, Wu K, Chiang H, Chang Y, Liu L, Huang Y, Hung J, Hsu Y, Wu Y, Tsai Y. The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy. Journal of Personalized Medicine 2022;12(6):902 View
  156. Huang S, Luo Q, Huang J, Wei J, Wang S, Hong C, Qiu P, Li C. A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma. Frontiers in Genetics 2022;13 View
  157. Zhong Y, Li M, Guo S, Li M, Cao Z, Luo X, Liu J, Liang R, Shao Y, Yang Y, Chen X, Wei C, Ling W, Zhu X, Huang Y, Zhang J. Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment. Journal of Oncology 2023;2023:1 View
  158. Duan Y, Du Y, Gu Z, Zheng X, Wang C. Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. Frontiers in Molecular Biosciences 2022;9 View
  159. Timpanaro A, Piccand C, Uldry A, Bode P, Dzhumashev D, Sala R, Heller M, Rössler J, Bernasconi M. Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International Journal of Molecular Sciences 2023;24(3):2601 View
  160. Gao T, Zhao L, Zhang F, Cao C, Fan S, Shi X. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors. World Journal of Surgical Oncology 2022;20(1) View
  161. Pakrashy S, Mandal P, Nanda Goswami J, Dey S, Maiti Choudhury S, Bhattacharya B, Emmerling F, Alasmary F, Dolai M. Bioinformatics and Network Pharmacology of the First Crystal Structured Clerodin: Anticancer and Antioxidant Potential against Human Breast Carcinoma Cell. ACS Omega 2022;7(51):48572 View
  162. Shen Q, Wang R, Liu X, Song P, Zheng M, Ren X, Ma J, Lu Z, Li J. HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer. Cancers 2022;14(16):3855 View
  163. Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, Li D, Wang D, Yang Z, Chen H. Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma. Cancers 2022;14(24):6220 View
  164. Wang J, Wang Q, Guan Y, Sun Y, Wang X, Lively K, Wang Y, Luo M, Kim J, Murphy E, Yao Y, Cai G, Fan D. Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function. Journal of Clinical Investigation 2022;132(19) View
  165. Wang S, Chen Z, Lv H, wang C, Wei H, Yu J. LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Journal of Clinical Laboratory Analysis 2023;37(1) View
  166. Han X, Long W, Liu Y, Xu J. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. Frontiers in Surgery 2022;9 View
  167. Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X, Zhang Y. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Frontiers in Surgery 2022;9 View
  168. Tan K, Wang K, Zhao A, Liu Z, Song W, Cheng Q, Li X, Chen Z, Yuan Y, Yang Z. Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target gene. Medical Oncology 2022;40(1) View
  169. Wu Y, Zhou T, Qian D, Liu X, Xu Y, Hong W, Meng X, Tang H. Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer. ACS Omega 2023;8(2):2780 View
  170. Sucularli C. Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma. Cancer Genetics 2022;268-269:28 View
  171. Nagasaka M, Inoue Y, Yoshida M, Miyajima C, Morishita D, Tokugawa M, Nakamoto H, Sugano M, Ohoka N, Hayashi H. The deubiquitinating enzyme USP17 regulates c‐Myc levels and controls cell proliferation and glycolysis. FEBS Letters 2022;596(4):465 View
  172. Hegedüs L, Livingstone E, Bánkfalvi Á, Viehof J, Enyedi Á, Bilecz Á, Győrffy B, Baranyi M, Tőkés A, Gil J, Marko-Varga G, Griewank K, Zimmer L, Váraljai R, Sucker A, Zaremba A, Schadendorf D, Aigner C, Hegedüs B. The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition. International Journal of Molecular Sciences 2022;23(6):3324 View
  173. Jovanović M, Stanković T, Stojković Burić S, Banković J, Dinić J, Ljujić M, Pešić M, Dragoj M. Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life 2022;12(9):1291 View
  174. Schmitt M, Gallistl J, Schüler-Toprak S, Fritsch J, Buechler C, Ortmann O, Treeck O. Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response. Cancers 2022;14(17):4108 View
  175. Rutherford T, Elder A, Lyons T. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a. Cell Death & Disease 2021;12(10) View
  176. Min J, Ma J, Wang Q, Yu D. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription. Clinics 2022;77:100081 View
  177. Chen Y, Chen C, Chang C, Huang B, Chen Y. Clerodane diterpene induces apoptosis/anoikis and suppresses migration and invasion of human bladder cancer cells through the histone deacetylases, integrin–focal adhesion kinase, and matrix metalloproteinase 9 signalling pathways. Human & Experimental Toxicology 2022;41 View
  178. Alsina-Sanchis E, Mülfarth R, Moll I, Böhn S, Wiedmann L, Jordana-Urriza L, Ziegelbauer T, Zimmer E, Taylor J, De Angelis Rigotti F, Stögbauer A, Giaimo B, Cerwenka A, Borggrefe T, Fischer A, Rodriguez-Vita J. Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages. Cancer Research 2022;82(23):4414 View
  179. Mao J, Wang D, Xu P, Wang Y, Zhang H, Wang S, Xu F, Wang J, Zhang F. Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells. Journal of Medicinal Chemistry 2022;65(24):16451 View
  180. Yan D, Li C, Zhou Y, Yan X, Zhi W, Qian H, Han Y. Exploration of Combinational Therapeutic Strategies for HCC Based on TCGA HCC Database. Oncologie 2022;24(1):101 View
  181. Fang W, Gan Y, Zhang L, Xiong J. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma. Frontiers in Oncology 2022;12 View
  182. Lin C, Yu C, Liu C, Chao T, Huang C, Tseng L, Lai J. CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer. Clinical and Translational Oncology 2022;24(11):2120 View
  183. Zheng Y, Li J, Ning L, Xie N. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Breast Cancer: Targets and Therapy 2022;Volume 14:475 View
  184. Liao Y, Liao Y, Li J, Li Y, Fan Y. The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis. Breast Cancer: Targets and Therapy 2023;Volume 15:135 View
  185. He Y, Li Y, Xiang J, Huang X, Zhao M, Wang Y, Chen R. TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma. Frontiers in Genetics 2022;13 View
  186. Bai B, Liu Y, Fu X, Qin H, Li G, Wang H, Sun S, Cai L. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α). Oxidative Medicine and Cellular Longevity 2022;2022:1 View
  187. Shi H, Zhang Y, Wang Y, Fang P, Liu Y, Li W. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1. Toxicology and Applied Pharmacology 2022;439:115926 View
  188. Acevedo-Díaz A, Morales-Cabán B, Zayas-Santiago A, Martínez-Montemayor M, Suárez-Arroyo I. SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways. Cancers 2022;14(11):2807 View
  189. Huang S, Hou Y, Hu M, Hu J, Liu X. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma. BMC Cancer 2022;22(1) View
  190. Li Y, Liang X, Che G, Chen Y, Luo L, Liu K, Xie R, Zeng L. Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer. Biomolecules 2022;12(10):1533 View
  191. Duan Y, Du Y, Mu Y, Gu Z, Wang C. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma. Frontiers in Molecular Biosciences 2022;9 View
  192. Hong Y, Aziz N, Park J, Lee D, Kim J, Kim S, Choi W, Lee C, Lee H, Huyen Trang H, Kim H, Jeon Y, Kim B, Kim Y, Kim K, Yoo B, Han J, Parameswaran N, Kim J, Hur H, Cho J. The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer. Cancer Letters 2022;544:215803 View
  193. Yadav P, Sharma P, Chetlangia N, Mayalagu P, Karunagaran D. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells. Chemico-Biological Interactions 2022;368:110224 View
  194. Baczewska M, Supruniuk E, Bojczuk K, Guzik P, Milewska P, Konończuk K, Dobroch J, Chabowski A, Knapp P. Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications. International Journal of Molecular Sciences 2022;23(16):8968 View
  195. Li Y, Chen M, Chen Q, Yuan M, Zeng X, Zeng Y, He M, Wang B, Han B. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer. Advances in Therapy 2023;40(4):1456 View
  196. Donovan J, Deng Z, Bian F, Shukla S, Gomez-Arroyo J, Shi D, Kalinichenko V, Kalin T. Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1. Frontiers in Oncology 2023;13 View
  197. Chen Y, Liu R, Ying W, Yang Y, Xiang S, Shao X, Cao J, Zhang Y, Yang B, He Q, Ying M. Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells. Acta Pharmacologica Sinica 2023;44(3):661 View
  198. Liu Y, Hu Y, Deng L, Xu Y. The Underlying Roles of Exosome-Associated PIGR in Fatty Acid Metabolism and Immune Signaling in Colorectal Cancer. Journal of Oncology 2022;2022:1 View
  199. Suo H, Xiao N, Wang K. Potential roles of synaptotagmin family members in cancers: Recent advances and prospects. Frontiers in Medicine 2022;9 View
  200. Sun X, Zhang T. Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer. Frontiers in Genetics 2022;13 View
  201. Shen Y, Huang Q, Ji M, Hsueh C, Zhou L. Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas. BMC Cancer 2022;22(1) View
  202. Paul A, George B, Saini S, Pillai M, Toi M, Costa L, Kumar R. Delineation of Pathogenomic Insights of Breast Cancer in Young Women. Cells 2022;11(12):1927 View
  203. Mehta V, Meena J, Kasana H, Munshi A, Chander H. Prognostic significance of CHAC1 expression in breast cancer. Molecular Biology Reports 2022;49(9):8517 View
  204. Xu Z, Liu S, Feng C, Xu F, Kong D, Mi J, Yang C, Zhang G, Wei P, Orgil B, Bergquist J, Tian G. Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer. Cell Death Discovery 2022;8(1) View
  205. Yang Y, Ye F, Xia T, Wang Q, Du J. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. BMC Cancer 2022;22(1) View
  206. Peng H, Du X, Zhang Y. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2022;9 View
  207. Li C, Yoshimura T, Tian M, Wang Y, Kondo T, Yamamoto K, Fujisawa M, Ohara T, Sakaguchi M, Matsukawa A. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Breast Cancer Research 2022;24(1) View
  208. Sharma P, Yadav P, Sundaram S, Venkatraman G, Bera A, Karunagaran D. HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sciences 2022;304:120727 View
  209. Ramos E, Yang B, Vasquez Y, Lin K, Choudhari R, Gadad S. Characterization of the Testis-specific LINC01016 Gene Reveals Isoform-specific Roles in Controlling Biological Processes. Journal of the Endocrine Society 2021;5(11) View
  210. Lv Z, Wang Q, Liu X, Du Z, Liang W, Liu T, Zheng Y, Ma B, Xue D. Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer. Frontiers in Genetics 2022;13 View
  211. Irshad R, Raj N, Gabr G, Manzoor N, Husain M. Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer. Frontiers in Pharmacology 2022;13 View
  212. Li S, Chen S, Dong Z, Song X, Li X, Huang Z, Li H, Huang L, Zhuang G, Lan R, Guo M, Li W, Saw P, Zhang L. Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer. Acta Pharmaceutica Sinica B 2023;13(3):967 View
  213. Lee H, Chang C, Huang Y, Wu K, Chiang H, Chang Y, Liu L, Hung J, Hsu Y, Wu Y, Tsai Y. Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma. Biology 2022;11(5):760 View
  214. Kang X, Zhao C, Liu Y, Wang G. The phosphorylation level of Cofilin-1 is related to the pathological subtypes of gastric cancer. Medicine 2022;101(43):e31309 View
  215. Zhao J, Guo M, Song Y, Liu S, Liao R, Zhang Y, Zhang Y, Yang Q, Gu Y, Huang X. Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022;12 View
  216. Evers M, Song J, Shriwas P, Greenbaum H, Chen X. From Transcriptomics, Metabolomics to Functional Studies: Extracellular ATP Induces TGF-β-Like Epithelial Mesenchymal Transition in Lung Cancer Cells. Frontiers in Oncology 2022;12 View
  217. Augimeri G, Fiorillo M, Morelli C, Panza S, Giordano C, Barone I, Catalano S, Sisci D, Andò S, Bonofiglio D. The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment. Cancers 2023;15(3):819 View
  218. Li C, Chen S, Liu C, Mo C, Gong W, Hu J, He M, Xie L, Hou X, Tang J, Ou M. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Hereditas 2022;159(1) View
  219. Liu L, Lv Z, Xue X, Xing Z, Zhu F. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers 2022;14(23):5781 View
  220. Lim E, Lim S, Tan K, Sathiya M, Cheng W, Lai K, Loh J, Yap W. In-Silico Analysis of Deleterious SNPs of FGF4 Gene and Their Impacts on Protein Structure, Function and Bladder Cancer Prognosis. Life 2022;12(7):1018 View
  221. Wang C, Cheng B. MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway. Bioengineered 2022;13(3):4869 View
  222. Lin X, Xiao M, Chen Z, Ding C, Zhang T, Li Q, Xu Y. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. Journal of Oncology 2022;2022:1 View
  223. Ji S, Long S, Yang Y, Liu Z, Wang R, Zhang H, Zhang S, Kuo C. Network Pharmacology and Molecular Docking on the Molecular Mechanism of Jiawei-Huang Lian-Gan Jiang Decoction in the Treatment of Colorectal Adenomas. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  224. Pang H, Wang J, Wei Q, Liu J, Chu X, Yuan C, Yang B, Li M, Ma D, Tang Y, Wang C, Zhang J. miR‐548ag functions as an oncogene by suppressing MOB1B in the development of obesity‐related endometrial cancer. Cancer Science 2023;114(4):1507 View
  225. Akrami S, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma. Computers in Biology and Medicine 2023;157:106529 View
  226. Jin Y, Cao J, Cheng H, Hu X. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma. Journal of Chemotherapy 2023;35(7):638 View
  227. Liu B, He X, Wang Y, Huang J, Zheng Y, Li Y, Lu L. Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis. Frontiers in Immunology 2022;13 View
  228. Seeneevassen L, Dubus P, Gronnier C, Varon C. Hippo in Gastric Cancer: From Signalling to Therapy. Cancers 2022;14(9):2282 View
  229. Huang X, Fu L, Cai Q, Fan F. Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma. Frontiers in Oncology 2023;13 View
  230. Poh A, Love C, Chisanga D, Steer J, Baloyan D, Chopin M, Nutt S, Rautela J, Huntington N, Etemadi N, O’Brien M, O’Keefe R, Ellies L, Macri C, Mintern J, Whitehead L, Gangadhara G, Boon L, Chand A, Lowell C, Shi W, Pixley F, Ernst M. Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Science Advances 2022;8(25) View
  231. Ibragimova M, Tsyganov M, Litviakov N. Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis. International Journal of Molecular Sciences 2022;23(22):13906 View
  232. Ju L, Shi Y, Liu G. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. PeerJ 2022;10:e14506 View
  233. Li X, Kang K, Peng Y, Shen L, Shen L, Zhou Y. Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers. Aging 2022;14(22):9221 View
  234. Chen B, Luo Y, Kang X, Sun Y, Jiang C, Yi B, Yan X, Chen Y, Shi R. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes. Frontiers in Genetics 2022;13 View
  235. Li N, Li R, Song B, Ge H, Qu Y, Zhang Z. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the METTL7B Gene. Journal of Oncology 2022;2022:1 View
  236. Wang J, Jin J, Liang Y, Zhang Y, Wu N, Fan M, Zeng F, Deng F. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma. Frontiers in Genetics 2022;13 View
  237. Chen X, Yuan Y, Zhou F, Huang X, Pu J, Niu X, Jiang X, Ding X. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma. Aging 2022;14(19):7866 View
  238. Lin Y, Lin P, Guo W, Huang J, Xu X, Zhuang X. PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer. Environmental Toxicology 2023;38(4):941 View
  239. Fadó R, Zagmutt S, Herrero L, Muley H, Rodríguez-Rodríguez R, Bi H, Serra D, Casals N. To be or not to be a fat burner, that is the question for cpt1c in cancer cells. Cell Death & Disease 2023;14(1) View
  240. Jia Y, Li J, Wu H, Wang W, Sun S, Feng C, Liu X, Li C, Zhang Y, Cai Y, Wei X, Yao P, Liu X, Zhang S, Wu F. Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer. Medicine 2023;102(6):e32927 View
  241. Shen J, Wang M, Li F, Yan H, Wang R, Zhou J. Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer. Breast Cancer: Targets and Therapy 2022;Volume 14:375 View
  242. Lone M, Gul S, Mehraj U, Sofi S, Dar A, Ganie S, Wani N, Mir M, Zargar M. Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors. Applied Biochemistry and Biotechnology 2023;195(10):6212 View
  243. Qiu M, Chen M, Lan Z, Liu B, Xie J, Li X. Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2. Bioengineered 2022;13(4):10123 View
  244. Dou X, Wang Z, Lu W, Miao L, Zhao Y. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way. BMC Pulmonary Medicine 2022;22(1) View
  245. Liu W, Zhang F, Yang K, Yan Y, Liu J. Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response. PLOS ONE 2023;18(1):e0280989 View
  246. Li D, Huang S, Luo C, Xu Y, Fu S, Liu K, Wu J. CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma. Current Oncology 2023;30(3):2653 View
  247. Chen Z, Wei Q. Developing an Improved Survival Prediction Model for Disease Prognosis. Biomolecules 2022;12(12):1751 View
  248. Biel T, Petrovskaya S, Mascia F, Ju T, Fashoyin-Aje L, Herremans K, Riner A, Underwood P, Gerber M, Donoghue M, Trevino J, Rao V, Fujiwara K. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients. PLOS ONE 2023;18(2):e0281182 View
  249. Quevedo-Ocampo J, Escobedo-Calvario A, Souza-Arroyo V, Miranda-Labra R, Bucio-Ortiz L, Gutiérrez-Ruiz M, Chávez-Rodríguez L, Gomez-Quiroz L. Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?. Technology in Cancer Research & Treatment 2022;21 View
  250. Mori J, White J, Elhussin I, Duduyemi B, Karanam B, Yates C, Wang H. Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients. Frontiers in Oncology 2022;12 View
  251. Hu Y, Xie Q, Chen S, Zhao W, Zhao X, Ruan Q, Zheng Z, Zhao H, Ma T, Guo J, Li L. Par3 promotes breast cancer invasion and migration through pull tension and protein nanoparticle-induced osmotic pressure. Biomedicine & Pharmacotherapy 2022;155:113739 View
  252. Bassiouni R, Idowu M, Gibbs L, Robila V, Grizzard P, Webb M, Song J, Noriega A, Craig D, Carpten J. Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer. Cancer Research 2023;83(1):34 View
  253. Feng Y, Han X, Zhang Z, Qiao H, Tang H. ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. Frontiers in Genetics 2023;13 View
  254. Zhao K, Gao M, Lin M, Niu X. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma. Disease Markers 2022;2022:1 View
  255. Sun X, Ma Q, Cheng Y, Huang H, Qin J, Zhang M, Qu S. Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance. Frontiers in Genetics 2023;14 View
  256. Das A, Prajapati A, Karna A, Sharma H, Uppal S, Lather V, Pandita D, Agarwal P. Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer. Chemico-Biological Interactions 2023;376:110443 View
  257. Kelly M, Wisniewska K, Regner M, Lewis M, Perreault A, Davis E, Phanstiel D, Parker J, Franco H. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer. Nature Communications 2022;13(1) View
  258. Zeng S, Xu Z, Liang Q, Thakur A, Liu Y, Zhou S, Yan Y. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis. Chemico-Biological Interactions 2023;373:110372 View
  259. Wang X, Wu S, Peng Z, Zhu H. SLCO4A1 is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated Immunity in Thyroid Cancer. International Journal of General Medicine 2021;Volume 14:9615 View
  260. Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T, Chen B, Jiang X, Cui R. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Frontiers in Immunology 2022;13 View
  261. Ishikawa A, Fujii H, Fukui T, Kido A, Katsuya N, Sentani K, Kuraoka K, Tazuma S, Sudo T, Serikawa M, Oka S, Oue N. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness. Pathology - Research and Practice 2023;241:154277 View
  262. Lee M, Lee Y, Huang S, Chang C, Ko C, Lee W, Chen T, Tzou S, Huang C, Tai M, Lin Y, Kung M, Tsai M, Chen Y, Chang Y, Wen Z, Huang C, Chu T. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes 2022;13(4):629 View
  263. Satoh K, Sakai S, Nishizuka M. Knockdown of RhoQ, a member of Rho GTPase, accelerates TGF-β-induced EMT in human lung adenocarcinoma. Biochemistry and Biophysics Reports 2022;32:101346 View
  264. Tóth G, Sugár S, Pál D, Fügedi K, Drahos L, Schlosser G, Oláh C, Reis H, Kovalszky I, Szarvas T, Turiák L. Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. Cancers 2022;14(19):4867 View
  265. De Palma F, Carbonnier V, Salvatore F, Kroemer G, Pol J, Maiuri M. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 2022;14(23):5980 View
  266. Sun W, Wang X, Wang D, Lu L, Lin H, Zhang Z, Jia Y, Nie X, Liu T, Fu W. CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer. Journal for ImmunoTherapy of Cancer 2022;10(7):e005063 View
  267. Chu M, Zheng K, Li X, Luo Z, Yang X, Wei C, Andreucci E. Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Analytical Cellular Pathology 2022;2022:1 View
  268. Peng H, Zhu E, Wang J, Du X, Wang C, Yang M, Zhang Y. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Frontiers in Pharmacology 2022;13 View
  269. Dioguardi M, Cantore S, Sovereto D, La Femina L, Caloro G, Spirito F, Scacco S, Di Cosola M, Lo Muzio L, Troiano G, Ballini A. Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis. Life 2022;12(8):1269 View
  270. Wei Q, Miao T, Zhang P, Jiang B, Yan H. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates. Frontiers in Genetics 2022;13 View
  271. Kim D, Jeong J, Lee D, Hyeon D, Park G, Jeon S, Lee K, Jang J, Hwang D, Kim H, Jung K. PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer. Nature Communications 2022;13(1) View
  272. Ouyang Y, Lu W, Wang Y, Wang B, Li F, Li X, Bai Y, Wang Y. Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify the potential mRNA biomarkers in breast cancer. Gene 2023;857:147174 View
  273. Liao H, Li H, Song J, Chen H, Si H, Dong J, Wang J, Bai X. Expression of the prognostic marker IL‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer. Journal of Clinical Laboratory Analysis 2023;37(3) View
  274. Koyanagi A, Kotani H, Iida Y, Tanino R, Kartika I, Kishimoto K, Harada M. Protective roles of cytoplasmic p21Cip1/Waf1 in senolysis and ferroptosis of lung cancer cells. Cell Proliferation 2022;55(12) View
  275. Guo M, Zhuang H, Huang J, Shao X, Bai N, Li M, Niu M, Wei W, Sun L, Li Y, Qiang Z. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression. Molecular and Cellular Biochemistry 2023;478(9):1899 View
  276. Hegde M, Daimary U, Jose S, Sajeev A, Chinnathambi A, Alharbi S, Shakibaei M, Kunnumakkara A. Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis. Frontiers in Genetics 2022;13 View
  277. Jin Z, Wu J, Lin J, Wang J, Shen Y. Identification of the Transcription Co-Factor–Related Gene Signature and Risk Score Model for Osteosarcoma. Frontiers in Genetics 2022;13 View
  278. Oh K, Nam A, Bang J, Seo H, Kim J, Yoon J, Kim T, Oh D. A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers. Oncogene 2022;41(32):3939 View
  279. Quinlan P, Figeuredo G, Mongan N, Jordan L, Bray S, Sreseli R, Ashfield A, Mitsch J, van den Ijssel P, Thompson A, Quinlan R. Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP. Cell Stress and Chaperones 2022;27(2):177 View
  280. Angel C, Stafford M, McNally C, Nesbitt H, McKenna D. MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. Cancers 2023;15(4):1291 View
  281. Magrath J, Kang H, Hartono A, Espinosa-Cotton M, Somwar R, Ladanyi M, Cheung N, Lee S. Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein. Frontiers in Cell and Developmental Biology 2022;10 View
  282. Meijuan C, Meng X, Fang L, Qian W. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments. Journal of Ovarian Research 2023;16(1) View
  283. Li Y, Zhang M, Wu L, Liu Y, Zhang Z, Zeng L, Lin N, Zhang C. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD. Journal of Biomedical Science 2022;29(1) View
  284. Tsujimoto G, Ito R, Yoshikawa K, Ueki C, Okada N. NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression. Frontiers in Cell and Developmental Biology 2022;10 View
  285. Le T, Payne S, Buckwald M, Hayes L, Parker S, Burge C, Oudin M. Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3. npj Breast Cancer 2022;8(1) View
  286. Leng R, Meng Y, Sun X, Zhao Y. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes. Frontiers in Oncology 2022;12 View
  287. Li C, Fang C, Chan M, Lu P, Ger L, Chu J, Chang Y, Chen C, Hsiao M. The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers. The Journal of Pathology: Clinical Research 2023;9(3):165 View
  288. Su J, Tian X, Xu W, Anwaier A, Ye S, Zhu S, Wang Y, Gu J, Shi G, Qu Y, Zhang H, Ye D. The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma. Cancers 2022;14(20):4992 View
  289. Dai D, Liu L, Guo Y, Shui Y, Wei Q. A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma. Cancers 2022;15(1):57 View
  290. Zhai Y, Zhang Y, Liu H, Zhang Z. Multi-angle Support Vector Survival Analysis with Neural Tangent Kernel Study. Arabian Journal for Science and Engineering 2023;48(8):10267 View
  291. Xu Z, Wang Y, Xu J, Ang X, Ge N, Xu M, Pei C. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining. Heliyon 2023;9(2):e13543 View
  292. Tozuka T, Noro R, Seike M, Honda K. Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability. Cancers 2022;14(18):4363 View
  293. Xu X, Ma L, Zhang X, Guo S, Guo W, Wang Y, Qiu S, Tian X, Miao Y, Yu Y, Wang J. A positive feedback circuit between RN7SK snRNA and m6A readers is essential for tumorigenesis. Molecular Therapy 2023;31(6):1615 View
  294. Dioguardi M, Cantore S, Sovereto D, La Femina L, Spirito F, Caloro G, Caroprese M, Maci M, Scacco S, Lo Muzio L, Di Cosola M, Troiano G, Ballini A. Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. Journal of Personalized Medicine 2022;12(9):1436 View
  295. Yang K, Li C, Liu Y, Gu X, Jiang L, Shi L. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer. Cells 2022;11(9):1427 View
  296. Eguchi T, Csizmadia E, Kawai H, Sheta M, Yoshida K, Prince T, Wegiel B, Calderwood S. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration. Cells 2022;11(24):3993 View
  297. Qi L, Wang L, Song F, Ding Z, Zhang Y. The role of miR-4469 as a tumor suppressor regulating inflammatory cell infiltration in colorectal cancer. Computational and Structural Biotechnology Journal 2022;20:3755 View
  298. Zhu X, Zhang Y, Wu Y, Diao W, Deng G, Li Q, Wu C, Falzone L. HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters. International Journal of Genomics 2022;2022:1 View
  299. Pacifico F, Mellone S, D'Incalci M, Stornaiuolo M, Leonardi A, Crescenzi E. Trabectedin suppresses escape from therapy-induced senescence in tumor cells by interfering with glutamine metabolism. Biochemical Pharmacology 2022;202:115159 View
  300. Xu J, Chen S, Liang J, Hao T, Wang H, Liu G, Jin X, Li H, Zhang J, Zhang C, He Y. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Frontiers in Immunology 2022;13 View
  301. Mary C, Soflaee M, Kesavan R, Gelin M, Brown H, Zacharias G, Mathews T, Lemoff A, Lionne C, Labesse G, Hoxhaj G. Crystal structure of human NADK2 reveals a dimeric organization and active site occlusion by lysine acetylation. Molecular Cell 2022;82(17):3299 View
  302. You S, Zhu X, Yang Y, Du X, Song K, Zheng Q, Zeng P, Yao Q, Muthu M. SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells. Journal of Oncology 2022;2022:1 View
  303. Yi Q, Liang Q, Liu Y, Gong Z, Yan Y. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma. Frontiers in Oncology 2022;12 View
  304. Chen S, Xu J, Yin S, Wang H, Liu G, Jin X, Zhang J, Wang H, Wang H, Li H, Liang J, He Y, Zhang C. Identification of a Two-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival in Diffuse-Type Gastric Cancer. Current Oncology 2022;30(1):171 View
  305. Rahmy S, Mishra S, Murphy S, Blagg B, Lu X. Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors. Frontiers in Immunology 2022;13 View
  306. Fang Z, Li C, Wu Z, Hou Y, Wu H, Liu J. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. World Journal of Gastrointestinal Oncology 2022;14(11):2138 View
  307. Mameri H, Buhagiar-Labarchède G, Fontaine G, Corcelle C, Barette C, Onclercq-Delic R, Beauvineau C, Mahuteau-Betzer F, Amor-Guéret M. Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cellular and Molecular Life Sciences 2022;79(8) View
  308. Son S, Kim H, Lim H, Lee J, Lee K, Shin I. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer. Cell Death & Disease 2023;14(2) View
  309. Yuan Y, Zhang X, Du K, Zhu X, Chang S, Chen Y, Xu Y, Sun J, Luo X, Deng S, Qin Y, Feng X, Wei Y, Fan X, Liu Z, Zheng B, Ashktorab H, Smoot D, Li S, Xie X, Jin Z, Peng Y. Circ_CEA promotes the interaction between the p53 and cyclin-dependent kinases 1 as a scaffold to inhibit the apoptosis of gastric cancer. Cell Death & Disease 2022;13(9) View
  310. Malpeli G, Barbi S, Innamorati G, Alloggio M, Filippini F, Decimo I, Castelli C, Perris R, Bencivenga M. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. Journal of Personalized Medicine 2022;12(12):2006 View
  311. Yuan M, Zhai Y, Men Y, Zhao M, Sun X, Ma Z, Yang X, Sun S, Bao Y, Liu Y, Hui Z. Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer. Thoracic Cancer 2022;13(23):3331 View
  312. Yu T, Wu F, Jia Y, Zhang X, Qi X, Jin Z, Hao T, Zhao J, Liu Z, Wang C, Niu M, Yue Q, Li M, Liu Y. RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer. Cell & Bioscience 2022;12(1) View
  313. Bang S, Jee S, Son H, Cha H, Sim J, Kim Y, Park H, Myung J, Kim H, Paik S. Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma. Pathology and Oncology Research 2022;28 View
  314. Yu X, Wang M, Qian J, Wu X. CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  315. Dai Q, Song F, Li X, Huang F, Zhao H. Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma. BMC Cancer 2022;22(1) View
  316. Köhler B, Dubovik S, Hörterer E, Wilk U, Stöckl J, Tekarslan-Sahin H, Ljepoja B, Paulitschke P, Fröhlich T, Wagner E, Roidl A. Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. Cancers 2022;14(22):5554 View
  317. Xu Z, Cai Y, Liu W, Kang F, He Q, Hong Q, Zhang W, Li J, Yan Y, Peng J. Downregulated exosome-associated gene FGF9 as a novel diagnostic and prognostic target for ovarian cancer and its underlying roles in immune regulation. Aging 2022;14(4):1822 View
  318. Wang Y, Zhou D, Kong Y, Yang Q, Ding Y, Wang W, Sheikh N. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. BioMed Research International 2022;2022(1) View
  319. Hu X, Zhou J, Zhang Y, Zeng Y, Jie G, Wang S, Yang A, Zhang M. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. Frontiers in Genetics 2022;13 View
  320. Wu K, Huang Y, Wu Y, Chang C, Chang Y, Chiang H, Liu L, Tsai Y, Hung J. Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming. Biology 2022;11(7):975 View
  321. Zhu C, Wang S, Du Y, Dai Y, Huai Q, Li X, Du Y, Dai H, Yuan W, Yin S, Wang H. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. BMC Gastroenterology 2022;22(1) View
  322. Liu Y, Zhang J, Wang Z, Zhang X, Dai Z, Wu W, Zhang N, Liu Z, Zhang J, Luo P, Wen Z, Yu J, Zhang H, Yang T, Cheng Q. Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 2022;10 View
  323. Konrad S, Schwamborn K, Krüger A, Honert K, Schmitt M, Hellmann D, Schmalfeldt B, Meindl A, Kiechle M, Quante A, Brambs C, Grill S, Ramser J. Ncald as a Potential Predictive Biomarker for the Efficacy of Platinum-Based Chemotherapy in Ovarian Cancer. Biomarkers in Medicine 2022;16(14):1029 View
  324. Wu Z, Wang Y, Li J, Wang H, Tuo X, Zheng J. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer. Frontiers in Genetics 2022;13 View
  325. Wang L, Zeng Q, Jiang S, Chen Z, Wang X, Li L, Li X. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. Frontiers in Oncology 2022;12 View
  326. Montgomery E, Xing E, Campbell M, Li P, Blachly J, Tsung A, Coss C. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022;23(22):13768 View
  327. Wright R, Vastolo V, Oliete J, Carbonell-Caballero J, Beato M. Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Frontiers in Endocrinology 2022;13 View
  328. Zhou C, Chen Z, Xiao B, Xiang C, Li A, Zhao Z, Li H. Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. Frontiers in Cell and Developmental Biology 2022;10 View
  329. Song Y, Ma R. Identifying the Potential Roles of PBX4 in Human Cancers Based on Integrative Analysis. Biomolecules 2022;12(6):822 View
  330. Zhang T, Goel A, Xu X, Wu Y, Tang E, Zhang F, Li Y, Li H, Cai Y, Weng W. N-mytistoyltransferase 1 and 2 are potential tumor suppressors and novel targets of miR-182 in human non-small cell lung carcinomas. Lung Cancer 2022;171:70 View
  331. Cui Z, Wang J, Chen G, Li D, Cheng B, Lai Y, Wu Z. The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression. Frontiers in Oncology 2023;12 View
  332. Savic D, Steinbichler T, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, Ganswindt U, Skvortsov S, Dudás J, Skvortsova I. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis. Cells 2023;12(2):336 View
  333. Zhao M, Fu Y, Liu L, Hou Y, Shi M, Zhou H, Zhang G, Garg R. Identification of Key Drug Targets and Molecular Mechanisms of Curcumae Rhizoma Acting on HBV-Related HCC: Weighted Correlation Network and Network Pharmacological Analyses. Evidence-Based Complementary and Alternative Medicine 2022;2022:1 View
  334. Chung W, Egan S, Xu K. A tumor-suppressive function for Notch3 in the parous mammary gland. Development 2022;149(19) View
  335. Zheng X, Xiuyi L, Zhu L, Xu K, Shi C, Cui L, Ding H. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma. Cancer Management and Research 2021;Volume 13:9329 View
  336. Liu Q, Lian Q, Song Y, Yang S, Jia C, Fang J. Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer. Frontiers in Oncology 2023;13 View
  337. Zhang H, Wang X, Li Y, Bai Y, Li Q, Wang S, Wei Y, Li J, Wen S, Zhao W. The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer. BMC Cancer 2023;23(1) View
  338. Kottorou A, Dimitrakopoulos F, Diamantopoulou G, Kalofonou F, Stavropoulos M, Thomopoulos K, Makatsoris T, Koutras A, Kalofonos H. Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients. Cancers 2023;15(6):1685 View
  339. Pentimalli F, Krstic-Demonacos M, Costa C, Mutti L, Bakker E. Intratumor microbiota as a novel potential prognostic indicator in mesothelioma. Frontiers in Immunology 2023;14 View
  340. Yang J, Li G, Huang Y, Liu Y. Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition. Toxicology and Applied Pharmacology 2023;466:116458 View
  341. Wang S, Liu Y, Li S, Chen Y, Liu Y, Yan J, Wu J, Li J, Wang L, Xiang R, Shi Y, Qin X, Yang S. COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma. Molecular Cancer Research 2023;21(3):199 View
  342. Yao W, Liu H, Xu F, Cai Z, Hang L, Lu M, Zhao Y, Yang C, Zong Y. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma. Frontiers in Genetics 2023;14 View
  343. Meng M, Gao R, Liu Z, Liu F, Du S, Song Y, He J. Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients. Frontiers in Pharmacology 2023;14 View
  344. Schrenk C, Bollmann L, Haist C, Bister A, Wiek C, Wecker M, Roth D, Petzsch P, Köhrer K, Hamacher A, Hanenberg H, Fluegen G, Kassack M. Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International Journal of Molecular Sciences 2023;24(6):5553 View
  345. Wang Y, Liu X, Yu K, Xu S, Qiu P, Zhang X, Wang M, Xu Y. A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer. iScience 2023;26(4):106330 View
  346. Wang G, Shen K, Xiao J, Fan H, Wang Y, Liu K, Zhou X, Cheng Q, Miao Y, Xu Z, Yang L. Long non‐coding RNA LGALS8‐AS1 facilitates PLAGL2‐mediated malignant phenotypes in gastric cancer. The Journal of Gene Medicine 2023;25(6) View
  347. Zhu Y, Zhao Y, Wen J, Liu S, Huang T, Hatial I, Peng X, Al Janabi H, Huang G, Mittlesteadt J, Cheng M, Bhardwaj A, Ashfeld B, Kao K, Maeda D, Dai X, Wiest O, Blagg B, Lu X, Cheng L, Wan J, Lu X. Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. Science Immunology 2023;8(81) View
  348. Kątnik E, Gomułkiewicz A, Piotrowska A, Grzegrzółka J, Rusak A, Kmiecik A, Ratajczak-Wielgomas K, Dzięgiel P. BCL11A Expression in Breast Cancer. Current Issues in Molecular Biology 2023;45(4):2681 View
  349. Gong W, Zhang S. YB1 participated in regulating mitochondrial activity through RNA replacement. Frontiers in Oncology 2023;13 View
  350. Soltan M, Eldeen M, Eid R, Alyamani N, Alqahtani L, Albogami S, Jafri I, Park M, Alsharif G, Fayad E, Mohamed G, Osman R, Kim B, Zaki M. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers. Frontiers in Molecular Biosciences 2023;10 View
  351. Sui H, Cui X, Shi C, Yan Z, Li H, Wang F. LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression. Cancer Science 2023;114(6):2634 View
  352. Montanaro M, Agostini M, Anemona L, Bonanno E, Servadei F, Finazzi Agrò E, Asimakopoulos A, Ganini C, Cipriani C, Signoretti M, Bove P, Rugolo F, Imperiali B, Melino G, Mauriello A, Scimeca M. ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. International Journal of Molecular Sciences 2023;24(7):6519 View
  353. Fosu K, Quarshie J, Sarpong K, Aikins A. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes. Genes 2023;14(4):800 View
  354. Yan J, Ye G, Shao Y, Zhou H. Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis. Frontiers in Genetics 2023;14 View
  355. Lee S, Jung H, Park J, Ahn J. Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes. International Journal of Molecular Sciences 2023;24(7):6445 View
  356. Fan C, Wang Q, Kuipers T, Cats D, Iyengar P, Hagenaars S, Mesker W, Devilee P, Tollenaar R, Mei H, ten Dijke P. LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation. The EMBO Journal 2023;42(10) View
  357. Selvaraj M, Kaur J, Murugan A. Computational method for aromatase-related proteins using machine learning approach. PLOS ONE 2023;18(3):e0283567 View
  358. Nguyen K, Boehling J, Tran M, Cheng T, Rivera A, Collins-Burow B, Lee S, Drewry D, Burow M. NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Cancers 2023;15(7):2067 View
  359. Huang K, Chen X, Geng Z, Xiong X, Cong Y, Pan X, Liu S, Ge L, Xu J, Jia X. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4. Functional & Integrative Genomics 2023;23(2) View
  360. Váncza L, Horváth A, Seungyeon L, Rókusz A, Dezső K, Reszegi A, Petővári G, Götte M, Kovalszky I, Baghy K. SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer. Cancers 2023;15(7):2037 View
  361. Liu D, Liu Y, Zhu W, Lu Y, Zhu J, Ma X, Xing Y, Yuan M, Ning B, Wang Y, Jia Y. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo–YAP1 pathway. BMC Medicine 2023;21(1) View
  362. Ho T, Sung T, Pan S, Huang W, Hsu K, Hsu J, Lin T, Hsu C, Yang C. The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo. Biomedicine & Pharmacotherapy 2023;162:114667 View
  363. Li J, Liang H, Xiao W, Wei P, Chen H, Chen Z, Yang R, Jiang H, Zhang Y. Whole-exome mutational landscape and molecular marker study in mucinous and clear cell ovarian cancer cell lines 3AO and ES2. BMC Cancer 2023;23(1) View
  364. Wang Y, Zhao H, He Y, Zhang P, Zeng C, Du T, Shen Q, Chen Y, Zhao S. IKZF4 acts as a novel tumor suppressor in non–small cell lung cancer by suppressing Notch signaling pathway. Cellular Signalling 2023;107:110679 View
  365. Gounou C, Bouvet F, Liet B, Prouzet‐Mauléon V, d'Agata L, Harté E, Argoul F, Siegfried G, Iggo R, Khatib A, Bouter A. Annexin‐A5 and annexin‐A6 silencing prevents metastasis of breast cancer cells in zebrafish. Biology of the Cell 2023;115(6) View
  366. Tomas Bort E, Joseph M, Wang Q, Carter E, Roth N, Gibson J, Samadi A, Kocher H, Simoncelli S, McCormick P, Grose R. Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion. eLife 2023;12 View
  367. Nandi I, Smith H, Sanguin-Gendreau V, Ji L, Pacis A, Papavasiliou V, Zuo D, Nam S, Attalla S, Kim S, Lusson S, Kuasne H, Fortier A, Savage P, Martinez Ramirez C, Park M, Katzenellenbogen J, Katzenellenbogen B, Muller W. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression. Journal of Clinical Investigation 2023;133(7) View
  368. Jiang Y, Song L, Lin Y, Nowialis P, Gao Q, Li T, Li B, Mao X, Song Q, Xing C, Zheng G, Huang S, Jin L. ROS-mediated SRMS activation confers platinum resistance in ovarian cancer. Oncogene 2023;42(20):1672 View
  369. Ding J, Ji X, Liu L, Chen D, Luo N, Yu X, Guo F. A prognostic and immunological analysis of 7B-containing Kelch structural domain (KLHDC7B) in pan-cancer: a potential target for immunotherapy and survival. Journal of Cancer Research and Clinical Oncology 2023;149(10):7857 View
  370. Lucà S, Franco R, Napolitano A, Soria V, Ronchi A, Zito Marino F, Della Corte C, Morgillo F, Fiorelli A, Luciano A, Palma G, Arra C, Battista S, Cerchia L, Fedele M. PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype. Cancers 2023;15(7):2190 View
  371. Ghannoum S, Fantini D, Zahoor M, Reiterer V, Phuyal S, Leoncio Netto W, Sørensen Ø, Iyer A, Sengupta D, Prasmickaite L, Mælandsmo G, Köhn-Luque A, Farhan H, Merks R. A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression. PLOS Computational Biology 2023;19(4):e1010995 View
  372. Cipolletti M, Leone S, Bartoloni S, Acconcia F. A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma. Frontiers in Endocrinology 2023;14 View
  373. Fu B, Zhou M, Song G, Zeng H, Gong Y, Jiang Y, Ke Y, Huang D, Peng H, Li Q. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma. Aging 2023;15(7):2734 View
  374. Zhang K, Yue B, Duan X, Chen W, Dai X, Chen Y, Li X, Lu J. Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer. Pathology - Research and Practice 2023;245:154462 View
  375. Jeong Y, Knutsdottir H, Shojaeian F, Lerner M, Wissler M, Henriet E, Ng T, Datta S, Navarro-Serer B, Chianchiano P, Kinny-Köster B, Zimmerman J, Stein-O’Brien G, Gaida M, Eshleman J, Lin M, Fertig E, Ewald A, Bader J, Wood L. Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion. Journal of Clinical Investigation 2023;133(8) View
  376. Su L, Zhang F, Liu M, Li H, Li Q, Zhu Y, Hou Y, Chen X, Wang X, Qian C, Yao C, Wang L, Jiao X, Zhu X, Xu Z, Zou C. The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer. Journal of Ethnopharmacology 2023;313:116491 View
  377. Vishnubalaji R, Alajez N. Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes. Cells 2023;12(8):1182 View
  378. Ding Y, Gong Y, Zeng H, Zhou X, Yu Z, Pan J, Zhou M, Liu S, Lai W. Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma. Aging 2023;15(7):2631 View
  379. Fan K, Zhang B, Han D, Sun Y. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. BMC Bioinformatics 2023;24(1) View
  380. Fu L, Lu K, Jiao Q, Chen X, Jia F. The Regulation and Double-Edged Roles of the Deubiquitinase OTUD5. Cells 2023;12(8):1161 View
  381. Murthy D, Attri K. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023;24(8):7304 View
  382. Kang E, Kim H, Lee H, Han W. Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation. Scientific Reports 2023;13(1) View
  383. Ju M, Jang E, Kang S, Roh Y, Jeong J, Han S. Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023;Volume 10:643 View
  384. Contreras-Sanzón E, Carlos-Reyes Á, Sierra-Martínez M, Acosta-Altamirano G, Luna-Rivero C, Núñez-Corona D, García-Hernández A, Ibarra-Sierra E, Vidrio-Morgado H, Alvarez-Sánchez M, Marchat L, López-Camarillo C. Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicry. Translational Oncology 2023;33:101680 View
  385. He J, Jiang X, Yu M, Wang P, Fu L, Zhang G, Cai H. MTF1 has the potential as a diagnostic and prognostic marker for gastric cancer and is associated with good prognosis. Clinical and Translational Oncology 2023;25(11):3241 View
  386. Guo L, An T, Zhou H, Wan Z, Huang Z, Chong T. MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment. Scientific Reports 2023;13(1) View
  387. Dai X, Cai L, Zhang Z, Li J. SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity. BMC Cancer 2023;23(1) View
  388. Piñeiro-Hermida S, Bosso G, Sánchez-Vázquez R, Martínez P, Blasco M. Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts. Cell Death & Differentiation 2023;30(6):1585 View
  389. Cao L, Chen Y, Xu S, Cheng H. Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?. Frontiers in Oncology 2023;13 View
  390. Xie H, Chen J, Ma C, Zhao J, Cui M. UBP43 promotes epithelial ovarian carcinogenesis via activation of β‐catenin signaling pathway. Cell Biology International 2023;47(8):1427 View
  391. Walakira A, Skubic C, Nadižar N, Rozman D, Režen T, Mraz M, Moškon M. Integrative computational modeling to unravel novel potential biomarkers in hepatocellular carcinoma. Computers in Biology and Medicine 2023;159:106957 View
  392. He Y, Xiang J, Li Y, Huang W, Gu F, Wang Y, Chen R. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment. Cancer Medicine 2023;12(11):12622 View
  393. Cai J, Shen W, Zhang G, Li X, Shen H, Li W, Tan C, Zhang T, Shi M, Yang Z, Li Y, Liu H, Zhao X. Xiao Chai Hu Tang alleviates the pancreatic tumorigenesis via improving the mtDNA N6-Methyladenine modification mediated mitochondrial dysfunction in Syrian hamster model. Phytomedicine 2023;116:154840 View
  394. Thippana M, Dwivedi A, Das A, Palanisamy M, Vindal V. Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis. Proteins: Structure, Function, and Bioinformatics 2023;91(8):1173 View
  395. Soltan M, Eldeen M, Sajer B, Abdelhameed R, Al-Salmi F, Fayad E, Jafri I, Ahmed H, Eid R, Hassan H, Al-Shraim M, Negm A, Noreldin A, Darwish K. Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. Biology 2023;12(4):613 View
  396. Ngule C, Hemati H, Ren X, Obaleye O, Akinyemi A, Oyelami F, Xiong X, Song J, Liu X, Yang J. Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer. Biomedicines 2023;11(4):1223 View
  397. Yang C, Guo W, Wang Y, Hu L, Wang J, Luo J, Yao X, Liu S, Tao L, Sun L, Lin L. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway. Journal of Ethnopharmacology 2023;314:116566 View
  398. Atalay Şahar E, Ballar Kirmizibayrak P. Differential Expression and Function of SVIP in Breast Cancer Cell Lines and In Silico Analysis of Its Expression and Prognostic Potential in Human Breast Cancer. Cells 2023;12(10):1362 View
  399. Cao J, Liu L, Xue L, Luo Y, Liu Z, Guo J. Long non-coding RNA TTTY14 promotes cell proliferation and functions as a prognostic biomarker in testicular germ cell tumor. Heliyon 2023;9(5):e16082 View
  400. Chen M, Zheng W, Fang L. Identifying liver metastasis-related hub genes in breast cancer and characterizing SPARCL1 as a potential prognostic biomarker. PeerJ 2023;11:e15311 View
  401. Shuvalov O, Kirdeeva Y, Fefilova E, Netsvetay S, Zorin M, Vlasova Y, Fedorova O, Daks A, Parfenyev S, Barlev N. 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells. Metabolites 2023;13(5):656 View
  402. Wu J, Yang F, Zhao M, Xiao H, Chen Y, Liu X, Zheng D. Antler-derived microRNA PC-5p-1090 inhibits HCC cell proliferation, migration, and invasion by targeting MARCKS, SMARCAD1, and SOX9. Functional & Integrative Genomics 2023;23(2) View
  403. Singh P, Rathi A, Minocha R, Sinha A, Haque M, Hassan M, Dohare R. Breast Cancer Prognostic Hub Genes Identified by Integrated Transcriptomic and Weighted Network Analysis: A Road Toward Personalized Medicine. OMICS: A Journal of Integrative Biology 2023;27(5):227 View
  404. Rathbun L, Magliocco A, Bamezai A. Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma. Oncotarget 2023;14(1):426 View
  405. Bu J, Zhang Y, Wu S, Li H, Sun L, Liu Y, Zhu X, Qiao X, Ma Q, Liu C, Niu N, Xue J, Chen G, Yang Y, Liu C. KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nature Communications 2023;14(1) View
  406. Shi Y, Yan J, Liu W, Deng J. Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity. BMC Cancer 2023;23(1) View
  407. Di Matteo A, Belloni E, Pradella D, Chiaravalli A, Pini G, Bugatti M, Alfieri R, Barzan C, Franganillo Tena E, Bione S, Terenzani E, Sessa F, Wyatt C, Vermi W, Ghigna C. Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. International Journal of Molecular Sciences 2023;24(9):8102 View
  408. Yan P, Cheng M, Wang L, Zhao W. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach. International Immunopharmacology 2023;119:110263 View
  409. Duan Y, Zhang X, Ying H, Xu J, Yang H, Sun K, He L, Li M, Ji Y, Liang T, Bai X. Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. Oncogene 2023;42(25):2061 View
  410. Deng C, Peng J, Yuan C, Li H, Li W, Chu H, Wei H, He Y, Zeng L, Huo M, Zhang C. Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network. Frontiers in Molecular Biosciences 2023;10 View
  411. Laskar F, Bappy M, Hossain M, Alam Z, Afrin D, Saha S, Ali Zinnah K, Liu Z. An In silico Approach towards Finding the Cancer-Causing Mutations in Human MET Gene. International Journal of Genomics 2023;2023:1 View
  412. Nam J, Schirmer A, Loh C, Drewry D, Macias E. Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro. Cancers 2023;15(10):2817 View
  413. Tan W, Zhang J, Deng Z, Dai F, Tang L, Hu W, Liu H. Pan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer. Cancer Medicine 2023;12(13):14833 View
  414. Labat-de-Hoz L, Rubio-Ramos A, Correas I, Alonso M. The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers. Cancers 2023;15(10):2801 View
  415. Zhu Y, Hu Y, Wang P, Dai X, Fu Y, Xia Y, Sun L, Ruan S. Comprehensive bioinformatics and experimental analysis of SH3PXD2B reveals its carcinogenic effect in gastric carcinoma. Life Sciences 2023;326:121792 View
  416. Elango R, Rashid S, Vishnubalaji R, Al-Sarraf R, Akhtar M, Ouararhni K, Decock J, Albagha O, Alajez N. Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. Cell Death & Disease 2023;14(7) View
  417. Salehi-Mazandarani S, Nikpour P. Analysis of a Four-Component Competing Endogenous RNA Network Reveals Potential Biomarkers in Gastric Cancer: An Integrated Systems Biology and Experimental Investigation. Advanced Biomedical Research 2023;12(1) View
  418. Alves-Vale C, Capela A, Tavares-Marcos C, Domingues-Silva B, Pereira B, Santos F, Gomes C, Espadas G, Vitorino R, Sabidó E, Borralho P, Nóbrega-Pereira S, Bernardes de Jesus B. Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy. Molecular Therapy - Nucleic Acids 2023;33:910 View
  419. Mukherjee D, Chakraborty S, Bercz L, D’Alesio L, Wedig J, Torok M, Pfau T, Lathrop H, Jasani S, Guenther A, McGue J, Adu-Ampratwum D, Fuchs J, Frankel T, Pietrzak M, Culp S, Strohecker A, Skardal A, Mace T. Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. iScience 2023;26(8):107408 View
  420. Duan Y, Du Y, Mu Y, Gu Z, Wang C. Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma. Aging 2023 View
  421. Gao L, Zhang J, Long Q, Yang Y, Li Y, Li G, Pu P, Tong S, He Y, Li Q, Chen Y, Liu Y, Kong X. SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023;1869(7):166780 View
  422. Saha A, Gavert N, Brabletz T, Ben-Ze’ev A. An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1. International Journal of Molecular Sciences 2023;24(17):13418 View
  423. Zeng H, Zhou X, Geng X, Huang S, Zhu Y, Zheng H, Li G, Huang D. GLIPR2 emerges as a potential predictor of prognosis for renal clear cell carcinoma, exhibiting substantial relevance with cellular metastasis and CD8+ T cell infiltration. Informatics in Medicine Unlocked 2024;49:101371 View
  424. Suzuki H, Yokoi A, Uno K, Yoshida K, Kitagawa M, Asano-Inami E, Matsuo S, Nagao Y, Suzuki K, Nakamura K, Yoshihara M, Tamauchi S, Shimizu Y, Ikeda Y, Yoshikawa N, Kajiyama H, Yamamoto Y. Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancer. Biochemical and Biophysical Research Communications 2023;680:211 View
  425. Zhuo J, Han J, Zhao Y, Hao R, shen C, Li H, Dai L, Sheng A, Yao H, Yang X, Liu W. RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer. Scientific Reports 2023;13(1) View
  426. HUANG N, LIU Z, LI R. Pan-cancer analysis reveals the relationship between SLC47A1 immune infiltration and clinical prognosis of human tumors. Journal of Holistic Integrative Pharmacy 2023;4(1):103 View
  427. Michail A, Gkikas D, Stellas D, Kaltezioti V, Politis P. Prox1 Suppresses the Proliferation of Breast Cancer Cells via Direct Inhibition of c-Myc Gene Expression. Cells 2023;12(14):1869 View
  428. Zhang Z, Wu H, Shen C, Zhou F. Comprehensive Characterization of Immune Cell Infiltration Characteristics and Drug Sensitivity Analysis in Inflammatory Breast Cancer Based on Bioinformatic Strategy. Biochemical Genetics 2024;62(2):1021 View
  429. Wu L, Chu J, Shangguan L, Cao M, Lu F. Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer. Aging 2023;15(21):12651 View
  430. Wang M, Zhang Y, Gao L, Zhang H, Yang Z, Liu J, Shan W, Zeng L, Zhang R, Li Y, Liu J. RIG-I promotes cell proliferation in esophageal squamous cell carcinoma by facilitating p21 degradation. Medical Oncology 2023;40(10) View
  431. Zhang L, Wu X, Fan X, Ai H. MUM1L1 as a Tumor Suppressor and Potential Biomarker in Ovarian Cancer: Evidence from Bioinformatics Analysis and Basic Experiments. Combinatorial Chemistry & High Throughput Screening 2023;26(14):2487 View
  432. Yadav A, Murthy T, Divyashri G, Prasad N. D, Prakash S, Vaishnavi V. V, Shukla R, Singh T. Computational screening of pathogenic missense nsSNPs in heme oxygenase 1 (HMOX1) gene and their structural and functional consequences. Journal of Biomolecular Structure and Dynamics 2024;42(10):5072 View
  433. Su Y, Xue C, Gu X, Sun Y, Zhang R, Li L. Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma. Heliyon 2023;9(6):e17223 View
  434. Wu Y, Xu Z, Chen X, Fu G, Tian J, Jin B. RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability. Cancer Medicine 2023;12(19):19889 View
  435. Li J, Wan X, Xie D, Yuan H, Pei Q, Luo Y, Chen Y, Xian J, Ye T. SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer. Cell Death & Disease 2023;14(8) View
  436. Huang Y, Qian Y, Xing Y, Pei Y, Zhang B, Li T, Pan X, Zhong A, Du J, Zhou T, Shi M. POLRMT over‐expression is linked to WNT/beta‐catenin signaling, immune infiltration, and unfavorable outcomes in lung adenocarcinoma patients. Cancer Medicine 2023;12(14):15691 View
  437. Dixit N, Motwani H, Patel S, Rawal R, Solanki H. Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach. Journal of Biomolecular Structure and Dynamics 2024;42(19):10237 View
  438. Song J, Xu F, An L, Yin Y, Liu J, Chai J, Yang Y, Li M, Jia Q, Wang Z. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma. Pathology - Research and Practice 2023;247:154577 View
  439. Chen W, Wang F, Yu X, Qi J, Dong H, Cui B, Zhang Q, Wu Y, An J, Ni N, Liu C, Han Y, Zhang S, Schmitt C, Deng J, Yu Y, Du J. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression. Oncogene 2024;43(18):1328 View
  440. Ashok G, Soundararajan A, Anbarasu A, Ramaiah S. Elucidating the molecular role of MUC5B in progressive lung adenocarcinoma: Prospects for early diagnosis. Journal of Molecular Recognition 2024;37(1) View
  441. Peng Q, Ren B, Xin K, Liu W, Alam M, Yang Y, Gu X, Zhu Y, Tian Y. CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers. European Journal of Medical Research 2023;28(1) View
  442. Wang Y, Zhu W, Ma R, Tian Y, Chen X, Gao P. PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1. Journal of Cellular and Molecular Medicine 2024;28(1) View
  443. Ning J, Liu M, Shen J, Wang D, Gao L, Li H, Cao J. Expression signature and prognostic value of CREC gene family in human colorectal cancer. BMC Cancer 2023;23(1) View
  444. Dioguardi M, Spirito F, Iacovelli G, Sovereto D, Laneve E, Laino L, Caloro G, Nabi A, Ballini A, Lo Muzio L, Troiano G. The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review. Non-Coding RNA 2023;9(5):54 View
  445. Sun X, Yuan Z, Zhang L, Ren M, Yang J, Xu Y, Hao J. Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer. Journal of Inflammation Research 2023;Volume 16:3381 View
  446. Wang Z, Ren H, Zhu G, Zhang L, Cao H, Chen B. High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer. BMC Cancer 2023;23(1) View
  447. Lin M, Hu L, Shen S, Liu J, Liu Y, Xu Y, Chen H, Sugimoto K, Li J, Kamitsukasa I, Hiwasa T, Wang H, Xu A. Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events. Stroke and Vascular Neurology 2024;9(2):108 View
  448. LEE S, PARK S. Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma. Korean Journal of Clinical Laboratory Science 2023;55(2):105 View
  449. Han B, He J, Chen Q, Yuan M, Zeng X, Li Y, Zeng Y, He M, Feng D, Ma D. Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation. Aging 2023 View
  450. Ma Z, Chen W, Liu Y, Yu L, Mao X, Guo X, Jiang F, Guo Q, Lin N, Zhang Y. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy. Autophagy 2024;20(3):541 View
  451. Aghajanzadeh T, Talkhabi M, Zali M, Hatami B, Baghaei K. Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. Non-coding RNA Research 2023;8(4):471 View
  452. Qiu J, Wang Z, Zhao L, Zhang P, Xu Y, Xia Q. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma. Frontiers in Molecular Biosciences 2023;10 View
  453. Croft D, Lodhia P, Lourenco S, MacKay C. Effectively utilizing publicly available databases for cancer target evaluation. NAR Cancer 2023;5(3) View
  454. Kurup J, Kim S, Kidder B. Identifying Cancer Type-Specific Transcriptional Programs through Network Analysis. Cancers 2023;15(16):4167 View
  455. Payá-Milans M, Peña-Chilet M, Loucera C, Esteban-Medina M, Dopazo J. Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models. International Journal of Molecular Sciences 2023;24(19):14732 View
  456. Al-Madhagi H. Integrative transcriptomics analysis of early-onset and late-onset colorectal cancer. Informatics in Medicine Unlocked 2023;43:101408 View
  457. Wu J, Cheng T, Zhu B, Gao H, Zheng L, Chen W. Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. Scientific Reports 2023;13(1) View
  458. Li J, Lv M, Huang Q, Hu R, Zhong X, Sun X, Feng W, Han Z, Ma M, Zhang W, Zhou X. FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma. Scientific Reports 2023;13(1) View
  459. Ishikawa A, Yasumatsu R, Fukui T, Kido A, Katsuya N, Sentani K, Kuraoka K, Oue N, Suzuki T, Oka S, Kotachi T, Tanabe K, Ohdan H, Ashktorab H, Smoot D, Yasui W. Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal Transition. Oncology 2024;102(4):354 View
  460. Gershoni A, Hassin O, Nataraj N, Baruch S, Avioz‐Seligman A, Pirona A, Fellus‐Alyagor L, Meir Salame T, Mukherjee S, Mallel G, Yarden Y, Aylon Y, Oren M. TAZ facilitates breast tumor growth by promoting an immune‐suppressive tumor microenvironment. Molecular Oncology 2023;17(12):2675 View
  461. Xie W, Wang W, Meng S, Wu X, Liu X, Liu Y, Kang X, Su Y, Lv X, Guo L, Wang C. A novel hypoxia‐stimulated lncRNA HIF1A‐AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription. Molecular Carcinogenesis 2023;62(12):1860 View
  462. Mansoori B, Kiani S, Mezajin A, Zandi P, Banaie H, Rostamzadeh D, Cho W, Duijf P, Mansoori B, Baradaran B. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2. Clinical Breast Cancer 2023;23(7):e480 View
  463. Lin Y, Lin T, Chen C, Wang R, Lin Y, Tseng T, Zhuang Y, Tang S, Lin Y, Pang J, Chakravarthy R, Lin H, Tzou S, Chao J. Enhancing Efficacy of Albumin-Bound Paclitaxel for Human Lung and Colorectal Cancers through Autophagy Receptor Sequestosome 1 (SQSTM1)/p62-Mediated Nanodrug Delivery and Cancer therapy. ACS Nano 2023;17(19):19033 View
  464. Yan X, Gao Z, Zhang L, Chen C. Reduced Expression of RBP7 is Associated with Resistance to Tamoxifen In Luminal A Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry 2023;23(8):929 View
  465. Wei F, Li T, Li J, Zhang Y, Liu T, Zhao Z, Zhu W, Guo H, Yang R. Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer. Gene 2023;878:147573 View
  466. Li J, Wu F, Su L, Zhu H, Yao J, Zhang M. SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma. Oncology Letters 2023;26(3) View
  467. Bao X, Ran J, Kong C, Wan Z, Wang J, Yu T, Ruan S, Ding W, Xia L, Zhang D. Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors. Heliyon 2023;9(8):e19112 View
  468. Yang D, Wang B, Li Y, Zhang J, Gong X, Qin H, Wang Y, Zhao Y, Wang Y. HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration. Biomedicines 2023;11(11):2889 View
  469. Huo Q, Wang J, Xie N. High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis. BMC Cancer 2023;23(1) View
  470. Kuai X, Lv J, Zhang J, Xu M, Ji J. Serpin Family A Member 1 Is Prognostic and Involved in Immunological Regulation in Human Cancers. International Journal of Molecular Sciences 2023;24(14):11566 View
  471. Guan X, Pavani K, Chunduru J, Broeckx B, Van Soom A, Peelman L. Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis. Cancers 2023;15(20):4915 View
  472. Xie D, Wang Z, Sun B, Qu L, Zeng M, Feng L, Guo M, Wang G, Hao J, Zhou G. High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast. Frontiers of Medicine 2023;17(5):907 View
  473. Feng L, Zhu S, Ma J, Hong Y, Wan M, Qiu Q, Li H, Li J. Integrated bioinformatics analysis and network pharmacology to explore the potential mechanism of Patrinia heterophylla Bunge against acute promyelocytic leukemia. Medicine 2023;102(40):e35151 View
  474. Lee H, Ha S, Choi S, Do S, Yoon S, Kim Y, Kim W. Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. International Journal of Molecular Sciences 2023;24(11):9530 View
  475. Vasiukov G, Zou Y, Senosain M, Rahman J, Antic S, Young K, Grogan E, Kammer M, Maldonado F, Reinhart-King C, Massion P. Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness. Scientific Reports 2023;13(1) View
  476. Al-saraireh Y, Alshammari F, Abu-azzam O, Al-dalain S, Al-sarayra Y, Haddad M, Makeen H, Al-Qtaitat A, Almermesh M, Al-sarayreh S. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention. Biomedicines 2023;11(11):2898 View
  477. Khan S, Lokman N, Oehler M, Ricciardelli C, Yool A. Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels. Cancers 2023;15(18):4507 View
  478. Syamprasad N, Jain S, Rajdev B, Panda S, Gangasani J, Challa V, Vaidya J, Kundu G, Naidu V. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chemico-Biological Interactions 2023;381:110566 View
  479. Somsuan K, Aluksanasuwan S. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma. Genomics & Informatics 2023;21(2):e22 View
  480. Chen Y, Liu Y, Lin Y, Tsai M, Wu S, Chang T, Hsu C, Wu H, Shih J. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis. Journal of Biomedical Science 2023;30(1) View
  481. Sinnarasan V, Paul D, Das R, Venkatesan A. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine. OMICS: A Journal of Integrative Biology 2023;27(6):260 View
  482. Wang H, Wang W, Wang W, Ma J, Su X, Zhang L, Hou Y, Liu J, Ren J, Luo X, Hao M. Folate deficiency promotes cervical squamous carcinoma SiHa cells progression by targeting miR-375/FZD4/β-catenin signaling. The Journal of Nutritional Biochemistry 2024;124:109489 View
  483. Guo X, Cao H, Hu M, Wu Y, Li J, Zhong J. KIF22 in the Prognosis and Immune Biomarking of Pan-Cancer. Journal of Immunology Research 2023;2023:1 View
  484. Purushothaman A, Oliva-Ramírez J, Treekitkarnmongkol W, Sankaran D, Hurd M, Putluri N, Maitra A, Haymaker C, Sen S. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. International Journal of Molecular Sciences 2023;24(19):14652 View
  485. Yamashita T, Takanashi Y, Uebayashi A, Oka M, Mizuno K, Kawase A, Oyama S, Kitamoto T, Kondo M, Omori S, Tao H, Takahashi Y, Sakamoto T, Kahyo T, Sugimura H, Setou M, Shiiya N, Funai K. Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile. Scientific Reports 2023;13(1) View
  486. da Silva E, Mesquita F, Aragão D, de Sousa Portilho A, Marinho A, de Oliveira L, Lima L, de Moraes M, Souza P, Montenegro R. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death. Toxicology and Applied Pharmacology 2023;475:116630 View
  487. Ren L, Qing X, Wei J, Mo H, Liu Y, Zhi Y, Lu W, Zheng M, Zhang W, Chen Y, Zhang Y, Pan T, Zhong Q, Li R, Zhang X, Ruan X, Yu R, Li J. The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer. Cell Death & Disease 2023;14(8) View
  488. Hicks H, Pozdeyev N, Sams S, Pugazhenthi U, Bales E, Hofmann M, McKenna L, Schweppe R. Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2. Molecular Cancer Research 2023;21(9):867 View
  489. Zhu J, Jiang Q. Twist1‑mediated transcriptional activation of Claudin‑4 promotes cervical cancer cell migration and invasion. Oncology Letters 2023;26(2) View
  490. Chu X, Xiao X, Wang G, Uosef A, Lou X, Arnold P, Wang Y, Kong G, Wen M, Minze L, Li X. Gasdermin D-mediated pyroptosis is regulated by AMPK-mediated phosphorylation in tumor cells. Cell Death & Disease 2023;14(7) View
  491. Lin J, Fang W, Xiang Z, Wang Q, Cheng H, Chen S, Fang J, Liu J, Wang Q, Lu Z, Ma L. Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion. Frontiers in Immunology 2023;14 View
  492. Jiang L, Gong Y, Jiang J, Zhao D. Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study. Journal of Cancer Research and Clinical Oncology 2023;149(14):13027 View
  493. Zhao H, Wang Y, He Y, Zhang P, Zeng C, Du T, Shen Q, Zhao S. ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway. Biology Direct 2023;18(1) View
  494. Chatterjee P, Bhowmik D, Roy S. A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions. Channels 2023;17(1) View
  495. He Z, Gu Y, Yang H, Fu Q, Zhao M, Xie Y, Liu Y, Du W. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology 2023;149(13):11661 View
  496. Mirza Z, Ansari M, Iqbal M, Ahmad N, Alganmi N, Banjar H, Al-Qahtani M, Karim S. Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis. Cancers 2023;15(12):3237 View
  497. Ma T, Tang Y, Wang T, Yang Y, Zhang Y, Wang R, Zhang Y, Li Y, Wu M, Tang M, Hu X, Zou C, Ren Y, Liu H, Zhang Q, Li H, Wu M, Li J, Zhou X. Chronic pulmonary bacterial infection facilitates breast cancer lung metastasis by recruiting tumor-promoting MHCIIhi neutrophils. Signal Transduction and Targeted Therapy 2023;8(1) View
  498. Wang R, Wang D, Bai X, Guo J, Xia S, Cheng Y, Gu Y, Wang Q, Nie J, Chen D, Liu W, Liang J. Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma. Cell Death Discovery 2023;9(1) View
  499. Huang Z, Yang H, Lao J, Deng W, Liu J. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma. PLOS ONE 2023;18(7):e0287303 View
  500. Prekovic S, Chalkiadakis T, Roest M, Roden D, Lutz C, Schuurman K, Opdam M, Hoekman L, Abbott N, Tesselaar T, Wajahat M, Dwyer A, Mayayo‐Peralta I, Gomez G, Altelaar M, Beijersbergen R, Győrffy B, Young L, Linn S, Jonkers J, Tilley W, Hickey T, Vareslija D, Swarbrick A, Zwart W. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. EMBO Molecular Medicine 2023;15(12) View
  501. Drif A, Avula B, Khan I, Efferth T. COX2-Inhibitory and Cytotoxic Activities of Phytoconstituents of Matricaria chamomilla L.. Applied Sciences 2023;13(15):8935 View
  502. Armstrong L, Willoughby C, McKenna D. Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer. Cells 2023;12(18):2207 View
  503. Titmarsh H, von Kriegsheim A, Wills J, O’Connor R, Dhaliwal K, Frame M, Pattle S, Dorward D, Byron A, Akram A. Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. Frontiers in Oncology 2023;13 View
  504. Verbruggen S, Nolan J, Duffy M, Pearce O, Jacobs C, Knight M. A Novel Primary Cilium‐Mediated Mechanism Through which Osteocytes Regulate Metastatic Behavior of Both Breast and Prostate Cancer Cells. Advanced Science 2024;11(2) View
  505. Xiao G, Xu X, Chen Z, Zeng J, Xie J. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas. Clinical Medicine Insights: Oncology 2023;17 View
  506. Yu L, Shueng P, Chiu H, Yen Y, Kuo T, Li C, Liu M, Ho C, Ho T, Wang B, Li C, Chen M, Shen Y, Lo C. Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy. ACS Nano 2023;17(14):13158 View
  507. Zhan F, He L, Yu Y, Chen Q, Guo Y, Wang L. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer. Scientific Reports 2023;13(1) View
  508. Wang L, Peng J. METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment. Scientific Reports 2023;13(1) View
  509. Song L, Zeng R, Yang K, Liu W, Xu Z, Kang F. The biological significance of cuproptosis-key gene MTF1 in pan-cancer and its inhibitory effects on ROS-mediated cell death of liver hepatocellular carcinoma. Discover Oncology 2023;14(1) View
  510. Wu J, Li J, Xu H, Qiu N, Huang X, Li H. Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple–negative breast cancer cells. Lipids in Health and Disease 2023;22(1) View
  511. Shihab I, Bouzid A, Yener B, Altaie A, Manasa Bhamidimarri P, Al Ameri M, Bendardaf R, Hamad M, Hamoudi R. Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells. F1000Research 2023;12:1117 View
  512. Wang X, Zhao B, Ren D, Hu X, Qiao J, Zhang D, Zhang Y, Pan Y, Fan Y, Liu L, Wang X, Ma H, Jia X, Song S, Zhao C, Liu J, Wang L. Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis. Cancer Biomarkers 2023;38(2):191 View
  513. Sicking M, Falke I, Löblein M, Eich H, Götte M, Greve B, Troschel F. The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance. Biomarker Research 2023;11(1) View
  514. Hayashi Y, Matsuo Y, Denda Y, Nonoyama K, Murase H, Ueda G, Aoyama Y, Kato T, Omi K, Imafuji H, Saito K, Morimoto M, Ogawa R, Takahashi H, Mitsui A, Kimura M, Takiguchi S. Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines. Oncology Reports 2023;50(3) View
  515. Peng Y, Li X, Kang K, Zhou Y. AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma. Cancer Cell International 2023;23(1) View
  516. Wang X, Wang Y, Chen X, He Y, Zhou X, Jiao S, Zhu Z, Wu C, Bao J. Identification of glycogene-based prognostic signature and validation of B3GNT7 as a potential biomarker and therapeutic target in breast cancer. Journal of Cancer Research and Clinical Oncology 2023;149(19):16957 View
  517. Liu S, Gong L, Huang F, Xu N, Yang K, Liu X, Li W. RNF114 facilitates the proliferation, stemness, and metastasis of colorectal cancer. Pathology - Research and Practice 2023;248:154716 View
  518. Ozcan G. PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer. Frontiers in Oncology 2023;13 View
  519. Dantas E, Murthy A, Ahmed T, Ahmed M, Ramsamooj S, Hurd M, Lam T, Malbari M, Agrusa C, Elemento O, Zhang C, Pappin D, McGraw T, Stiles B, Altorki N, Goncalves M. TIMP1 is an early biomarker for detection and prognosis of lung cancer. Clinical and Translational Medicine 2023;13(10) View
  520. Wang X, Ji Y, Qi J, Zhou S, Wan S, Fan C, Gu Z, An P, Luo Y, Luo J. Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells. Cell Death & Disease 2023;14(8) View
  521. Wang D, Zhang Y, Liao Z, Ge H, Güngör C, Li Y. KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. Scientific Reports 2023;13(1) View
  522. Posta M, Győrffy B. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clinical and Translational Science 2023;16(8):1479 View
  523. Sharma D, Hager C, Shang L, Tran L, Zhu Y, Ma A, Magnuson B, Lesko M, Wicha M, Burness M. The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. Breast Cancer Research 2023;25(1) View
  524. Tang Y, Sun Z, Wu S, Zhang C, Zhang Y, Cao Y. Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (CTNNB1) synergizes with cisplatin in lung cancer. Biomedicine & Pharmacotherapy 2023;168:115828 View
  525. Bitler B, Bailey C, Yamamoto T, McMellen A, Kim H, Watson Z. Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma. Molecular Carcinogenesis 2023;62(11):1717 View
  526. Liu L, Xiao B, Hirukawa A, Smith H, Zuo D, Sanguin-Gendreau V, McCaffrey L, Nam A, Muller W. Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways. Proceedings of the National Academy of Sciences 2023;120(33) View
  527. Price Z, Lokman N, Sugiyama M, Koya Y, Yoshihara M, Oehler M, Kajiyama H, Ricciardelli C. Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. Cellular and Molecular Life Sciences 2023;80(11) View
  528. Diedrich J, Cole C, Pianko M, Colacino J, Bernard J. Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival. Cancers 2023;15(21):5255 View
  529. Nianyong Y, Li G. Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-3p/FMR1 axis in malignant metastasis of clear cell renal cell carcinoma. Aging 2023 View
  530. Kong W, Huang Y, Jiang P, Tu Y, Li N, Wang J, Zhou Q, Zheng Y, Gou S, Tian C, Yuan R. YAP1 affects the prognosis through the regulation of stemness in endometrial cancer. PeerJ 2023;11:e15891 View
  531. Momin I, Rigler J, Chitrala K. Analysis of Potential Biomarkers in Frontal Temporal Dementia: A Bioinformatics Approach. International Journal of Molecular Sciences 2023;24(19):14910 View
  532. Yang Z, Qi Y, Wang Y, Chen X, Wang Y, Zhang X. Identifying Network Biomarkers in Early Diagnosis of Hepatocellular Carcinoma via miRNA–Gene Interaction Network Analysis. Current Issues in Molecular Biology 2023;45(9):7374 View
  533. Grazia G, Bastos D, Villa L. CD40/CD40L expression and its prognostic value in cervical cancer. Brazilian Journal of Medical and Biological Research 2023;56 View
  534. Kubaichuk K, Kietzmann T. USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis. Cells 2023;12(12):1585 View
  535. Xie X, Laster K, Li J, Nie W, Yi Y, Liu K, Seong Y, Dong Z, Kim D. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer. Cellular and Molecular Life Sciences 2023;80(9) View
  536. Wang Z, Zhang J, Shi S, Ma H, Wang D, Zuo C, Zhang Q, Lian C. Predicting lung adenocarcinoma prognosis, immune escape, and pharmacomic profile from arginine and proline-related genes. Scientific Reports 2023;13(1) View
  537. Li K, Peng Z, Wang R, Li X, Du N, Liu D, Zhang J, Zhang Y, Ma L, Sun Y, Tang S, Ren H, Yang Y, Sun X. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Molecular Cancer 2023;22(1) View
  538. Pan J, Gao Y. Prognostic significance and immune characteristics of GPR27 in gastric cancer. Aging 2023;15(17):9144 View
  539. Mayengbam S, Singh A, Yaduvanshi H, Bhati F, Deshmukh B, Athavale D, Ramteke P, Bhat M. Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells. Cancer & Metabolism 2023;11(1) View
  540. Yang S, Zhou D, Zhang C, Xiang J, Xi X. Function of m 5 C RNA methyltransferase NOP2 in high-grade serous ovarian cancer. Cancer Biology & Therapy 2023;24(1) View
  541. Rong B, Chen X, Xie G, Han L, Chen H, Sun Q, Zhou Y. Gastric Cancer Growth Modulated by circSNTB2/miR-6938-5p/G0S2 and PDCD4. Combinatorial Chemistry & High Throughput Screening 2023;26(11):1990 View
  542. Kuo W, Chu P, Wang C, Huang P, Chan S. MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression. Biology Direct 2023;18(1) View
  543. Sun Q, An R, Li J, Liu C, Wang M, Wang C, Wang Y. The role of CXCL8 and CCNB1 in predicting hepatocellular carcinoma in the context of cirrhosis: implications for early detection and immune-based therapies. Journal of Cancer Research and Clinical Oncology 2023;149(13):11471 View
  544. Yun R, Hong E, Kim J, Park B, Kim S, Lee B, Song Y, Kim S, Park S, Kang J. N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer. Cell Death & Disease 2023;14(8) View
  545. Gong H, Zhang P, Hu X, Zhang B. Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer. Translational Oncology 2024;39:101808 View
  546. Tabassum G, Singh P, Gurung R, Hakami M, Alkhorayef N, Alsaiari A, Alqahtani L, Hasan M, Rashid S, Kumar A, Dev K, Dohare R. Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach. Scientific Reports 2023;13(1) View
  547. de Azevedo A, Carvalho T, Mara C, Giner I, de Oliveira J, Gradia D, Cavalli I, Ribeiro E. Major regulators of the multi-step metastatic process are potential therapeutic targets for breast cancer management. Functional & Integrative Genomics 2023;23(2) View
  548. Zhao Z, Luan T, Wan J, Du H, Hu J, Liu H, Gong X, Kuang G, Wang B. Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. Medicina 2023;59(9):1639 View
  549. Wang B, Shen X, Pan L, Li Z, Chen C, Yao Y, Tang D, Gao W. The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D1. Molecular Carcinogenesis 2023;62(11):1630 View
  550. Samart P, Heenatigala Palliyage G, Issaragrisil S, Luanpitpong S, Rojanasakul Y. Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition. Cell & Bioscience 2023;13(1) View
  551. Dwivedi K, Rajpal A, Rajpal S, Kumar V, Agarwal M, Kumar N. Enlightening the path to NSCLC biomarkers: Utilizing the power of XAI-guided deep learning. Computer Methods and Programs in Biomedicine 2024;243:107864 View
  552. González-Castrillón L, Wurmser M, Öhlund D, Wilson S. Dysregulation of core neurodevelopmental pathways—a common feature of cancers with perineural invasion. Frontiers in Genetics 2023;14 View
  553. Sanchez-Cabrero D, Garcia-Guede Á, Burdiel M, Pernía O, Colmenarejo-Fernandez J, Gutierrez L, Higuera O, Rodriguez I, Rosas-Alonso R, Rodriguez-Antolín C, Losantos-García I, Vera O, De Castro-Carpeño J, Ibanez de Caceres I. miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients. International Journal of Molecular Sciences 2023;24(14):11464 View
  554. Ke B, Liang Z, Li B, Wang X, Liu N, Liang H, Zhang R. EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer. PeerJ 2023;11:e15559 View
  555. Qusairy Z, Gangloff A, Leung S. Dysregulation of Cholesterol Homeostasis in Ovarian Cancer. Current Oncology 2023;30(9):8386 View
  556. Polak K, Tamagno I, Parameswaran N, Smigiel J, Chan E, Yuan X, Rios B, Jackson M. Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs. Molecular Cancer Research 2023;21(9):975 View
  557. Ding J, Li C, Shu K, Chen W, Cai C, Zhang X, Zhang W, Dutta S. Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer. PLOS ONE 2023;18(8):e0289960 View
  558. Accattatis F, Caruso A, Carleo A, Del Console P, Gelsomino L, Bonofiglio D, Giordano C, Barone I, Andò S, Bianchi L, Catalano S. CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses. Nutrients 2023;15(13):2839 View
  559. Liu J, Wang Y, Zhao Z, Ge Y. Bioinformatics analysis and experimental validation of tumorigenic role of PPIA in gastric cancer. Scientific Reports 2023;13(1) View
  560. Dogra S, Elayapillai S, Qu D, Pitts K, Filatenkov A, Houchen C, Berry W, Moxley K, Hannafon B. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer. Cancer Letters 2023;578:216437 View
  561. Zhu C, Du Y, Huai Q, Fang N, Xu W, Yang J, Li X, Zhang Y, Zhang X, Dai H, Li X, Wang H, Dai Y. The Identification of Gamma-Glutamyl Hydrolase in Uterine Corpus Endometrial Carcinoma: a Predictive Model and Machine Learning. Reproductive Sciences 2024;31(2):532 View
  562. Gupta S, Mittal P, Kundu B, Singh A, Singh I. Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer. Journal of Biomolecular Structure and Dynamics 2024;42(22):12122 View
  563. Xiao M, Li F, Xie P, Qi Y, Xie J, Pei W, Luo H, Guo M, Gu Y, Piao X. Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1. Chemico-Biological Interactions 2023;383:110674 View
  564. Mukherjee A, Yadav P, Mukunthan K. Unveiling Potential Targeted Therapeutic Opportunities for Co-Overexpressed Targeting Protein for Xklp2 and Aurora-A Kinase in Lung Adenocarcinoma. Molecular Biotechnology 2024;66(10):2792 View
  565. Kuang Y, Feng J, Jiang Y, Jin Q, Wang Q, Zhang C, He Y. Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis. International Journal of Immunopathology and Pharmacology 2023;37 View
  566. Oto J, Le Q, Schäfer S, Kiesel L, Marí-Alexandre J, Gilabert-Estellés J, Medina P, Götte M. Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets. Cancers 2023;15(12):3125 View
  567. Pernar Kovač M, Tadić V, Kralj J, Duran G, Stefanelli A, Stupin Polančec D, Dabelić S, Bačić N, Tomicic M, Heffeter P, Sikic B, Brozovic A. Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer. Cellular and Molecular Life Sciences 2023;80(10) View
  568. Guo S, Ma Y, Li X, Li W, He X, Yuan Z, Hu Y. Identification of stromal cell proportion-related genes in the breast cancer tumor microenvironment using CorDelSFS feature selection: implications for tumor progression and prognosis. Frontiers in Genetics 2023;14 View
  569. Umemori K, Ono K, Eguchi T, Kawai H, Nakamura T, Ogawa T, Yoshida K, Kanemoto H, Sato K, Obata K, Ryumon S, Yutori H, Katase N, Okui T, Nagatsuka H, Ibaragi S. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma. Oral Oncology 2023;142:106433 View
  570. Gu X, Dai X, Huang Y, Zhang Y, Dong L, Gao C, Wang F. Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients. Scientific Reports 2023;13(1) View
  571. Zhang P, Zhao J, Yuan L, Ju L, Wang H, Wang F, Chen L, Cai W. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Scientific Reports 2023;13(1) View
  572. Fan Y, Lu I, Hsu M, Kuo W, Wu S, Lan S, Wang P, Chen C, Liu H, Su C. Synthetic lethality in human bladder cancer cells by curcumin via concurrent Aurora A inhibition and autophagy induction. The Journal of Nutritional Biochemistry 2023;121:109438 View
  573. Petrini I, Cecchini R, Mascaró M, Ponzoni I, Carballido J. Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data. Genes 2023;14(6):1250 View
  574. Castro-Guijarro A, Sanchez A, Flamini M. Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+ Breast Cancer. Cancers 2023;15(17):4374 View
  575. Wu H, Wu Z, Hou Y, Fang Z, Wu B, Deng Y, Cui Y, Liu J. SIX4 , a Potential Therapeutic Target for Estrogen Receptor-Positive Breast Cancer Patients, is Associated with low Promoter Methylation Level. Epigenomics 2023;15(18):911 View
  576. Chen L, Ballout F, Lu H, Hu T, Zhu S, Chen Z, Peng D. Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus. Cancers 2023;15(19):4821 View
  577. Ramalingam P, Priyadharshini A, Emerson I, Arumugam S. Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma. Frontiers in Medicine 2023;10 View
  578. Shi Q, Zheng X, Hu Y, Zhou Z, Fang M, Huang X. Methylation of hypoxia-inducible factor 3 subunit alpha contributes to poor prognosis in lung adenocarcinoma. Journal of Applied Genetics 2023;64(4):769 View
  579. Wu H, Wu J, Yeh Y, Wu T, Chao C, Wang W, Chen T. DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker. iScience 2023;26(8):107269 View
  580. Wang C, Jiang X, Zhao Q, Xie Z, Cai H. The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis. Biomedical Reports 2023;19(5) View
  581. Dhillon A, Singh A, Bhalla V. iMVAN: integrative multimodal variational autoencoder and network fusion for biomarker identification and cancer subtype classification. Applied Intelligence 2023;53(22):26672 View
  582. Di Giorgio C, Bellini R, Lupia A, Massa C, Urbani G, Bordoni M, Marchianò S, Rosselli R, De Gregorio R, Rapacciuolo P, Sepe V, Morretta E, Monti M, Moraca F, Cari L, Ullah K, Natalizi N, Graziosi L, Distrutti E, Biagioli M, Catalanotti B, Donini A, Zampella A, Fiorucci S. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer. Cellular Oncology 2024;47(2):695 View
  583. Kuchitsu Y, Nishihara N, Kodera Y, Tamura K, Imai M, Nagashio R. Acquisition of diagnosis markers for lung adenocarcinoma by shotgun analysis targeting membrane proteins. Electrophoresis Letters 2023;67(1):19 View
  584. Dong R, Qin C, Yin Y, Han L, Xiao C, Wang K, Wei R, Xia Y, Kong L. Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells. British Journal of Pharmacology 2023 View
  585. Voutsadakis I. Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer. Current Issues in Molecular Biology 2023;45(11):8670 View
  586. Li Q, Yang Z, He X, Yang X. Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer. Scientific Reports 2023;13(1) View
  587. Wu J, Liu C, Wang T, Liu H, Wei B. Deubiquitinase inhibitor PR‐619 potentiates colon cancer immunotherapy by inducing ferroptosis. Immunology 2023;170(3):439 View
  588. Obermayer A, Chang D, Nobles G, Teng M, Tan A, Wang X, Chen Y, Eschrich S, Rodriguez P, Grass G, Meshinchi S, Tarhini A, Chen D, Shaw T. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing. BMC Bioinformatics 2023;24(1) View
  589. Wang M, Li J, Yang X, Yan Q, Wang H, Xu X, Lu Y, Li D, Wang Y, Sun R, Zhang S, Zhang Y, Zhang Z, Meng F, Li Y. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis. Cancer Gene Therapy 2023;30(11):1485 View
  590. 石野 孔, 大橋 隆. オミクス解析を用いたバイオマーカー開発から空間的分子解析による形態理解へ. Nihon Ika Daigaku Igakkai Zasshi 2023;19(2):78 View
  591. Liu P, Liu Z, Luo Q, Fu Q, Zhang X, Yu P, Zhou S, Wang Y, Zhang J, Chen S, Zhang H, Zhu Q, Qin T. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports 2023;13(1) View
  592. Pérez-Aguilar B, Marquardt J, Muñoz-Delgado E, López-Durán R, Gutiérrez-Ruiz M, Gomez-Quiroz L, Gómez-Olivares J. Changes in the Acetylcholinesterase Enzymatic Activity in Tumor Development and Progression. Cancers 2023;15(18):4629 View
  593. Han W, Shi C, Chen H, Zhou Q, Ding W, Chen F, Liang Z, Teng Y, Shao Q, Dong X. Role of LncRNA MIR99AHG in breast cancer: Bioinformatic analysis and preliminary verification. Heliyon 2023;9(9):e19805 View
  594. Hsu F, Liu W, Lee S, Jeng L, Chen J. Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis. Phytomedicine 2023;119:154947 View
  595. Arumi-Planas M, Rodriguez-Baena F, Cabello-Torres F, Gracia F, Lopez-Blau C, Nieto M, Sanchez-Laorden B. Microenvironmental Snail1-induced immunosuppression promotes melanoma growth. Oncogene 2023;42(36):2659 View
  596. Xiu M, Bao W, Wang J, Chen J, Li Y, Hai Y. High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma. BMC Cancer 2023;23(1) View
  597. Soltan M, Alhanshani A, Shati A, Alqahtani Y, Alshaya D, Alharthi J, Altalhi S, Fayad E, Zaki M, Eid R. Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines 2023;11(8):2254 View
  598. Juan-Guadarrama D, Beltrán-Navarro Y, Reyes-Cruz G, Vázquez-Prado J. Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types. International Journal of Molecular Sciences 2023;24(22):16427 View
  599. Wang K, Jiang X, Jiang Y, Liu J, Du Y, Zhang Z, Li Y, Zhao X, Li J, Zhang R. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A. Journal of Experimental & Clinical Cancer Research 2023;42(1) View
  600. Agostini A, Guerriero I, Piro G, Quero G, Roberto L, Esposito A, Caggiano A, Priori L, Scaglione G, De Sanctis F, Sistigu A, Musella M, Larghi A, Rizzatti G, Lucchetti D, Alfieri S, Sgambato A, Bria E, Bizzozero L, Arena S, Ugel S, Corbo V, Tortora G, Carbone C. Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer. Journal of Translational Medicine 2023;21(1) View
  601. Tan X, Wang Z, Liao S, Yi M, Tao D, Zhang X, Leng X, Shi J, Xie S, Yang Y, Liu Y. NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis. Cancer Science 2024;115(2):465 View
  602. Wang S, Liu Y, Xiao H, Chen Z, Yang X, Yin J, Li Y, Yuan C, Yan S, Chen G, Gao Q, Kong B, Sun C, Song K. Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer. Cell Death & Disease 2023;14(11) View
  603. Dwivedi K, Rajpal A, Rajpal S, Kumar V, Agarwal M, Kumar N. XLR-Net: Explainable AI-driven improved L1-regularized deep neural architecture for NSCLC biomarker identification. Computational Biology and Chemistry 2024;108:107990 View
  604. Bao Y, Qiao Y, Choi J, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove S, Cao X, Su F, Wang R, Chang Y, Kryczek I, Cieslik M, Green M, Zou W, Chinnaiyan A. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proceedings of the National Academy of Sciences 2023;120(49) View
  605. Huang P, Chang C, Lin Y, Chen C, Chen T, Chuang L, Liu C, Huang C, Li W. Pyruvate Kinase Differentially Alters Metabolic Signatures during Head and Neck Carcinogenesis. International Journal of Molecular Sciences 2023;24(23):16639 View
  606. Menadi S, Kucuk B, Cacan E. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Biochemical Genetics 2024;62(4):2721 View
  607. Chan S, Kuo W, Wang L. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer. Journal of Biomedical Science 2023;30(1) View
  608. Ma J, Xiang C, Zhu H, Bai B, Wang P, Zhao G. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer. Heliyon 2024;10(1):e23163 View
  609. Samadi P, Shahnazari M, Shekari A, Maghool F, Jalali A. A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma. Cancer Cell International 2023;23(1) View
  610. Kwon J, Jang Y, Yun B, Kang S, Kim Y, Kim B, Cho N. MET overexpression in ovarian cancer via CD24‐induced downregulation of miR‐181a: A signalling for cellular quiescence‐like state and chemoresistance in ovarian CSCs. Cell Proliferation 2024;57(5) View
  611. Bachert S, Di J, Zhang S, Short H, Piecoro D, McDonald R, Myint Z, Hensley P, Allison D. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?. Human Pathology 2024;143:42 View
  612. Llinàs-Arias P, Ensenyat-Mendez M, Íñiguez-Muñoz S, Orozco J, Valdez B, Salomon M, Matsuba C, Solivellas-Pieras M, Bedoya-López A, Sesé B, Mezger A, Ormestad M, Unzueta F, Strand S, Boiko A, Hwang E, Cortés J, DiNome M, Esteller M, Lupien M, Marzese D. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors. Molecular Cancer 2023;22(1) View
  613. Mukherjee S, Chakraborty S, Basak U, Pati S, Dutta A, Dutta S, Roy D, Banerjee S, Ray A, Sa G, Das T. Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination. Discover Oncology 2023;14(1) View
  614. Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, Lv G, Zong Q, Wang L, Wu Z, Feng Q, Yang W, Wang H. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Science Advances 2023;9(49) View
  615. Peng X, Cai Z, Chen D, Ye F, Hong L. Prognostic significance and immune characteristics of APOE in gastric cancer. Aging 2023;15(23):13840 View
  616. Gu Y, Wang M, Gong Y, Li X, Wang Z, Wang Y, Jiang S, Zhang D, Li C. Unveiling Breast Cancer Risk Profiles: A Survival Clustering Analysis Empowered by an Online Web Application. Future Oncology 2023;19(40):2651 View
  617. Jian Y, Zhang L, Gong L, Ding M, Sun X, Yu X, Lv S, Li J, Yang D, Wang S. CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma. Cancer Cell International 2023;23(1) View
  618. Yakubovich E, Cook D, Rodriguez G, Vanderhyden B. Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis. npj Systems Biology and Applications 2023;9(1) View
  619. Sessler T, Quinn G, Wappett M, Rogan E, Sharkey D, Ahmaderaghi B, Lawler M, Longley D, McDade S. surviveR: a flexible shiny application for patient survival analysis. Scientific Reports 2023;13(1) View
  620. Chang S, Mezzano-Robinson V, Zhou H, Moreira A, Pillai R, Ramaswami S, Loomis C, Heguy A, Tsirigos A, Pass H. Digital spatial profiling to predict recurrence in grade 3 stage I lung adenocarcinoma. The Journal of Thoracic and Cardiovascular Surgery 2024;168(3):648 View
  621. Xu S, Liu D, Qin Z, Liang Z, Xie H, Yi B, Wang K, Lin G, Liu R, Yang K, Xu Y, Zhang H. Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer. Aging 2023;15(24):15134 View
  622. Al-Yahya S, Al-Saif M, Al-Ghamdi M, Moghrabi W, Khabar K, Al-Souhibani N. Post-transcriptional regulation of BIRC5/survivin expression and induction of apoptosis in breast cancer cells by tristetraprolin. RNA Biology 2024;21(1):1 View
  623. Liao C, Wang X. TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinformatics 2023;24(1) View
  624. Patil N, Abdelrahim O, Leupold J, Allgayer H. JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer. Cancers 2023;16(1):24 View
  625. Lefebvre A, Trioën C, Renaud S, Laine W, Hennart B, Bouchez C, Leroux B, Allorge D, Kluza J, Werkmeister E, Grolez G, Delhem N, Moralès O. Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin‐9 dependent mechanism. Journal of Extracellular Vesicles 2023;12(12) View
  626. Li C, Yin Y, Tao R, Lin Y, Wang T, Shen Q, Li R, Tao K, Liu W. ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer. Cell Death Discovery 2023;9(1) View
  627. Wang F, Hu D, Lou X, Wang Y, Wang L, Zhang T, Yan Z, Meng N, Zou Y. BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer. Gene 2024;898:148109 View
  628. Gómez-Valenzuela F, Wichmann I, Suárez F, Kato S, Ossandón E, Hermoso M, Fernández E, Cuello M. Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Cancers 2023;16(1):80 View
  629. Xu K, Zheng X, Shi H, Ou J, Ding H. MAD2L2, a key regulator in ovarian cancer and promoting tumor progression. Scientific Reports 2024;14(1) View
  630. Iwabuchi S, Takahashi K, Kawaguchi K, Nagatsu A, Imafuku T, Shichino S, Matsushima K, Taketomi A, Honda M, Hashimoto S. Phospholipase A2 Group IIA Is Associated with Inflammatory Hepatocellular Adenoma. Cancers 2023;16(1):159 View
  631. Rodriguez G, Yakubovich E, Murshed H, Maranda V, Galpin K, Cudmore A, Hanna A, Macdonald E, Ramesh S, Garson K, Vanderhyden B. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens. Frontiers in Immunology 2024;14 View
  632. Hu Y, Jiang N, Wang X, Wu X, Bo J, Chen Y, Zeng Y, Wei X, Zhang H, Li M. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer. Life Sciences 2024;338:122389 View
  633. Xia T, Ye F, Zhao W, Min P, Qi C, Wang Q, Zhao M, Zhang Y, Du J. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and Ovarian Cancer Cell Invasion. International Journal of Molecular Sciences 2023;25(1):518 View
  634. Chen C, Aluksanasuwan S, Somsuan K. Expression of anoctamin 7 (ANO7) is associated with poor prognosis and mucin 2 (MUC2) in colon adenocarcinoma: a study based on TCGA data. Genomics & Informatics 2023;21(4):e46 View
  635. Chiu H, Lee H, Lee H, Lu H, Lin K, Lin Y, Lin C. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma. Journal of Translational Medicine 2024;22(1) View
  636. Li C, Yang L, Zhang Y, Hou Q, Wang S, Lu S, Tao Y, Hu W, Zhao L. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer. Frontiers in Immunology 2024;14 View
  637. Shan Y, Liu D, Li Y, Wu C, Ye Y. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer. PeerJ 2024;12:e16594 View
  638. Zhao S, Wang Q, Zhang X, Ma B, Shi Y, Yin Y, Kong W, Zhang W, Li J, Yang H. MARCH5-mediated downregulation of ACC2 promotes fatty acid oxidation and tumor progression in ovarian cancer. Free Radical Biology and Medicine 2024;212:464 View
  639. Zhou W, Zhao Z, Lin A, Yang J, Xu J, Wilder-Romans K, Yang A, Li J, Solanki S, Speth J, Walker N, Scott A, Wang L, Wen B, Andren A, Zhang L, Kothari A, Yao Y, Peterson E, Korimerla N, Werner C, Ullrich A, Liang J, Jacobson J, Palavalasa S, O’Brien A, Elaimy A, Ferris S, Zhao S, Sarkaria J, Győrffy B, Zhang S, Al-Holou W, Umemura Y, Morgan M, Lawrence T, Lyssiotis C, Peters-Golden M, Shah Y, Wahl D. GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress. Cancer Discovery 2024;14(1):158 View
  640. Liu X, Yuan R, Peng J, Xu A, Nie X, Tang R, Li G. SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer. Scientific Reports 2024;14(1) View
  641. Chen C, Liu H, Li Y, Xu Q, Liu J. Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma. BMC Cancer 2024;24(1) View
  642. Gan Z, Abudurexiti A, Hu X, Chen W, Zhang N, Sang W. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer. Medicine 2024;103(2):e35722 View
  643. Luk C, Lee S, Naidovski N, Liu F, Tay A, Wang L, Riordan S, Zhang L. Investigation of Campylobacter concisus gastric epithelial pathogenicity using AGS cells. Frontiers in Microbiology 2024;14 View
  644. Fu B, Zhou M, Geng X, Jiang Y, Zeng H, Zhou X, Yu Z, Pan J, Zhu Y, Zheng H, Huang S, Gong Y, Huang D, Zhong Y. LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior. Aging 2024 View
  645. Cisneros-Villanueva M, Fonseca-Montaño M, Ríos-Romero M, López-Camarillo C, Jiménez-Morales S, Langley E, Rosette-Rueda A, Cedro-Tanda A, Hernández-Sotelo D, Hidalgo-Miranda A. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. Scientific Reports 2024;14(1) View
  646. Li L, Yang L, Liu L, Liu F, Li A, Zhu Y, Wen H, Xue X, Tian Z, Sun H, Li P, Zhao X. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer. Acta Pharmacologica Sinica 2024;45(5):1060 View
  647. Li Y, Wei D, Chen Z, Chen Y, Deng Y, Li M, Zhao Y, Niu K. RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities. Experimental Cell Research 2024;435(2):113932 View
  648. Van Stiphout C, Kelly G, Pallegar N, Elbakry E, Vilchis-Celis A, Christian S, Viloria-Petit A. Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells. Exploration of Targeted Anti-tumor Therapy 2023;5(1):1 View
  649. Guo Z, Liang J, Zhang X, Ai Q, Xie Z, Zhao H, Wu F, Tan Z, Yin W, Ji L. PCM1: A Potential Prognostic Biomarker Correlated with Immune Infiltration in Lung Adenocarcinoma. Current Proteomics 2023;20(3):208 View
  650. Cipolletti M, Acconcia F. PMM2 controls ERα levels and cell proliferation in ESR1 Y537S variant expressing breast cancer cells. Molecular and Cellular Endocrinology 2024;584:112160 View
  651. Suleman M, Khattak A, Akbar F, Rizwan M, Tayyab M, Yousaf M, Khan A, Albekairi N, Agouni A, Crovella S. Analysis of E2F1 single-nucleotide polymorphisms reveals deleterious non-synonymous substitutions that disrupt E2F1-RB protein interaction in cancer. International Journal of Biological Macromolecules 2024;260:129559 View
  652. Yang Q, Peng X, Nian Z, Yuan S, Wang Z, Song Y, Shamsnur R, Wang H, Yi T. UCHL-3 as a potential biomarker of ovarian cancer. Gynecologic Oncology 2024;182:156 View
  653. Wang X, Tao Y, Zhang C, Tian J, Yu W. Expression heterogeneity, tumor immune characteristics and the prognosis effects of OPRL1 in patients with tumors: a pan-cancer study combined with bioinformation analyses and in vitro validation. Anesthesiology and Perioperative Science 2024;2(1) View
  654. Alaa Eldeen M, Mamdouh F, Abdulsahib W, Eid R, Alhanshani A, Shati A, Alqahtani Y, Alshehri M, Samir A. Zaki M, Soltan M, Noreldin A. Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors. Pharmaceuticals 2024;17(2):152 View
  655. Singh P, Solanki R, Tasneem A, Suri S, Kaur H, Shah S, Dohare R. Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics approach. Journal of Genetic Engineering and Biotechnology 2024;22(1):100337 View
  656. Li J, Liu C, Su H, Dong H, Wang Z, Wang Y, Zhao P, Zhang C, Zhao Y, Ma X. Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma. Aging 2024 View
  657. Matsumoto M, Ogawa N, Fukuda T, Bando Y, Nishimura T, Usuda J. Protein interaction networks characterizing the A549 cells Klotho transfected are associated with activated pro-apoptotic Bim and suppressed Wnt/β-catenin signaling pathway. Scientific Reports 2024;14(1) View
  658. Zhou J, Hu Y, Cao Y, Ding S, Zeng L, Zhang Y, Cao M, Duan G, Zhang X, Bian X, Tian G. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy. Journal of Colloid and Interface Science 2024;660:869 View
  659. Yang J, Wu X, You J. Unveiling the potential of HSPA4: a comprehensive pan-cancer analysis of HSPA4 in diagnosis, prognosis, and immunotherapy. Aging 2024 View
  660. Du T, Hu X, Hou Z, Wang W, You S, Wang M, Ji M, Xue N, Chen X. Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition. Cellular and Molecular Life Sciences 2024;81(1) View
  661. Dong R, Wang Z, Cao D, Li Y, Fei Y, Gao P, Zhu M, Chen Z, Cai J, Zuo X. The ‘Other’ subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma. IET Systems Biology 2024;18(1):23 View
  662. Ni T, Zhao R, Wu J, Li C, Xue G, Lin X. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation. Biochemical Genetics 2024;62(6):4446 View
  663. Sheng G, Li F, Jin W, Wang K. Pan-caner analysis identifies PSMA7 as a targets for amplification at 20q13.33 in tumorigenesis. Scientific Reports 2024;14(1) View
  664. Zapata-García J, Jave-Suárez L, Aguilar-Lemarroy A. Delving into the Role of Receptor-like Tyrosine Kinase (RYK) in Cancer: In Silico Insights into Its Diagnostic and Prognostic Utility. Journal of Molecular Pathology 2024;5(1):66 View
  665. Joshi V, Stacey A, Feng Y, Kalita‐de Croft P, Duijf P, Simpson P, Lakhani S, McCart Reed A. NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis. The Journal of Pathology: Clinical Research 2024;10(2) View
  666. Mendiburu‐Eliçabe M, García‐Sancha N, Corchado‐Cobos R, Martínez‐López A, Chang H, Hua Mao J, Blanco‐Gómez A, García‐Casas A, Castellanos‐Martín A, Salvador N, Jiménez‐Navas A, Pérez‐Baena M, Sánchez‐Martín M, Abad‐Hernández M, Carmen S, Claros‐Ampuero J, Cruz‐Hernández J, Rodríguez‐Sánchez C, García‐Cenador M, García‐Criado F, Vicente R, Castillo‐Lluva S, Pérez‐Losada J. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence. Clinical and Translational Medicine 2024;14(2) View
  667. Feng Y, Jin C, Wang T, Chen Z, Ji D, Zhang Y, Zhang C, Zhang D, Peng W, Sun Y. The Uridylyl Transferase TUT7‐Mediated Accumulation of Exosomal miR‐1246 Reprograms TAMs to Support CRC Progression. Advanced Science 2024;11(15) View
  668. Choudhury C, Gill M, McAleese C, Butcher N, Ngo S, Steyn F, Minchin R. The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction. Pharmacological Reviews 2024;76(2):300 View
  669. Wang Q, Li L, Gao X, Zhang C, Xu C, Song L, Li J, Sun X, Mao F, Wang Y. Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75–IP3R‐Ca2+‐AMPK Axis. Advanced Science 2024;11(15) View
  670. Giraud J, Chalopin D, Ramel E, Boyer T, Zouine A, Derieppe M, Larmonier N, Adotevi O, Le Bail B, Blanc J, Laurent C, Chiche L, Derive M, Nikolski M, Saleh M. THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1. Cell Reports 2024;43(2):113773 View
  671. Feng L, Zhang N, Luo L, Liu J, Yao Y, Gao M, Pan J, He C. Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma. Cancer Management and Research 2024;Volume 16:95 View
  672. Shi L, Shangguan J, Lu Y, Rong J, Yang Q, Yang Y, Xie C, Shu X. ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression. Journal of Translational Medicine 2024;22(1) View
  673. Jang Y, Kang S, Han H, Kim B, Cho N. CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation. Cell Death Discovery 2024;10(1) View
  674. Gurung R, Masood M, Singh P, Jha P, Sinha A, Ajmeriya S, Sharma M, Dohare R, Haque M. Uncovering the role of aquaporin and chromobox family members as potential biomarkers in head and neck squamous cell carcinoma via integrative multiomics and in silico approach. Journal of Applied Genetics 2024;65(4):839 View
  675. Yoo W, Kim A, Kook H, Noh K. Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma. Frontiers in Pharmacology 2024;15 View
  676. Hua R, Ma Y, Yang L, Hao J, Hua Q, Shi L, Yao X, Zhi H, Liu Z. Experimental evidence for cancer resistance in a bat species. Nature Communications 2024;15(1) View
  677. Mohamed A, Salama A, Sabaa M, Toraih E, Elshazli R. GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover Susceptibility to Bladder Carcinoma. Archives of Medical Research 2024;55(3):102970 View
  678. Antonisamy A, Rajendran K, Dhanaraj P. Network pharmacology integrated molecular docking of fucoidan against oral cancer and in vitro evaluation- A study using GEO datasets. Journal of Biomolecular Structure and Dynamics 2024:1 View
  679. Nishimura T, Végvári Á, Nakamura H, Fujii K, Sakai H, Naruki S, Furuya N, Saji H. Cancer cell immunity-related protein co-expression networks are associated with early-stage solid-predominant lung adenocarcinoma. Frontiers in Oncology 2024;14 View
  680. Liu S, Liang Z, Wang Y, Ren Y, Gu Y, Qiao Y, He H, Li Y, Cheng Y, Liu Y. MCM2 is involved in subtyping and tamoxifen resistance of ERα‐positive breast cancer by acting as the downstream factor of ERα. Biotechnology Journal 2024;19(2) View
  681. Asghariazar V, Makaremi S, Zare E, Danesh H, Matin S, Fouladi N, Safarzadeh E. Oleuropein induces apoptosis in gastric cancer cell lines by regulating mir-34a, mir-21, and related genes: An experimental and bioinformatic study. International Journal of Biological Macromolecules 2024;265:130527 View
  682. Ershov P, Yablokov E, Mezentsev Y, Ivanov A. Long Intergenic Non-Coding RNAs of Human Chromosome 18: Focus on Cancers. Biomedicines 2024;12(3):544 View
  683. Zhang Z, Zhang L, Li J, Feng R, Li C, Liu Y, Sun G, Xiao F, Zhang C. Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing. Computational and Structural Biotechnology Journal 2024;23:1144 View
  684. Alkafaas S, Elsalahaty M, Ismail D, Radwan M, Elkafas S, Loutfy S, Elshazli R, Baazaoui N, Ahmed A, Hafez W, Diab M, Sakran M, El-Saadony M, El-Tarabily K, Kamal H, Hessien M. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target. Cancer Cell International 2024;24(1) View
  685. Harada M, Kotani H, Iida Y, Tanino R, Minami T, Komohara Y, Yoshikawa K, Uemura H. Hypoxia‐related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis. Cancer Science 2024;115(5):1405 View
  686. Peng H, Feng K, Jia W, Li Y, Lv Q, Zhang Y. An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness. Apoptosis 2024;29(5-6):898 View
  687. Thirunavukkarasu M, Ramesh P, Karuppasamy R, Veerappapillai S. Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer. Journal of Applied Genetics 2025;66(1):115 View
  688. Seeneevassen L, Zaafour A, Sifré E, Genevois C, Nguyen T, Pobiedonoscew Y, Giese A, Guignard J, Tiffon C, Rousseau B, Raymond A, Belleannée G, Boeuf H, Gronnier C, Martin O, Giraud J, Lehours P, Dubus P, Varon C. Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor. Cell Death Discovery 2024;10(1) View
  689. Tu X, Chen L, Zheng Y, Mu C, Zhang Z, Wang F, Ren Y, Duan Y, Zhang H, Tong Z, Liu L, Sun X, Zhao P, Wang L, Feng X, Fang W, Liu X. S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function. Journal of Experimental & Clinical Cancer Research 2024;43(1) View
  690. Zhang K, Zheng X, Sun Y, Feng X, Wu X, Liu W, Gao C, Yan Y, Tian W, Wang Y. TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation. Cancer Biology & Therapy 2024;25(1) View
  691. Wen W, Li Y, Cao X, Li Y, Liu Z, Tang Z, Xie L, He R. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical Breast Cancer 2024;24(6):e429 View
  692. Chen C, Huang F, Li X, Liu L, Zhang J, Zhao J, Zhang W, Li H, Xu W, Qi Y, Wang Y. Identification of splicing factors signature predicting prognosis risk and the mechanistic roles of novel oncogenes in HNSCC. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024;1870(4):167115 View
  693. Li A, Li M, Wang J, Zhou J, Yang T, Fan M, Zhang K, Gao H, Ren H, Chen M. MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma. Biomarkers in Medicine 2024;18(2):79 View
  694. Ramachandran D, Tyrer J, Kommoss S, DeFazio A, Riggan M, Bowtell D, Fereday S, Traficante N, Hung J, Webb P, Fasching P, Lambrechts D, García M, Rodríguez-Antona C, Goodman M, Modugno F, Moysich K, Karlan B, Lester J, Kjaer S, Jensen A, Høgdall E, Goode E, Cliby W, Kumar A, Wang C, Cunningham J, Winham S, Monteiro A, Schildkraut J, Cramer D, Terry K, Titus L, Bjorge L, Thomsen L, Friedlander M, Obermair A, Grant P, Beesley V, Blomfield P, Brand A, Davis A, Leung Y, Nicklin J, Quinn M, Livingstone K, O’Neill H, Williams M, Pejovic T, Høgdall C, McNeish I, May T, Huntsman D, Pfisterer J, Canzler U, Park-Simon T, Schröder W, Belau A, Hanker L, Harter P, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Baumann K, Hilpert F, Burges A, Winterhoff B, Schürmann P, Speith L, Hillemanns P, Berchuck A, Johnatty S, Ramus S, Chenevix-Trench G, Pharoah P, Dörk T, Heitz F. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. npj Genomic Medicine 2024;9(1) View
  695. Liu L, Chen X, Wu L, Huang K, Wang Z, Zheng Y, Zheng C, Zhang Z, Chen J, Wei J, Chen S, Jin W, Chen J, Wei D, Xu Y. Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis. Experimental Hematology & Oncology 2024;13(1) View
  696. Romito O, Lemettre A, Chantôme A, Champion O, Couty N, Ouldamer L, Hempel N, Trebak M, Goupille C, Potier‐Cartereau M. Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells. Molecular Oncology 2024;18(8):1853 View
  697. Jha V, Tripathi P. Decentralized multiple hypothesis testing in Cognitive IOT using massive heterogeneous data. Cluster Computing 2024;27(5):6889 View
  698. Sinha A, Ghosh A, Ghosh A, Mathai S, Bhaumik J, Mukhopadhyay A, Maitra A, Biswas N, Sengupta S. MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2. Clinical Epigenetics 2024;16(1) View
  699. Karim S, Iqbal M, Aljoud F, Alburae N, Nisar Z, Alganmi N, Banjar H, Mirza Z. Diagnostic, prognostic and treatment response of perilipin1 gene in breast cancer. Journal of King Saud University - Science 2024;36(5):103161 View
  700. Barai P, Chen J. Beyond protein synthesis: non-translational functions of threonyl-tRNA synthetases. Biochemical Society Transactions 2024;52(2):661 View
  701. Chen R, Wu J, Che Y, Jiao Y, Sun H, Zhao Y, Chen P, Meng L, Zhao T. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology. European Journal of Medical Research 2024;29(1) View
  702. Zeng S, Xu Z, Liu Y, Zhou S, Yan Y. CRABP2 reduces the sensitivity of Olaparib in ovarian cancer by downregulating Caspase-8 and decreasing the production of reactive oxygen species. Chemico-Biological Interactions 2024;393:110958 View
  703. Ye F, Xia T, Zhao M, Zhao W, Min P, Wang Y, Wang Q, Zhang Y, Du J. PlexinA1 promotes gastric cancer migration through preventing MICAL1 protein ubiquitin/proteasome-mediated degradation in a Rac1-dependent manner. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024;1870(4):167124 View
  704. Jin T, Ding L, Chen J, Zou X, Xu T, Xuan Z, Wang S, Chen J, Wang W, Zhu C, Zhang Y, Huang P, Pan Z, Ge M. BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability. Journal of Cellular and Molecular Medicine 2024;28(7) View
  705. Chen C, Li Y, Liu H, Liao M, Yang J, Liu J. FAT1 upregulation is correlated with an immunosuppressive tumor microenvironment and predicts unfavorable outcome of immune checkpoint therapy in non-small cell lung cancer. Heliyon 2024;10(7):e28356 View
  706. Yang S, Du J, Wang W, Zhou D, Xi X. APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer. BMC Cancer 2024;24(1) View
  707. Pang R, Sun W, Yang Y, Wen D, Lin F, Wang D, Li K, Zhang N, Liang J, Xiong C, Liu Y. PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes. Nature Biomedical Engineering 2024;8(9):1162 View
  708. Grimes D, Rassamegevanon T, Marignol L. In silico analysis of overall survival with YBX1 in male and female solid tumours. Scientific Reports 2024;14(1) View
  709. Lim W, Hwang I, Zhang J, Chen Z, Han J, Jeon J, Koo B, Kim S, Lee J, Kim Y, Pienta K, Amend S, Austin R, Ahn J, Park S. Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues. eLife 2024;12 View
  710. Joseph S, Eugin Simon S, Bohm M, Kim M, Pye M, Simmons B, Graves D, Thomas-Gooch S, Tanveer U, Holt J, Ponnusamy S, Sipe L, Hayes D, Cook K, Narayanan R, Pierre J, Makowski L. FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers 2024;16(7):1368 View
  711. Lim W, Hwang I, Zhang J, Chen Z, Han J, Jeon J, Koo B, Kim S, Lee J, Kim Y, Pienta K, Amend S, Austin R, Ahn J, Park S. Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues. eLife 2024;12 View
  712. Abumustafa W, Castven D, Sharif-Askari F, Abi Zamer B, Hamad M, Marquardt J, Muhammad J. PRMT5 Mediated HIF1α Signaling and Ras-Related Nuclear Protein as Promising Biomarker in Hepatocellular Carcinoma. Biology 2024;13(4):216 View
  713. Wang C, Lei L, Xu Y, Li Y, Zhang J, Xu Y, Si S. Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells. Pharmaceuticals 2024;17(4):425 View
  714. Ospital I, Táquez Delgado M, Nicoud M, Corrêa M, Borges Fernandes G, Andrade I, Lauretta P, Martínez Vivot R, Comba M, Zanardi M, Speisky D, Uriburu J, Fernandes J, Medina V. Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer. Biomedicine & Pharmacotherapy 2024;174:116527 View
  715. Abumustafa W, Castven D, Becker D, Salih S, Manzoor S, Zamer B, Talaat I, Hamad M, Marquardt J, Muhammad J. Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy. Cellular Signalling 2024;119:111166 View
  716. Sanvicente A, Díaz-Tejeiro C, Nieto-Jiménez C, Paniagua-Herranz L, López Cade I, Balázs G, Moreno V, Pérez-Segura P, Calvo E, Ocaña A. In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies. International Journal of Molecular Sciences 2024;25(7):3987 View
  717. Le L, Choi C, Han J, Kim E, Trinh V, Kim Y, Ryu S. Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis. Frontiers in Oncology 2024;14 View
  718. Bartoloni S, Pescatori S, Bianchi F, Cipolletti M, Acconcia F. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer. Scientific Reports 2024;14(1) View
  719. Zhang Y, Gao C, Luo J, Khan A, Salem‐Bekhit M, Salem M, Qi Z, Jiang B. RETRACTED: Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications. International Wound Journal 2024;21(4) View
  720. Huang S, Liu J, Hu J, Hou Y, Hu M, Zhang B, Luo H, Fu S, Chen Y, Liu X, Chen Z, Wang L. GHITM regulates malignant phenotype and sensitivity to PD‐1 blockade of renal cancer cells via Notch signalling. Journal of Cellular and Molecular Medicine 2024;28(8) View
  721. Armstrong L, Willoughby C, McKenna D. The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p. International Journal of Molecular Sciences 2024;25(8):4301 View
  722. Rose M, Burgess J, Cheong C, Adams M, Shahrouzi P, O’Byrne K, Richard D, Bolderson E. The expression and role of the Lem-D proteins Ankle2, Emerin, Lemd2, and TMPO in triple-negative breast cancer cell growth. Frontiers in Oncology 2024;14 View
  723. Parreno V, Loubiere V, Schuettengruber B, Fritsch L, Rawal C, Erokhin M, Győrffy B, Normanno D, Di Stefano M, Moreaux J, Butova N, Chiolo I, Chetverina D, Martinez A, Cavalli G. Transient loss of Polycomb components induces an epigenetic cancer fate. Nature 2024;629(8012):688 View
  724. Eskandarion M, Eskandarieh S, Shakoori Farahani A, Mahmoodzadeh H, Shahi F, Oghabian M, Shirkoohi R. Prediction of novel biomarkers for gastric intestinal metaplasia and gastric adenocarcinoma using bioinformatics analysis. Heliyon 2024;10(9):e30253 View
  725. Zhou W, Halder S, Herwald S, Ghijsen M, Shafi G, Uttarwar M, Rosen E, Franc B, Kishore S. Frequent Amplification and Overexpression of PSMA in Basallike Breast Cancer from Analysis of The Cancer Genome Atlas. Journal of Nuclear Medicine 2024;65(7):1004 View
  726. Beg A, Parveen R, Fouad H, Yahia M, Hassanein A. Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approach. Journal of Ovarian Research 2024;17(1) View
  727. Kwiatkowski M, Krajewski A, Durślewicz J, Buchholz K, Grzanka D, Gagat M, Zabrzyński J, Klimaszewska-Wiśniewska A. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma. Scientific Reports 2024;14(1) View
  728. Grauers Wiktorin H, Aydin E, Kiffin R, Vilhav C, Bourghardt Fagman J, Kaya M, Paul S, Westman B, Bratlie S, Naredi P, Hellstrand K, Martner A. Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer. Cancer Research Communications 2024;4(4):1135 View
  729. Bareja C, Dwivedi K, Uboveja A, Mathur A, Kumar N, Saluja D. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics. Scientific Reports 2024;14(1) View
  730. Ahmadi M, Mohajeri Khorasani A, Morshedzadeh F, Saffarzadeh N, Ghaderian S, Ghafouri-Fard S, Mousavi P. HLF is a promising prognostic, immunological, and therapeutic biomarker in human tumors. Biochemistry and Biophysics Reports 2024;38:101725 View
  731. Manoharan S, Perumal E. Early-stage biomarkers identification by integrated genomic analysis in hepatocellular carcinoma. Medicine in Omics 2024;12:100037 View
  732. Dutt P, Haider N, Mouaaz S, Podmore L, Stambolic V. β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells. Proceedings of the National Academy of Sciences 2024;121(19) View
  733. Nonoyama K, Matsuo Y, Sugita S, Eguchi Y, Denda Y, Murase H, Kato T, Imafuji H, Saito K, Morimoto M, Ogawa R, Takahashi H, Mitsui A, Kimura M, Takiguchi S. Expression of ZKSCAN3 protein suppresses proliferation, migration, and invasion of pancreatic cancer through autophagy. Cancer Science 2024;115(6):1964 View
  734. Han J, Che N, Mo J, Zhang D, Liang X, Dong X, Zhao X, Sun B. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer. BMC Cancer 2024;24(1) View
  735. Nasser M, Refky B, Abdeen H, Neamatallah M, Nada H, Abd Elghaffar M. Expression of Nuclear Division Cycle 80 Complex Genes in Ovarian Cancer and Correlation with the Clinicopathological Features and Survival Outcomes. Indian Journal of Gynecologic Oncology 2024;22(2) View
  736. Zhang L, Wang S, Wang L. Prognostic value and immunological function of cuproptosis-related genes in lung adenocarcinoma. Heliyon 2024;10(9):e30446 View
  737. Lin Y, Liu W, Wu Y, Cai H, Zheng Q, Wei Y, Xu N, Xue X. Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications. International Journal of Immunopathology and Pharmacology 2024;38 View
  738. Verma R, Lokhande K, Srivastava P, Singh A. Elucidating B4GALNT1 as potential biomarker in hepatocellular carcinoma using machine learning models and mutational dynamics explored through MD simulation. Informatics in Medicine Unlocked 2024;48:101514 View
  739. Sinha A, Ghosh S, Ghosh A, Ghosh A, Mathai S, Bhaumik J, Mukhopadhyay A, Maitra A, Biswas N, Sengupta S. Unfurling the functional association between long intergenic noncoding RNAs (lincRNAs) and HPV16-related cervical cancer pathogenesis through weighted gene co-expression network analysis of differentially expressed lincRNAs and coding genes. Carcinogenesis 2024;45(7):451 View
  740. Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D. PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration. Journal of Hepatocellular Carcinoma 2024;Volume 11:813 View
  741. Liu S, Wang Z, Hu L, Ye C, Zhang X, Zhu Z, Li J, Shen Q. Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer. Translational Oncology 2024;45:101982 View
  742. Noblejas-López M, García-Gil E, Pérez-Segura P, Pandiella A, Győrffy B, Ocaña A. T-reg transcriptomic signatures identify response to check-point inhibitors. Scientific Reports 2024;14(1) View
  743. Bai C, Wang C, Hua J, Zhao N, Li T, Li W, Niu W, Zhong B, Yang S, Chen C, Zhao G, Qiu L, Jiang Z, Li L, Li Y, Wang H. Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024;1870(6):167234 View
  744. Gharib E, Rejali L, Piroozkhah M, Zonoobi E, Nasrabadi P, Arabsorkhi Z, Baghdar K, Shams E, Sadeghi A, Kuppen P, Salehi Z, Nazemalhosseini-Mojarad E. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p. Journal of Translational Medicine 2024;22(1) View
  745. Zhang J, Yang J, Li X, Mao L, Zhang Y, Liu Y, Bao Y. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer. Molecular Genetics and Genomics 2024;299(1) View
  746. Shao Y, Li R, Chen G, Zhang L. Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification. International Journal of General Medicine 2024;Volume 17:2187 View
  747. Hou C, Lv P, Yuan H, Zhao L, Wang Y, Zhang H, Yang G, Zhang X. Bevacizumab induces ferroptosis and enhances CD8+ T cell immune activity in liver cancer via modulating HAT1 and increasing IL-9. Acta Pharmacologica Sinica 2024;45(9):1951 View
  748. Li Y, Gu F, Huang X, Huang W, Xiang J, Yue J, Wang Y, Chen R. FRZB: a potential prognostic marker for head and neck squamous cell carcinoma. Brazilian Journal of Medical and Biological Research 2024;57 View
  749. Jha V, Tripathi P. Multiple hypothesis testing in cognitive IoT sensor network. Ad Hoc Networks 2024;162:103559 View
  750. Ebott J, McAdams J, Kim C, Jansen C, Woodman M, De La Cruz P, Schrol C, Ribeiro J, James N. Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment. Frontiers in Pharmacology 2024;15 View
  751. Zong Y, Zhu A, Liu P, Fu P, Li Y, Chen S, Gao X. Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas. Heliyon 2024;10(11):e31875 View
  752. Dixcy Jaba Sheeba J, Hegde S, Tamboli N, Nadig N, Keshavamurthy R, Ranganathan P. Gene expression signature of castrate resistant prostate cancer. Gene 2024;925:148603 View
  753. Patterson M, Meijers A, Ryder E, Wootton L, Scarth J, Evans D, Turner A, Wasson C, Darell J, Theobald D, Cogan J, James C, Wang M, Ladbury J, Morgan I, Samson A, Morgan E, Macdonald A. E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer. Oncogene 2024;43(28):2184 View
  754. Liao Q, Xiong J. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53. Experimental and Therapeutic Medicine 2024;27(6) View
  755. Mallikarjuna T, Thummadi N, Vindal V, Manimaran P. Prioritizing cervical cancer candidate genes using chaos game and fractal-based time series approach. Theory in Biosciences 2024;143(3):183 View
  756. Eid R, Mamdouh F, Abdulsahib W, Alshaya D, Al-Salmi F, Ali Alghamdi M, Jafri I, Fayad E, Alsharif G, Zaki M, Alshehri M, Noreldin A, Alaa Eldeen M. ACTL6A: unraveling its prognostic impact and paving the way for targeted therapeutics in carcinogenesis. Frontiers in Molecular Biosciences 2024;11 View
  757. Edtmayer S, Witalisz-Siepracka A, Zdársky B, Heindl K, Weiss S, Eder T, Dutta S, Graichen U, Klee S, Sharif O, Wieser R, Győrffy B, Poli V, Casanova E, Sill H, Grebien F, Stoiber D. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia. Cell Death & Disease 2024;15(5) View
  758. Agorku D, Bosio A, Alves F, Ströbel P, Hardt O. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Letters 2024;595:216985 View
  759. Xiao Y, Ma M, Gu Q, Xiao Y. The Mechanism of Scopolamine’s Effect on Migration Function of Lung Cancer Cells: A Network Pharmacology and Bioinformatics Perspective. International Journal of Clinical Practice 2024;2024:1 View
  760. Fischer S, Weber L, Stielow B, Frech M, Simon C, Geller M, Könnecke J, Finkernagel F, Forné I, Nist A, Bauer U, Stiewe T, Neubauer A, Liefke R. IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells. Nucleic Acids Research 2024;52(13):7590 View
  761. Yao G, Yu S, Hou F, Xiao Z, Li G, Ji X, Wang J. Rab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness. Molecular Medicine 2024;30(1) View
  762. Li A, Zhang K, Zhou J, Li M, Fan M, Gao H, Ma R, Gao L, Chen M. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. International Journal of Biological Macromolecules 2024;272:132797 View
  763. Sanchez-Lopez J, Juarez-Mancera M, Bustamante B, Ruiz-Silvestre A, Espinosa M, Mendoza-Almanza G, Ceballos-Cancino G, Melendez-Zajgla J, Maldonado V, Lizarraga F. Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses. RNA Biology 2024;21(1):601 View
  764. Poulet S, Dai M, Wang N, Yan G, Boudreault J, Daliah G, Guillevin A, Nguyen H, Galal S, Ali S, Lebrun J. Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer. Molecular Cancer 2024;23(1) View
  765. Lu W, Cui J, Wang W, Hu Q, Xue Y, Liu X, Gong T, Lu Y, Ma H, Yang X, Feng B, Wang Q, Zhang N, Xu Y, Liu M, Nussinov R, Cheng F, Ji H, Huang J. PPIA dictates NRF2 stability to promote lung cancer progression. Nature Communications 2024;15(1) View
  766. Hashemi M, Tahmasebi-Birgani M, Talaiezadeh A, Saberi A. Upregulation of SLC25A32 in Tumorous Tissues of Patients with Non-Metastatic Colorectal Cancer: A Pilot Study. Indian Journal of Clinical Biochemistry 2024 View
  767. Bharti R, Dey G, Khan D, Myers A, Huffman O, Saygin C, Braley C, Richards E, Sangwan N, Willard B, Lathia J, Fox P, Lin F, Jha B, Brown J, Yu J, Dwidar M, Joehlin-Price A, Vargas R, Michener C, Longworth M, Reizes O. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer. Molecular Cancer 2024;23(1) View
  768. Olivera Santana B, de Loyola M, Gualberto A, Pittella-Silva F. Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis. International Journal of Molecular Sciences 2024;25(11):6097 View
  769. Qiu L, Li R, Wang Y, Lu Z, Tu Z, Liu H. PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex. British Journal of Cancer 2024;131(3):577 View
  770. Ferrer C, Cho H, Boon R, Bernasocchi T, Wong L, Cetinbas M, Haggerty E, Mitsiades I, Wojtkiewicz G, McLoughlin D, Aboushousha R, Abdelhamid H, Kugel S, Rheinbay E, Sadreyev R, Juric D, Janssen-Heininger Y, Mostoslavsky R. The glutathione S-transferase Gstt1 drives survival and dissemination in metastases. Nature Cell Biology 2024;26(6):975 View
  771. Liu J, Zhao W, Luan Y, Tian Z. FAM189A2 plays a tumour suppressor role in lung adenocarcinoma by influencing cell apoptosis, CXCR4 expression and tight junction proteins. Tissue and Cell 2024;89:102441 View
  772. Yang Z, Shen X, Wang Z, Li R, Hou W, Liu Z, Gao Y, Zhu C, Qin X. The Biological Function of POLA2 in Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2024;27(12):1758 View
  773. Yu Y, Cao W, Cheng F, Shi Z, Han L, Yi J, da Silva E, Dopeso H, Chen H, Yang J, Wang X, Zhang C, Zhang H. FOXK2 amplification promotes breast cancer development and chemoresistance. Cancer Letters 2024;597:217074 View
  774. Nuñez-Ríos J, Reyna-Jeldes M, Mata-Martínez E, Campos-Contreras A, Lazcano-Sánchez I, González-Gallardo A, Díaz-Muñoz M, Coddou C, Vázquez-Cuevas F, Mohammed A. Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells. PLOS ONE 2024;19(6):e0304062 View
  775. Arizmendi-Izazaga A, Navarro-Tito N, Jiménez-Wences H, Evaristo-Priego A, Priego-Hernández V, Dircio-Maldonado R, Zacapala-Gómez A, Mendoza-Catalán M, Illades-Aguiar B, De Nova Ocampo M, Salmerón-Bárcenas E, Leyva-Vázquez M, Ortiz-Ortiz J. Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1α Axis. Current Issues in Molecular Biology 2024;46(6):6199 View
  776. Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, Romano E, Corrado A, Longo D, Iozzo M, Ippolito L, Comito G, Giannoni E, Meattini I, Avgustinova A, Chiarugi P, Bachi A, Morandi A. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Molecular Medicine 2024;16(7):1533 View
  777. Vidana Gamage H, Albright S, Smith A, Farmer R, Shahoei S, Wang Y, Fink E, Jacquin E, Weisser E, Bautista R, Henn M, Schane C, Nelczyk A, Ma L, Das Gupta A, Bendre S, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann P, Boidot R, Vegran F, Fanning S, Apetoh L, Hergenrother P, Nelson E. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. Cancer Letters 2024;597:217086 View
  778. Kennedy A, Richardson E, Higham J, Kotsantis P, Mort R, Shih B, Yu G. Evergene: an interactive webtool for large-scale gene-centric analysis of primary tumours. Bioinformatics Advances 2024;4(1) View
  779. De Silva S, Alli-Shaik A, Gunaratne J. Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data. Scientific Data 2024;11(1) View
  780. Li P, Cui P, Yue Q, Xu Z, Liu Z. Exploring the potential biological significance of KDELR family genes in lung adenocarcinoma. Scientific Reports 2024;14(1) View
  781. Wei J, Mayberry C, Lv X, Hu F, Khan T, Logan N, Wilson J, Sears J, Chaussabel D, Chang C. IL3-Driven T Cell–Basophil Crosstalk Enhances Antitumor Immunity. Cancer Immunology Research 2024;12(7):822 View
  782. Liao W, Liu T, Li Y, Liang H, Deng J, Shen F. The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer. Journal of Obstetrics and Gynaecology 2024;44(1) View
  783. Marolt N, Pavlič R, Kreft T, Gjorgoska M, Rižner T. Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance. Biomedicine & Pharmacotherapy 2024;177:117069 View
  784. Drif A, Yücer R, Damiescu R, Ali N, Abu Hagar T, Avula B, Khan I, Efferth T. Anti-Inflammatory and Cancer-Preventive Potential of Chamomile (Matricaria chamomilla L.): A Comprehensive In Silico and In Vitro Study. Biomedicines 2024;12(7):1484 View
  785. Zhang Y, Chen H, Zhang W, Zhou H. Identification of cancer-associated fibroblast-related Ectodysplasin-A as a novel indicator for prognosis and immune response in gastric cancer. Heliyon 2024;10(13):e34005 View
  786. Armesto M, Nemours S, Arestín M, Bernal I, Solano-Iturri J, Manrique M, Basterretxea L, Larrinaga G, Angulo J, Lecumberri D, Iturregui A, López J, Lawrie C. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients. International Journal of Molecular Sciences 2024;25(13):6881 View
  787. Sun S, Li Q, Liu G, Huang X, Li A, Guo H, Qi L, Zhang J, Song J, Su X, Zhang Y. Endosomal protein DENND10/FAM45A integrates extracellular vesicle release with cancer cell migration. BMC Biology 2024;22(1) View
  788. Tambay V, Raymond V, Voisin L, Meloche S, Bilodeau M. Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024;25(14):7558 View
  789. Patterson M, Cogan J, Cassidy R, Theobald D, Wang M, Scarth J, Anene C, Whitehouse A, Morgan E, Macdonald A. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer. Nature Communications 2024;15(1) View
  790. Bao Y, Tang Z, Chen R, Yu X, Qi X. Pan-cancer analysis identifies olfactory receptor family 7 subfamily A member 5 as a potential biomarker for glioma. PeerJ 2024;12:e17631 View
  791. Song N, Wang Z, Shi P, Cui K, Fan Y, Zeng L, Di W, Li J, Su W, Wang H. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma. Oncology Letters 2024;28(2) View
  792. Xi Q, Yang G, He X, Zhuang H, Li L, Lin B, Wang L, Wang X, Fang C, Chen Q, Yang Y, Yu Z, Zhang H, Cai W, Li Y, Shen H, Liu L, Zhang R. M6A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8+ T cells and phagocytosis of macrophages. Advanced Science 2024 View
  793. Zhang L. Comprehensive analysis of the Cullin family of genes reveals that CUL7 and CUL9 are the significant prognostic biomarkers in colorectal cancer. American Journal of Translational Research 2024;16(5):1907 View
  794. Zhou Z, Fan B, Qiu Q, Cheng H, Wang L, Wu Y, Xie J, Ni C, Li N. Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma. Gene 2024;928:148764 View
  795. Ishikawa A, Fukui T, Kido A, Katsuya N, Kuraoka K, Uraoka N, Suzuki T, Oka S, Kotachi T, Ashktorab H, Smoot D, Yasui W. Discovering cancer stem‐like molecule, nuclear factor I X, using spatial transcriptome in gastric cancer. Cancer Science 2024;115(9):3180 View
  796. Li G. Comprehensive analysis of CPNE1 predicts prognosis and drug resistance in gastric adenocarcinoma. American Journal of Translational Research 2024;16(6):2233 View
  797. Han X. Thyroid cancer prognostic biomarker ARL4A and its relationship with immune infiltration. International Journal of Clinical and Experimental Pathology 2024;17(4):108 View
  798. Passi G, Lieberman S, Zahdeh F, Murik O, Renbaum P, Beeri R, Linial M, May D, Levy-Lahad E, Schneidman-Duhovny D. Discovering predisposing genes for hereditary breast cancer using deep learning. Briefings in Bioinformatics 2024;25(4) View
  799. Vanmeerbeek I, Naulaerts S, Sprooten J, Laureano R, Govaerts J, Trotta R, Pretto S, Zhao S, Cafarello S, Verelst J, Jacquemyn M, Pociupany M, Boon L, Schlenner S, Tejpar S, Daelemans D, Mazzone M, Garg A. Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science Advances 2024;10(29) View
  800. Montecillo-Aguado M, Soca-Chafre G, Antonio-Andres G, Morales-Martinez M, Tirado-Rodriguez B, Rocha-Lopez A, Hernandez-Cueto D, Sánchez-Ceja S, Alcala-Mota-Velazco B, Gomez-Garcia A, Gutiérrez-Castellanos S, Huerta-Yepez S. Upregulated Nuclear Expression of Soluble Epoxide Hydrolase Predicts Poor Outcome in Breast Cancer Patients: Importance of the Digital Pathology Approach. International Journal of Molecular Sciences 2024;25(15):8024 View
  801. Liu X, Chen Y, Li Y, Bai J, Zeng Z, Wang M, Dong Y, Zhou Y. STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer. Biology Direct 2024;19(1) View
  802. Lu Y, Wang D, Chen G, Shan Z, Li D. Exploring the molecular landscape of osteosarcoma through PTTG family genes using a detailed multi-level methodology. Frontiers in Genetics 2024;15 View
  803. Rujescu C, Sicoe-Murg O, Milin I, Ciolac R. Survival Probability of Tourist Accommodation Establishments in Romania in Relation to the Action of Some Relevant Factors. Sustainability 2024;16(15):6344 View
  804. Yang Y, Gao Y, Liu X, Huang Z, Zhang Y, Zhang Y, Liu Z, Chen Y, Pei Z. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration. Experimental and Therapeutic Medicine 2024;28(2) View
  805. Di S, Chen W, Yang W, Zhang X, Dong K, Tian Y, Sun Y, Qian C, Chen J, Liu Z, Gong Z, Chu J, Zhou W, Pan X, Cui X. DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway. Cell Death & Disease 2024;15(7) View
  806. Huang H, Xie J, Wang F, Jiao S, Li X, Wang L, Liu D, Wang C, Wei X, Tan P, Tu P, Li J, Hu Z. Commiphora myrrha n-hexane extract suppressed breast cancer progression through induction of G0/G1 phase arrest and apoptotic cell death by inhibiting the Cyclin D1/CDK4-Rb signaling pathway. Frontiers in Pharmacology 2024;15 View
  807. Yamauchi T, Okano Y, Terada D, Yasukochi S, Tsuruta A, Tsurudome Y, Ushijima K, Matsunaga N, Koyanagi S, Ohdo S. Epigenetic repression of de novo cysteine synthetases induces intra-cellular accumulation of cysteine in hepatocarcinoma by up-regulating the cystine uptake transporter xCT. Cancer & Metabolism 2024;12(1) View
  808. Kato C, Iizuka-Ohashi M, Honda M, Konishi E, Yokota I, Boku S, Mizuta N, Morita M, Sakaguchi K, Taguchi T, Watanabe M, Naoi Y. Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024;1870(8):167458 View
  809. Soltani Khaboushan A, Salimian S, Mehraban S, Bahramy A, Zafari N, Kajbafzadeh A, Johnson J, Majidi Zolbin M. Prognostic significance of non-coding RNAs related to the tumorigenic epithelial-mesenchymal transition (EMT) process among ovarian cancer patients: A systematic review and meta-analysis. Heliyon 2024;10(16):e35202 View
  810. Özturk N, Ceylan H, Demir Y. The hepatoprotective potential of tannic acid against doxorubicin‐induced hepatotoxicity: Insights into its antioxidative, anti‐inflammatory, and antiapoptotic mechanisms. Journal of Biochemical and Molecular Toxicology 2024;38(8) View
  811. Wang X, Zhang T, Zheng B, Lu Y, Liang Y, Xu G, Zhao L, Tao Y, Song Q, You H, Hu H, Li X, Sun K, Li T, Zhang Z, Wang J, Lan X, Pan D, Fu Y, Yue B, Zheng H. Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth. Nature Cell Biology 2024;26(9):1597 View
  812. Mafi S, Dehghani M, Khalvati B, Abidi H, Ghorbani M, Jalali P, Whichelo R, Salehi Z, Markowska A, Reyes A, Pecic S, Łos M, Ghavami S, Nikseresht M. Targeting PERK and GRP78 in colorectal cancer: Genetic insights and novel therapeutic approaches. European Journal of Pharmacology 2024;982:176899 View
  813. Zhang H, Lin J, Zheng S, Ma L, Pang Z, Yin H, Meng C, Wang Y, Han Q, Zhang X, Li Z, Cao L, Liu L, Fei T, Gao D, Yang L, Peng X, Ding C, Wang S, Sheng R. CDKL3 is a targetable regulator of cell cycle progression in cancers. Journal of Clinical Investigation 2024;134(16) View
  814. Fageer S, Alamin M, Attaelmanan A, Alfaki M. Pan-Cancer Analysis Reveals Long Non-coding RNA (lncRNA) Embryonic Stem Cell-Related Gene (ESRG) as a Promising Diagnostic and Prognostic Biomarker. Cureus 2024 View
  815. Nasir N, Chuah S, Shuen T, Prawira A, Ba R, Lim M, Chua J, Nguyen P, Lim C, Wasser M, Hazirah S, Lim T, Leow W, Loh T, Wan W, Pang Y, Soon G, Cheow P, Kam J, Iyer S, Kow A, Dan Y, Bonney G, Chung A, Goh B, Chow P, Albani S, Zhai W, Ouyang J, Toh H, Chew V. GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma. Hepatology Communications 2024;8(9) View
  816. Torres-Ruiz S, Garrido-Cano I, Lameirinhas A, Burgués O, Hernando C, Martínez M, Rojo F, Bermejo B, Tapia M, Carbonell-Asins J, Peña C, Lluch A, Cejalvo J, Tormo E, Eroles P. MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer. Cell Death Discovery 2024;10(1) View
  817. Zhai Z, Cui Z, Zhang Y, Song P, Wu J, Tan Z, Lin S, Ma X, Guan F, Kang H. Integrated pan-cancer analysis and experimental verification of the roles of meiotic nuclear divisions 1 in breast cancer. Biochemical and Biophysical Research Communications 2024;739:150600 View
  818. Feng W, Ting Y, Tang X, Liu D, Zhou W, Li Y, Shen Z. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells. Heliyon 2024;10(17):e36897 View
  819. Ghosh A, Sinha A, Ghosh A, Roy S, Mallick S, Kumar V, Mathai S, Bhaumik J, Mukhopadhyay A, Sen S, Chandra A, Maitra A, Biswas N, Majumder P, Sengupta S. Biological and clinical relevance of correlated expression levels of coding and long noncoding RNAs in HPV16 positive cervical cancers. Human Genomics 2024;18(1) View
  820. Huang J, Tan R. HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer. BMC Women's Health 2024;24(1) View
  821. Hegde S, Wagh K, Narayana S, Abikar A, Nambiar S, Ananthamurthy S, Narayana N, Reddihalli P, Chandraiah S, Ranganathan P. microRNA profile of endometrial cancer from Indian patients-identification of potential biomarkers for prognosis. Biochemistry and Biophysics Reports 2024;39:101812 View
  822. Suto A, Minaguchi T, Qi N, Fujieda K, Itagaki H, Tenjimbayashi Y, Shikama A, Tasaka N, Akiyama A, Nakao S, Nakahashi-Oda C, Kobayashi Y, Shibuya A, Satoh T. CD25+FOXP3+CD45RA− regulatory T-cell infiltration as a prognostic biomarker for endometrial carcinoma. BMC Cancer 2024;24(1) View
  823. Jiang Y, Li W, Zhang J, Liu K, Wu Y, Wang Z. NFS1 as a Candidate Prognostic Biomarker for Gastric Cancer Correlated with Immune Infiltrates. International Journal of General Medicine 2024;Volume 17:3855 View
  824. Li L, Xie D, Yu S, Ma M, Fan K, Chen J, Xiu M, Xie K, Li Y, Gao Y. WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer Research 2024;84(17):2776 View
  825. Zhang L, Huang Y, Yang Y, Liao B, Hou C, Wang Y, Qin H, Zeng H, He Y, Gu J, Zhang R. TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes. Scientific Reports 2024;14(1) View
  826. Zhu H, Wei Y, Guo J, Liu X. Double-negative T cells with a distinct transcriptomic profile are abundant in the peripheral blood of patients with breast cancer. Breast Cancer Research and Treatment 2025;209(1):103 View
  827. Zhang R, Cui N, He Y, Wang T, Feng D, Wang Y, Bao T, Su C, Qin Y, Shi J, Li J. Pirarubicin combined with TLR3 or TLR4 agonists enhances anti-tumor efficiency. International Immunopharmacology 2024;142:113068 View
  828. Lee H, Hong S, Kim G, You H, Lee E, Jeong J, Ahn J, Kim J. Generative Models Utilizing Padding Can Efficiently Integrate and Generate Multi-Omics Data. AI 2024;5(3):1614 View
  829. Kaya M. MicroRNAs and Their Targets Could Have a Crucial Role in Breast Cancer Drug Resistance: A Bioinformatics Research. Genel Tıp Dergisi 2024;34(4):458 View
  830. Evans E, Page E, Choi A, Shonibare Z, Kahn A, Arend R, Mythreye K. Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer. Cancer Medicine 2024;13(17) View
  831. Guo Q, Zhou Y, Ni H, Niu M, Xu S, Zheng L, Zhang W. The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells. Journal of Translational Medicine 2024;22(1) View
  832. Kumar B, Singh A, Basar R, Uprety N, Li Y, Fan H, Cortes A, Kaplan M, Acharya S, Shaim H, Xu A, Wu M, Ensley E, Fang D, Banerjee P, Garcia L, Tiberti S, Lin P, Rafei H, Munir M, Moore M, Shanley M, Mendt M, Kerbauy L, Liu B, Biederstädt A, Gokdemir E, Ghosh S, Kundu K, Reyes-Silva F, Jiang X, Wan X, Gilbert A, Dede M, Mohanty V, Dou J, Zhang P, Liu E, Muniz-Feliciano L, Deyter G, Jain A, Rodriguez-Sevilla J, Colla S, Garcia-Manero G, Shpall E, Chen K, Abbas H, Rai K, Rezvani K, Daher M. BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML. Science Translational Medicine 2024;16(764) View
  833. Balcioglu O, Gates B, Freeman D, Hagos B, Mehrabad E, Ayala-Talavera D, Spike B. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation. npj Breast Cancer 2024;10(1) View
  834. Kumar V, Tomar A, Thapliyal A, Yadav S, Indurthi D. Proteomics and Bioinformatics Investigations Link Overexpression of FGF8 and Associated Hub Genes to the Progression of Ovarian Cancer and Poor Prognosis. Biochemistry Research International 2024;2024(1) View
  835. Prasad P, Chongtham J, Tripathi S, Ganguly N, Mittal S, Srivastava T. Targeted inhibition of NRF2 reduces the invasive and metastatic ability of HIP1 depleted lung cancer cells. Biochemical and Biophysical Research Communications 2024;733:150676 View
  836. Pyne E, Reardon M, Christensen M, Rodriguez Mateos P, Taylor S, Iles A, Choudhury A, Pamme N, Pires I. Investigating the impact of the interstitial fluid flow and hypoxia interface on cancer transcriptomes using a spheroid-on-chip perfusion system. Lab on a Chip 2024;24(19):4609 View
  837. Takeda M, Ito H, Kitahata K, Sato S, Nishide A, Gamo K, Managi S, Tezuka T, Yoshizawa A, Kim M. α-Parvin Expression in Breast Cancer Tissues: Correlation with Clinical Parameters and Prognostic Significance. Cells 2024;13(18):1572 View
  838. Leal A, Liby K. The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice. International Journal of Molecular Sciences 2024;25(18):9985 View
  839. Shao Z. Comprehensive multi-omics analysis and prognostic significance of fibroblast growth factor binding protein 1 (FGFBP1) in pancreatic adenocarcinoma. American Journal of Translational Research 2024;16(8):4101 View
  840. Vicente-Muñoz S, Davis J, Lane A, Lane A, Waltz S, Wells S. Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes. Frontiers in Oncology 2024;14 View
  841. Liao Y, Yang P, Yang C, Zhuang K, Fahira A, Wang J, Liu Z, Yan L, Huang Z. Clinical signature and associated immune metabolism of NLRP1 in pan‐cancer. Journal of Cellular and Molecular Medicine 2024;28(18) View
  842. Ishida C, Myers S, Kubota C, Shao W, McGuire M, Liu C, Ewachiw T, Mukhopadhyay D, Ke S, Wang H, Rasheed Z, Anders R, Espenshade P. SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma. Cancer Research Communications 2024;4(9):2539 View
  843. Yang Q, Li X. Pan-cancer analysis of ADAR1 with its prognostic relevance in low-grade glioma. Immunobiology 2024;229(6):152855 View
  844. Zou H, Yin Y, Xiong K, Luo X, Sun Z, Mao B, Xie Q, Tan M, Kong R. Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment 2024;23 View
  845. Ooko E, Ali N, Efferth T. Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types. Biology 2024;13(10):793 View
  846. Mubthasima P, Kannan A. Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression. Medical Oncology 2024;41(11) View
  847. Xu Y, Han X, You S, Zhu W, Zhang M, Lu C, He J, Yao Q. SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming. Scientific Reports 2024;14(1) View
  848. Pashirzad M, Sahebkar A. The Prognostic Value and Clinical Significance of lncRNA SNHG5 Expression in Patients with Multiple Malignancies: A Bioinformatic and Meta-analysis. Current Cancer Drug Targets 2024;24(12):1286 View
  849. Han F, Fan X, Hu M, Wen J, Wang J, Zhang D, Wang S, Ding Y, Ye Y, Jiao H. Nup210 Promotes Colorectal Cancer Progression by Regulating Nuclear Plasma Transport. Laboratory Investigation 2024;104(11):102149 View
  850. Kang T, Lan X, Mi T, Chen H, Alli S, Lim S, Bhatara S, Vasandan A, Ward G, Bentivegna S, Jang J, Spatz M, Han J, Schlotmann B, Jespersen J, Derenzo C, Vogel P, Yu J, Baylin S, Jones P, O’Connell C, Grønbæk K, Youngblood B, Zebley C. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy. Science 2024;386(6718) View
  851. Wang C, Li M, Huang S, Huang W, He T, Wusiman M, Zhu H, Liu Z. Choline ameliorates tris (2‐chloroisopropyl) phosphate‐induced hepatocellular carcinoma metastasis by inhibiting ROS/Nrf2/Keap1‐mediated autophagy. Food Frontiers 2025;6(1):418 View
  852. Kubaichuk K, Seitz T, Bergmann U, Glumoff V, Mennerich D, Kietzmann T. Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type IIB. Oncogenesis 2024;13(1) View
  853. Luo M, Gu Y, Zhou F, Chen S. Implementation of the Observational Medical Outcomes Partnership Model in Electronic Medical Record Systems: Evaluation Study Using Factor Analysis and Decision-Making Trial and Evaluation Laboratory-Best-Worst Methods. JMIR Medical Informatics 2024;12:e58498 View
  854. Loganathan T, S. M, Zayed H, Doss C G. Computational insights into irinotecan's interaction with UBE2I in ovarian and endometrial cancers. Computational Biology and Chemistry 2024;113:108250 View
  855. Chen S, Shen B, Wu Y, Shen L, Qi H, Cao F, Huang T, Tan H, Zhang G, Fan W. Identification of prognosis-related cyclin-dependent kinases and potential response drugs in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2023;19(1):108 View
  856. Hu J, Li C, Ge Y, Yang J, Zhu S, He C. Mapping the Evolution of Digital Health Research: Bibliometric Overview of Research Hotspots, Trends, and Collaboration of Publications in JMIR (1999-2024). Journal of Medical Internet Research 2024;26:e58987 View
  857. Alkhateeb M, Aljarba N, Yousafi Q, Anwar F, Biswas P. Elucidating gastric cancer mechanisms and therapeutic potential of Adociaquinone A targeting EGFR: A genomic analysis and Computer Aided Drug Design (CADD) approach. Journal of Cellular and Molecular Medicine 2024;28(20) View
  858. Zhou K, Xie M, Liu Y, Zheng L, Pu J, Wang C. Virtual screening and network pharmacology-based synergistic coagulation mechanism identification of multiple components contained in compound Kushen Injection against hepatocellular carcinoma. Journal of Ayurveda and Integrative Medicine 2024;15(5):101055 View
  859. Yay F, Ayan D. Bioinformatic analysis of neuropeptide related genes in patients diagnosed with invasive breast carcinoma. Computers in Biology and Medicine 2024;183:109304 View
  860. Zhang Z, Zhao M, Zhou Z, Ren X, He Y, Shen T, Zeng H, Li K, Zhang Y. Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma. Frontiers in Oncology 2024;14 View
  861. Sun M, Han Z, Luo Z, Ge L, Zhang X, Feng K, Zhang G, Xu F, Zhou H, Han H, Jiang W. PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer. Scientific Reports 2024;14(1) View
  862. Sharma A, Sharma G, Gao Z, Li K, Li M, Wu M, Kim C, Chen Y, Gautam A, Choi H, Kim J, Kwak J, Lam S, Shui G, Paul S, Feng Y, Kang K, Im S, Rudra D. Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells. Cellular & Molecular Immunology 2024;21(12):1474 View
  863. Zhang H, Liu C, Jin Y, Wang Z, Guan Y, Jia Z, Cui T, Zhang Z, Zhang X. Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF/JAK2/STAT3 axis. Frontiers in Pharmacology 2024;15 View
  864. Chen J, Cao W, Li Y, Zhu J. Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer. Medicine 2024;103(42):e40132 View
  865. Gomes J, Nicolau-Neto P, de Almeida J, Lisboa L, de Souza-Santos P, Ribeiro-Pinto L, Soares-Lima S, Simão T. HOXA7 Expression Is an Independent Prognostic Biomarker in Esophageal Squamous Cell Carcinoma. Genes 2024;15(11):1430 View
  866. Karaosmanoğlu O. Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts. Advances in Medical Sciences 2025;70(1):17 View
  867. Xu Y, Cai Y, Deng Y, He Y, Wu J, Chang S, Yan X, Wang J. RAC2 as a Tumor-Suppressive Biomarker Associated with T Cell Infiltration in Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals 2025;40(1):62 View
  868. Bakhshandeh S, Heras U, Taïeb H, Varadarajan A, Lissek S, Hücker S, Lu X, Garske D, Young S, Abaurrea A, Caffarel M, Riestra A, Bragado P, Contzen J, Gossen M, Kirsch S, Warfsmann J, Honarnejad K, Klein C, Cipitria A. Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Science Advances 2024;10(45) View
  869. Khan A, Ali S, Zahid M, Abdelsalam S, Albekairi N, Al‐Zoubi R, Shkoor M, Wei D, Agouni A. Exploring the Dynamic Interplay of Deleterious Variants on the RAF1–RAP1A Binding in Cancer: Conformational Analysis, Binding Free Energy, and Essential Dynamics. Proteins: Structure, Function, and Bioinformatics 2025;93(3):684 View
  870. Chen P, Wang H, Zhang Y, Qu S, Zhang Y, Yang Y, Zhang C, He K, Dang H, Yang Y, Li S, Yu Y. Construction of a Prognostic Model for Mitochondria and Macrophage Polarization Correlation in Glioma Based on Single‐Cell and Transcriptome Sequencing. CNS Neuroscience & Therapeutics 2024;30(11) View
  871. Jha V, Tripathi P. Selective hypothesis testing in cognitive IoT sensor network. The Journal of Supercomputing 2025;81(1) View
  872. Qian S, Liu H, Zhang M, Zhang L, Dai Y, Ye X, Wen W, Cheng R. Pan-cancer landscape analysis of NOP58 and its oncogenic driving role in lung adenocarcinoma. Scientific Reports 2024;14(1) View
  873. Maghool F, Kadkhodaei Elyaderani P, Mohammadzadeh S, Hosseini A, Heidari A, Samadi P. Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan-cancer analysis. Egyptian Journal of Medical Human Genetics 2024;25(1) View
  874. Luo Z. Role of SLC31A1 in prognosis and immune infiltration in breast cancer: a novel insight. International Journal of Clinical and Experimental Pathology 2024;17(10):329 View
  875. Chen Y, Wang M, Huang S, Han L, Cai Y, Xu X, Sun S, Chen Z, Chen J, Yu J, Du H, Li H, Zheng J, Ma B, Wang G. Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors. Pharmacological Research 2024;210:107506 View
  876. Sadaf , Zafar M, Massey S, Aloliqi A, Anwar S, Ali A, Hussain M, Bhardwaj T, Dev K. LATS2 and FAT4 as key candidate genes of hippo pathway associated with the risk and progression of breast cancer: an in-silico approach. Scientific Reports 2024;14(1) View
  877. Lee W, Song G, Bae H. In vitro and in silico study of the synergistic anticancer effect of alpinumisoflavone with gemcitabine on pancreatic ductal adenocarcinoma through suppression of ribonucleotide reductase subunit-M1. European Journal of Pharmaceutical Sciences 2025;204:106969 View
  878. da Silva E, Mesquita F, Pinto L, Gomes B, de Oliveira E, Burbano R, Moraes M, de Souza P, Montenegro R. Transcriptome analysis displays new molecular insights into the mechanisms of action of Mebendazole in gastric cancer cells. Computers in Biology and Medicine 2025;184:109415 View
  879. Zhao S, Chen H, Zhou Y, Wang Q, Liang X, Yang N, Yan L, Yang J. Six Transmembrane Epithelial Antigen 1 as a Prognostic Biomarker in Carcinomas: A Meta-Analysis. Frontiers in Bioscience-Landmark 2023;28(11) View
  880. Liu L, Yao Z, Liu Y, Li Y, Ding Y, Hu J, Liu Z, Shi P, Chen K, Liu Z, Zhang W, Hou Y. A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors. Genes 2024;15(12):1527 View
  881. Liao L, Zhang M, Xu X, Zhang S, Guo Y. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression. Frontiers in Bioscience-Landmark 2024;29(2) View
  882. Vo T, McNeela E, O’Donovan O, Rani S, Mehta J. Mechanism of miRNAs and miRNA-mRNA Regulatory Networks in Modulating Drug Resistance in HER2-Positive Breast Cancer: An Integrative Bioinformatics Approach. Cancers 2024;16(23):3962 View
  883. Dinh T, Rogg M, Cosenza‐Contreras M, Li M, Zirngibl M, Pinter N, Kurowski K, Hause F, Pauli L, Imberg F, Huynh A, Schmid M, Glavinsky I, Braun L, Van Wymersch C, Bergmann L, Ungefug X, Kunz M, Werner T, Bernhard P, Espadas G, Brombacher E, Schueler J, Sabido E, Kreutz C, Gratzke C, Werner M, Grabbert M, Bronsert P, Schell C, Schilling O. Proteomic analysis of non‐muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment. The Journal of Pathology 2025;265(1):41 View
  884. Liang J, Deng X, Zhang Y, Fei T, Ouyang M, Yu C, Xiang Y, Jia D, Duan F. Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications. Frontiers in Genetics 2024;15 View
  885. Ashok G, AlAsmari A, AlAsmari F, Livingstone P, Anbarasu A, Ramaiah S. Transcriptomic, mutational and structural bioinformatics approaches to explore the therapeutic role of FAP in predominant cancer types. Discover Oncology 2024;15(1) View
  886. Luo D, Fang M, Shao L, Wang J, Liang Y, Chen M, Gui X, Yan J, Wang W, Yu L, Fan X, Wu Q. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. Frontiers in Bioscience-Landmark 2023;28(10) View
  887. Song Y, Wang X, Ma R. Multi-omics uncovers the potential functions of transcription factor Dp-1 in human digestive cancers. Biomedical Signal Processing and Control 2025;101:107240 View
  888. Yao D, Deng Y, Zhang S, Liang L, Zhang L, Weng S, Chen S. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark 2023;28(5) View
  889. Nguyen K, Tran M, Rivera A, Cheng T, Windsor G, Chabot A, Cavanaugh J, Collins-Burow B, Lee S, Drewry D, Flaherty P, Burow M. MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Frontiers in Bioscience-Landmark 2022;27(5) View
  890. Zhu K, Lv Q, Lu X, Wang Y, Dai X. Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation. Free Radical Biology and Medicine 2025;226:364 View
  891. Wu T, Xiang M, Li Y, Gao Y, Teng D, Sun M, Guo W, Zhou Y. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology. Frontiers in Bioscience-Landmark 2023;28(12) View
  892. Xu J, Zhu Y, Liu Q, Xu C, Wang W, Sun J, Ding X, Liu B, Chen L. Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma. Oncology 2024:1 View
  893. Attaelmanan A, Alzubair S, Ahmmed A, Abdelgalil A, Ali F, Khalafalla A, Attaelmanan G, Alfaki M. A Comprehensive Pan-Cancer Analysis Reveals GRB7 as a Potential Diagnostic and Prognostic Biomarker. Cureus 2024 View
  894. Yu T, Li X. Clinical Trials of High-intensity Focused Ultrasound for Cancer: Concerns Arising from Low Post-Hoc Power. Current Medicinal Chemistry 2025;32(1):2 View
  895. Norouzinasab F, Salimian N, Mokhtari K, Akbari M, Maghsoudloo M, Entezari M, Taheriazam A, Farahani N, Hashemi M. Discovery of LINC01614 associated with the SPP1 gene in colorectal cancer. Pathology - Research and Practice 2025;266:155761 View
  896. Lu J, Yang L, Yang X, Chen B, Liu Z. Investigating the clinical significance of OAS family genes in breast cancer: an in vitro and in silico study. Hereditas 2024;161(1) View
  897. Balaji S, Anbarasu S, Ramaiah S, Anbarasu A. Targeting IKZF1 via HDAC1: Combating Acute Myeloid Leukemia. Integrative Biology 2024;16 View
  898. Wang S, Cui M, Zhou N, Tong M, Wu S, Li H, Cao Z. Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer. Scientific Reports 2024;14(1) View
  899. Shi N, Xia X, Chen Y, Ye Y, Tang X, Li Z. Bibliometrics analysis of IL-27 as a unique cytokine (2002–2023) and impact on cancer progression. Aging Research 2024;2(4):9340033 View
  900. Nasier-Hussain M, Samanje J, Mokhtari K, Nabi-Afjadi M, Fathi Z, Hoseini A, Bahreini E. Serum levels of oxidative stress, IL-8, and pepsinogen I/II ratio in Helicobacter pylori and gastric cancer patients: potential diagnostic biomarkers. BMC Gastroenterology 2025;25(1) View
  901. Alshwayyat S, Kamal H, Alshwayyat T, Alshwayyat M, Alkhatib M, Erjan A. Does Adjuvant Radiotherapy Enhance Survival in Intracranial Solitary Fibrous Tumor Patients?. World Neurosurgery 2025;194:123545 View
  902. Chen S, Luo X, Wang W, Chen X, Ma N, Zhu X, Zhou T, Gao Q, Zhao D. ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration. Scientific Reports 2024;14(1) View
  903. Chen X. Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation. American Journal of Translational Research 2024;16(12):7286 View
  904. Ungvari Z, Bartha Á, Ungvari A, Fekete M, Bianchini G, Győrffy B. Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types. GeroScience 2025 View
  905. Khan J, Bareja C, Dwivedi K, Mathur A, Kumar N, Saluja D. Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers. Scientific Reports 2025;15(1) View
  906. Wang R, Zhang W, Wu J, Chen W, Zhao M, Xu Y, Li X, Song J. Estrogen sulfotransferase SULT1E1 expression correlates with progression and prognosis of lung adenocarcinoma. Scientific Reports 2025;15(1) View
  907. Muchtar A, Onomura D, Ding D, Nishitsuji H, Shimotohno K, Okada S, Ueda K, Watashi K, Wakita T, Iida K, Yoshiyama H, Iizasa H. MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX. Frontiers in Microbiology 2025;15 View
  908. Kaya M, Abuaisha A, Suer I, Emiroglu S, Önder S, Onay Ucar E, Yenerel M, Palanduz S, Cefle K, Ozturk S, Kurt Z, Wang R. Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B. PLOS ONE 2025;20(1):e0307420 View
  909. Jiang F, Ahmad S, kanwal S, Hameed Y, Tang Q. Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in silico and in vitro study. Hereditas 2025;162(1) View
  910. Ding W, Han W, Shi C, Yao L, Liang Z, Zhou M, Wang H. Roles of the CDCA gene family in breast carcinoma. Science Progress 2025;108(1) View
  911. Dasgupta S. Multiplexed Molecular Endophenotypes Help Identify Hub Genes in Non-Small Cell Lung Cancer: Unlocking Next-Generation Cancer Phenomics. OMICS: A Journal of Integrative Biology 2025;29(1):8 View
  912. Jang J, Jung J, Kang H, Kim W, Kim W, Lee H, Cho J, Hong R, Kim J, Chung J, Chun K, Kim S. Kindlin-1 promotes gastric cancer cell motility through the Wnt/β-catenin signaling pathway. Scientific Reports 2025;15(1) View
  913. Zhang D, Zhang E, Cai Y, sun Y, Zeng P, Jiang X, Lian Y. Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment. Hereditas 2025;162(1) View
  914. Tan W, Dai F, Ci Q, Deng Z, Liu H, Cheng Y. Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer. BMC Women's Health 2025;25(1) View
  915. Zheng J, Gong J, Andreucci E. SLC1A4 Promotes Malignant Transformation of Hepatocellular Carcinoma by Activating the AKT Signaling. Analytical Cellular Pathology 2025;2025(1) View
  916. Wang T, Lei Y, Sun J, Wang L, Lin Y, Wu Z, Zhang S, Cao C, Wang H. Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment. Frontiers in Oncology 2025;14 View
  917. Yay F, Yıldırım H, Kuş F, Yalçın Ş. Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted therapy. Biomarkers 2025;30(2):147 View
  918. Zardab M, Roberts R, Hughes C, Imrali A, Saad A, Chelala C, Grose R, Kocher H. AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility. Scientific Reports 2025;15(1) View
  919. Sun M, Garnier L, Chevalier R, Roumain M, Wang C, Angelillo J, Montorfani J, Pick R, Brighouse D, Fournier N, Tarussio D, Tissot S, Lobaccaro J, Petrova T, Jandus C, Speiser D, Kopf M, Pot C, Scheiermann C, Homicsko K, Muccioli G, Garg A, Hugues S. Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma. Nature Communications 2025;16(1) View
  920. Kindt C, Ehmsen S, Traynor S, Policastro B, Nissen N, Jakobsen M, Hundebøl M, Johansen L, Bak M, Arbajian E, Staaf J, Ditzel H, Alves C. RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer. Frontiers in Oncology 2025;14 View
  921. Jin S, Liang L, Huang X, Wang K. The function and effect on prognosis of ANXA2 in gastric cancer peritoneal metastasis patients in cold region. Frigid Zone Medicine 2025;4(4):242 View
  922. Wang L, Deng X, Tang J, Gong Y, Bu S, Li Z, Liao B, Ding Y, Dai T, Liao Y, Li Y. Identification of EARS2 as a Potential Biomarker with Diagnostic, Prognostic, and Therapeutic Implications in Colorectal Cancer. ImmunoTargets and Therapy 2025;Volume 14:65 View
  923. Rodrigues-Junior D, Tsirigoti C, Psatha K, Kletsas D, Aivaliotis M, Heldin C, Moustakas A. TGF-β induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles. Journal of Experimental & Clinical Cancer Research 2025;44(1) View
  924. Bao Y, Cruz G, Zhang Y, Qiao Y, Mannan R, Hu J, Yang F, Gondal M, Shahine M, Kang S, Mahapatra S, Chu A, Choi J, Yu J, Lin H, Miner S, Robinson D, Wu Y, Zheng Y, Cao X, Su F, Wang R, Hosseini N, Cieslik M, Kryczek I, Vaishampayan U, Zou W, Chinnaiyan A. The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade. Cancer Discovery 2025;15(2):363 View
  925. Shreya S, Mohapatra D, Naik G, Kathait P, Malang S, Patel P, Shambhavi , Alam G, Sahu A. Cancer multi-omics-based differential expression analysis and prognostic potential of identified hub targets of myco-metabolites for breast carcinoma and lung carcinoma. Future Journal of Pharmaceutical Sciences 2025;11(1) View
  926. Wei S, Li Y, Zhou J, Xia Y. Exploring MAP3K genes in gastric cancer: biomarkers, tumor microenvironment dynamics, and chemotherapy resistance. Hereditas 2025;162(1) View
  927. Zhu W, Zhang Y, Yang L, Chen L, Chen C, Shi Q, Xu Z. Construction of a lung adenocarcinoma prognostic model based on KEAP1/NRF2/HO‑1 mutation‑mediated upregulated genes and bioinformatic analysis. Oncology Letters 2025;29(3) View
  928. Shan Z, Chen X, Chen H, Zhou X. Investigating the impact of Ras‐related protein RAB7A on colon adenocarcinoma behavior and its clinical significance. BioFactors 2025;51(1) View
  929. Deaver J, Ryan P, O’Reilly C, Uranga S, López S, Sheffield-Moore M, Nghiem P, Riechman S, Fluckey J. MCF7 breast cancer anabolic capacity reduced with CRISPR/Cas9-mediated stable overexpression of DEPTOR. American Journal of Physiology-Cell Physiology 2025;328(2):C670 View
  930. You J, Yu Q, Chen R, Li J, Zhao T, Lu Z. A prognostic model for lung adenocarcinoma based on cuproptosis and disulfidptosis related genes revealing the key prognostic role of FURIN. Scientific Reports 2025;15(1) View
  931. Karaman E, Yay F, Ayan D, Bayram E, Erturk S. The Clinopathological and Prognostic Significance of SPOCK1 in Gynecological Cancers: A Bioinformatics Based Analysis. Biology 2025;14(2):209 View
  932. Liu X, Liu J, Zeng Y, Qiao D, Wang Q. AL365181.3 as a novel prognostic biomarker for lung adenocarcinoma. Scientific Reports 2025;15(1) View
  933. Yang X. Contemplating the prognostic and therapeutic potential of CD19: a comprehensive analysis across diverse cancer types. American Journal of Translational Research 2024;16(11):6365 View
  934. Shu H. PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response. American Journal of Translational Research 2024;16(11):6346 View
  935. Xu J. Comprehensive analysis of the pituitary tumor-transforming gene (PTTG) family in lung adenocarcinoma: diagnostic, prognostic, and therapeutic implications. American Journal of Translational Research 2024;16(11):6326 View
  936. QADDOORI Y, AL-KHAFAJI A, KHASHMAN B, ABDULGHAFOUR K. The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients. Experimental Oncology 2025;46(4):393 View
  937. Kołakowska K, Kiśluk J, Nikliński J. A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer—State-of-the-Art Review and Future Perspectives. International Journal of Molecular Sciences 2025;26(5):1857 View
  938. Aslan E, Yavas C, Akcali N, Eslamkhah S, Meral G, Batur L. The functional correlation between mir-16-5p and BIRC5 gene in colorectal cancer: integrated analysis of transcriptomics and in vitro validation. Molecular Biology Reports 2025;52(1) View
  939. Huan Y, She P, Cai X, Qi J, Zhang C. Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification. Journal of the Egyptian National Cancer Institute 2025;37(1) View
  940. Nakayama H, Murakami A, Nishida-Fukuda H, Fukuda S, Matsugi E, Nakahara M, Kusumoto C, Kamei Y, Higashiyama S. Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2. Scientific Reports 2025;15(1) View
  941. Romero-López M, Jiménez-Wences H, Nuñez-Martínez H, Cruz-De la Rosa M, Alarcón-Millán J, Fernández-Tilapa G. Overexpression of miR-23b–3p+miR-218-5p+miR-124-3p differentially modifies the transcriptome of C-33A and CaSki cells and the regulation of cellular processes involved in the progression of cervical cancer. Computers in Biology and Medicine 2025;188:109886 View
  942. Dioguardi M, Musella G, Bizzoca M, Sovereto D, Guerra C, Laterza P, Martella A, Lo Muzio L, Di Domenico M, Cantore S, Ballini A. The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. International Journal of Molecular Sciences 2025;26(5):2183 View
  943. ZENG S, CHEN X, YI Q, THAKUR A, YANG H, YAN Y, LIU S. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma. Oncology Research 2024;32(2):261 View
  944. TANG Z, WANG L, WU G, QIN L, TAN Y. FGD5 as a novel prognostic biomarker and its association with immune infiltrates in lung adenocarcinoma. BIOCELL 2023;47(11):2503 View
  945. Zhao W, Sun J, Zhou B, Qiao H, Zhang J. Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target. Discover Oncology 2025;16(1) View
  946. Chien Y, Wu J, Liu L, Yu Y. Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis. Cell Death Discovery 2025;11(1) View
  947. Parmar G, Chudasama J, Shah A, Aundhia C, Kardani S. Targeting cell cycle arrest in breast cancer by phytochemicals from Caryto urens L. fruit ethyl acetate fraction: in silico and in vitro validation. Journal of Ayurveda and Integrative Medicine 2025;16(2):101095 View
  948. Bulliard M, Pinjusic K, Iacobucci L, Schmuziger C, Fournier N, Constam D. Kallikrein-8 mediates furin-independent Activin-A precursor processing to stimulate tumor growth in melanoma. Nature Communications 2025;16(1) View
  949. Tóth S, Kaszás D, Sónyák J, Tőkés A, Padányi R, Papp B, Nagy R, Vörös K, Csizmadia T, Tordai A, Enyedi Á. The calcium pump PMCA4b promotes epithelial cell polarization and lumen formation. Communications Biology 2025;8(1) View
  950. Chen Y. The role of Prolyl 3-Hydroxylase 1 (P3H1) in tumor development and prognosis: a pan-cancer analysis with validation in colonic adenocarcinoma. American Journal of Translational Research 2025;17(2):770 View
  951. Xu H, Zheng S, Zhang Q, Xu Y, Zhang H, Hu T, Zhang X, E J, Li X, Wang R, Liu H, Xie R. CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer. Cell Biology and Toxicology 2025;41(1) View
  952. Zhang L, Wang S, Wang L. Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma. Oncology Reports 2025;53(4):1 View
  953. Loganathan T, George Priya Doss C. Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis. Frontiers in Molecular Biosciences 2025;12 View
  954. Wada N, Sakai S, Inoue Y, Nishizuka M. Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2025;1872(4):119935 View
  955. Choppavarapu L, Fang K, Liu T, Ohihoin A, Jin V. Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therapeutic avenue. Cell Reports 2025;44(4):115450 View
  956. Liu C. Mechanistic insights into CDCA gene family-mediated glioblastoma progression: implications for diagnosis, prognosis, and therapeutic targeting. Hereditas 2025;162(1) View
  957. Shi Z. ATP7A as a prognostic biomarker and potential therapeutic target in gastric cancer. American Journal of Translational Research 2025;17(1):512 View
  958. Guo P, Dai T, Jin X, Wu H, Qiu S, Tang C, Feng S. MFAP2 promotes the malignant progression of gastric cancer via activating the PI3K/AKT signaling pathway. Journal of Receptors and Signal Transduction 2025:1 View
  959. Zhang T, Zhang Y, Wang X, Hu H, Lin C, Xu Y, Zheng H. Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy. Cancer Gene Therapy 2025 View
  960. Yan Z, Huang A, Ma D, Hong C, Zhang S, He L, Rao H, Luo S. ATP6AP1 promotes cell proliferation and tamoxifen resistance in luminal breast cancer by inducing autophagy. Cell Death & Disease 2025;16(1) View
  961. Huang S, Zhang J, He T, Zhou J, Liu Z. Midnolin Correlates With Anti‐Tumour Immunity and Promotes Liver Cancer Progression Through β‐Catenin. Journal of Cellular and Molecular Medicine 2025;29(6) View
  962. Huang H. Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy. American Journal of Translational Research 2025;17(2):1200 View
  963. Shoqafi A, Ali R, Lashen A, Jeyapalan J, Ibrahim A, Toss M, Rakha E, Algethami M, Alqahtani S, Mongan N, Ramotar D, Madhusudan S. Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers. International Journal of Molecular Sciences 2025;26(7):3239 View
  964. Nelson K, Reil K, Tsuji S, Parikh A, Robinson M, House C, McGuire K, Giacalone M. VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity. Molecular Cancer Therapeutics 2025;24(4):587 View
  965. Chen Y, Yang X, Li Q. PDLIM1 Inhibits Chemoresistance by Blocking DNA Damage Repair in Gastric Cancer. Recent Patents on Anti-Cancer Drug Discovery 2025;20(2):260 View
  966. Song H, Gao M, Bao Z, Yang Y, Chen Y, Hao J. Expression and clinical significance of ITGA3 in breast cancer. Open Medicine 2025;20(1) View
  967. Tan X, Wu C, Banerjee P, Wang S, Cardin D, Xu Y, Creighton C, Russell W. Dichotomous roles of ACBD3 in NSCLC growth and metastasis. Oncogene 2025 View
  968. Zhang Y, Li B, Li J, Zhao J, Li Y, Kang S. NDRG1/2 as a prognostic predictive biomarker of cervical cancer and its correlation with immune infiltration. Biomarkers in Medicine 2025:1 View
  969. Pawlak M, Kałuzińska-Kołat Ż, Pasieka Z, Kołat D, Płuciennik E. The critical role of COL1A1 revealed by integrated bioinformatics analysis of differentially-expressed genes in colorectal cancer and inflammatory bowel disease. Computers in Biology and Medicine 2025;190:110116 View
  970. Schwartz A, Chao G, Robinson M, Conley B, Ahmed Adam M, Wells G, Hoang A, Albekioni E, Gallo C, Weeks J, Yunker K, Quichocho G, George U, Niesman I, House C, Turcan Ş, Sohl C. Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor models. Journal of Biological Chemistry 2025:108477 View
  971. Li Z, Li X, Yang M, Pei X, Que T, Xian J, Jin H. DDX24 inhibits clear cell renal cell carcinoma progression by directly regulating AKR1B10. Cellular Signalling 2025;132:111804 View
  972. Torok Z, Garai K, Bovari-Biri J, Adam Z, Miskei J, Kajtar B, Sarosi V, Pongracz J. Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancer. Respiratory Research 2025;26(1) View
  973. McQueen S, Chin W, Cunliffe H, McDonald F. Stable overexpression of the epithelial sodium channel alpha subunit reduces migration and proliferation in breast cancer cells. Breast Cancer Research and Treatment 2025 View

Books/Policy Documents

  1. Ono K, Eguchi T. Chaperones. View